Dietary consumption, fluid consumption and risk of developing bladder cancer by Isa, Fatima
1 
 
DIETARY CONSUMPTION, FLUID 
CONSUMPTION AND RISK OF 




By                                                                                                                   





A thesis submitted to 
The University of Birmingham 
For the degree of 












College of Medical and Dental Sciences  
Health and Population sciences 
















This unpublished thesis/dissertation is copyright of the author and/or third 
parties. The intellectual property rights of the author or third parties in respect 
of this work are as defined by The Copyright Designs and Patents Act 1988 or 
as modified by any successor legislation.   
 
Any use made of information contained in this thesis/dissertation must be in 
accordance with that legislation and must be properly acknowledged.  Further 
distribution or reproduction in any format is prohibited without the permission 







This thesis focuses on three different parts: (1) An analyses of dietary consumption, diet 
diversity and risk of developing bladder cancer within a case-control study in China. 
This study showed that higher diet diversity, particularly a diet varied in fruit may 
reduce the risk of developing bladder cancer. In addition, there was a positive 
association between the consumption of red meat, organ meat, leafy vegetables, bulb 
vegetables or preserved vegetables may increase the risk of bladder cancer. The 
consumption of citrus fruits, stone fruits, vine fruits, flower vegetables, fresh fish, 
potatoes and dairy products may decrease the risk of developing bladder cancer. (2) A 
dose-response meta-analysis on the association between total fluid consumption and 
bladder cancer was conducted. The results of this study suggest a non-linear relationship 
between total fluid intake and bladder cancer risk in men.  Also, the findings indicates 
that low to moderate fluid consumption was not associated with an increased risk of 
developing bladder cancer; although fluid consumption exceeding 8 cups per day might 
increase the risk of developing bladder cancer. (3) A pooled analysis on fluid 
consumption and risk of developing bladder cancer using individual patient data from 
the Bladder Cancer Epidemiology and Nutritional Determinant consortium. The results 
suggest that excess consumption of coffee per day may increase the risk of developing 
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This thesis focuses on the association between dietary consumption, fluid consumption and 
bladder cancer risk. The overall structure of this thesis takes the form of six chapters 
including the introduction and discussion. Chapter one presents an overview and general 
background information including epidemiology of bladder cancer, current gaps in 
research into dietary consumption, fluid consumption and risk of developing bladder 




1.2 Anatomy and physiology of the urinary bladder 
The urinary bladder is a concave, muscular organ that is located within the lower part of 
the pelvis.1  The kidneys produce urine and the ureters transport the urine from the kidneys 
into the bladder.  The main function of the urinary bladder is to collect and store urine for 
excretion.2 The bladder can store approximately 500 millilitres for approximately two to 
five hours.3 The bladder is made up of a muscle called the ‘detrusor muscle’ which 
expands depending on the amount of urine accumulated. When the urinary bladder is full, 
the brain sends signals to the detrusor muscle to contract and excrete urine out through a 
tube called the urethra.4 In males, the urethra runs from the base of the bladder through the 
prostate gland and ends at the tip of the penis. In females, the urethra is shorter, straight 







Cancer is a heterogeneous group of diseases characterised by uncontrolled proliferation of 
abnormal cells.6 A tumour develops typically when cells proliferate in an uncontrolled 
manner, and if left untreated or diagnosed at a benign stage, the tumour might later 
progress into cancer. Each cell in the body contains genes that regulate cell division and 
differentiation. Alterations which occur in the DNA sequence within a gene is a natural 
process called mutation.7 The four types of genes most frequently implicated in the 
development of cancer are: (1) oncogenes, (2) tumour suppressor genes, (3) suicide genes 
and (4) DNA repair genes.8 The oncogenes stimulate cell growth, while the tumour 
suppressor genes are inhibitors of cell growth.8 The suicide genes carry out apoptosis or 
Figure 1.1: The urinary tract organs (male left – female right) 
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"programmed cell death" and during cell division, the DNA repair genes repair damages in 
the DNA sequence.7 Therefore, damage to one or more of these genes can lead to cancer. 
There are different types of cancers and the name of the cancer usually relates to the type 
of cells or the organ they originate from.  
1.4 Bladder cancer 
Bladder cancer is an abnormal growth of cells that emerges from the tissue of the bladder.9 
Bladder cancer may develop when urinary bladder cells undergo mutations in suppressor 
genes, for example the TP53 or RB1 gene,10 and FGFR or RAS oncogenes.11   Bladder 
cancer can be classified according to the extent which the cancer has spread into the wall 
of the bladder (stage) and the pattern of growth (grade) and also the type of cells that make 
up the tumour (morphology).  
1.5 Histology of the urinary bladder and staging 
The wall of the bladder is consists of four different layers: epithelium (bladder lining), 
lamina propria (connective tissue), muscularis propria or detursor muscle and perivesical 




The epithelium is the innermost lining of the bladder that comes into contact with the 
urine. The function of the epithelium is to prevent urine from being reabsorbed into the 
body. The epithelium is also referred to as transitional epithelium or urothelium and 
consists of multiple layers of transitional cells. The transitional cells are the cells lining the 
innermost part of the bladder.  
The layer below the epithelium is the lamina propria (connective tissue) which consists of 
connective tissue and blood vessels. Found within the lamina propria (connective tissue) is 
Figure 1.2: Four different layers of the wall of the bladder 
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the superficial layer of the muscle called the muscularis muscosae. Below the lamina 
propria is a layer of deep muscle known as the detursor muscle. The outermost layer is the 
perivesical soft tissue consisting of fats, fibrous tissue and blood vessels.13  
Urologists usually differentiate bladder cancer cases based on the histological 
characteristics of the bladder wall. The cells usually appear in three different shapes: 
cuboidal, flattened and umbrella. There are three main histological types of bladder cancer: 
transitional cell carcinomas, squamous cell carcinomas and adenocarcinomas. 
Approximately 90% of all diagnosed bladder cancers are transitional cell carcinomas and 
the remaining 10% are other types of bladder cancer which include squamous cell 
carcinomas and adenocarcinomas.14   
1.5.1 Tumour staging  
Bladder cancer can be divided into two types: non-muscle invasive bladder cancer 
(NMIBC) and muscle invasive bladder cancer (MIBC). The Tumour Nodes Metastases 
(TNM) classification system is widely used by clinicians to report the degree of cancer 
spread. The TNM classification system is used to evaluate cancer in three aspects: (1) 
extent and size of the tumour that developed in the bladder wall (T), (2) cancer spread to 
the regional lymph nodes near the bladder (N) and (3) distant metastases to adjacent 
organs, abdominal wall and pelvis (M).15 
Table 1.1 presents the staging of bladder cancer based on the TNM classification 7th 
edition from 2009.15 Confined to the epithelium and lamina propria are the Tis, Ta and T1 
tumours which are non-invasive or superficial tumours. The T2-T4 tumours are muscle 


























TABLE 1.1: TNM classification of bladder cancer 2009 
T-Primary  Tumour 
Tx Primary tumour cannot be assessed 
T0 No evidence of primary tumour 
Ta Non-invasive papillary carcinoma 
Tis Carcinoma in situ: ‘flat tumour’ 
T1 Tumour invades subepithelial connective tissue 
T2 Tumour invades muscle: 
T2a Tumour invades superficial muscle (inner half) 
T2b Tumour invades deep muscle (outer half) 
T3 Tumour invades perivesical tissue: 
T3a Microscopically 
T3b Macroscopically (extravesical mass) 
T4 Tumour invades any of the following organs: prostate, uterus, 
vagina, pelvic wall, abdominal wall 
T4a Tumour invades prostate, uterus or vagina 
T4b Tumour invades pelvic wall or abdominal wall 
N-Lymph  Nodes 
NX Regional lymph nodes cannot be assessed due to lack of information 
N0 No cancer in any lymph nodes 
N1 There is cancer in one lymph node in the pelvis (the lower part of 
the tummy, between your hip bones) 
N2 There is cancer more than one lymph node in the pelvis 
N3 There is cancer in one or more lymph nodes just outside the pelvis 
Metastasis  
M0 There are no signs of distant spread 
M1 The cancer has spread to distant parts of the body. (The most 




1.5.2 Tumour grading  
Tumour grading is described as the degree of differentiation of tumour cells.17 In bladder 
cancer, grading is based on the microscopic comparison of bladder cancer cells to normal 
bladder cells. The World Health Organization (WHO) has two grading systems (Table 
1.2); one developed in 1973, and the second subsequently updated in 2004, both grading 
systems are commonly used by oncologists and pathologists for reporting of the various 
grades of bladder cancer.18  Based on the 1973 grading system bladder cancer cells are 
graded as low, medium and high. For low grade cancers the cells are well differentiated 
and are confined in the bladder lining. In medium grade, the cells are moderately 
differentiated and may have started spreading to the muscle layer. For high grade cancers, 
the cells are poorly differentiated and grow very quickly and may have spread to the 
muscle layer of the bladder. The 2004 grading system is used to grade early bladder cancer 
and is divided into four groups: urothelial papilloma, papillary urothelial neoplasm of low 
malignant potential (PUNLMP), low-grade papillary urothelial carcinoma and high-grade 
papillary urothelial carcinoma.19 
 
Table 1.2: WHO grading in 1973 and 2004 
1973 WHO grading 
Urothelial papilloma 
Grade 1: well (low) differentiated 
Grade 2: moderately (medium) differentiated 
Grade 3: poorly (high) differentiated 
 
2004 WHO grading 
Urothelial papilloma 
Papillary urothelial neoplasm of low malignant potential (PUNLMP) 
Low-grade papillary urothelial carcinoma 





1.6 Symptoms of bladder cancer  
Bladder cancer can go undetectable for a long time due to the lack of clear symptoms in 
many patients. Painless haematuria is the presence of blood in the urine and is one of the 
most common indicators of bladder cancer.20 However, haematuria is often not detectable 
with the naked eye and only urine analysis may be able to identify the presence of blood in 
the urine. Patients may experience other symptoms such as vesicle irritation (i.e. burning 
sensation when passing urine), increased frequency or urgency of urination.20 
1.7 Diagnosis of bladder cancer 
At the early stage of a diagnosis of bladder cancer, approximately 70-80% of patients are 
typically diagnosed with non-invasive tumours and approximately 20-30% are typically 
diagnosed with muscle invasive tumours.21   
1.7.1 Cystoscopy 
Cystoscopy is recognised as the gold standard for diagnosis of bladder cancer. For this 
procedure, a thin light tube, with a camera called the cystoscope, is inserted into the 
bladder of the patient to examine the inside of the bladder wall for abnormalities.22 First, a 
local anaesthetic gel is applied to the urethra of the patient to facilitate insertion of the 
cytoscope. The cytoscope is then inserted via the urethra into the bladder. Despite the local 
anaesthesia used for this procedure, patients may still experience discomfort and distress. 
Other procedures for detecting bladder cancer that may be used by the urologist include 




A biopsy is conducted by the urologist after the cystoscopy procedure. During the biopsy 
procedure the patient is usually given a general anaesthetic and a small sample of the 
bladder tissue is removed. The pathologist then investigates the tissue for abnormal cells.23
29 
 
1.7.3 Urine cytology 
Urine cytology is helpful in detecting bladder cancer and potential bladder cancer 
recurrence(s) during follow-up of bladder cancer patients. Urine tests such as the Bladder 
Tumour Associated Antigen (BTA) test and Nuclear Matrix Protein 22 (NMP22) test are 
carried out to detect bladder tumours. The patients provide a sample of urine which is then 
examined for any abnormal cells. Urine cytology is not always 100% accurate because it 
detects abnormal cells that are not cancerous and in addition, has poor accuracy in 
detecting low-grade tumours.24 
1.7.4 Ultrasound and intravenous urogram 
Ultrasounds and intravenous urogram (IVU) are frequently used for identifying the 
presence of tumours in the bladder or urinary tract. The intravenous urogram is an X-ray 
that is used to examine the urinary system.25 There are also other procedures that may aid 
in the diagnosis of bladder cancer such as the computerised tomography scan and magnetic 
resonance (MR).26 
1.8 Treatment of bladder cancer 
1.8.1 Transurethral resection of the bladder tumour (TURB) 
Initial treatment for non-invasive bladder tumours usually consists of transurethral 
resection of the bladder tumour (TURB).27 Transurethral resection is a surgical procedure 
in which the urologist inserts a cystoscope and a resection instrument into the bladder 
through the urethra and removes any tumour tissue present from the bladder wall. Adjuvant 
treatments, such as Bacille-Calmate Guerin (BCG) and chemotherapy usually involving 
cytotoxic drug mitomycin, are typically used to eradicate any tumour cells that might 
30 
 
remain after the TURB. The adjuvant treatments given to patients with non-muscle 
invasive bladder cancer depend on the grade of the tumour.28 
1.8.2 Radical cystectomy 
Approximately 23–46%  of all patients who undergo a radical cystectomy can expect to 
survive at least five years from original bladder cancer diagnosis.29 Radical cystectomy is 
the standard treatment for patients diagnosed with muscle invasive bladder cancer.30 
Radical cystectomy involves the surgical removal of the entire bladder. In addition to the 
removal of the bladder in men, the prostate and seminal vesicles are usually removed. In 
women, the cervix, uterus, fallopian tubes, ovaries and the vaginal wall may also be 
removed.30 However, patients above the age of 75 years, who are more likely to have co-
morbidities such as cardiac diseases, and cannot have radical cystectomy may undergo a 
different treatment approach which involves a combination of radiotherapy and 
chemotherapy, usually cisplatin medication.31  
1.9 Epidemiology of bladder cancer 
1.9.1 Worldwide occurrence of bladder cancer 
In terms of cancer incidence, bladder cancer is the ninth most frequently occurring cancer 
worldwide.32 In 2012, approximately 429,000 new cases were diagnosed and 165,000 
deaths occurred worldwide.32 The incidence of bladder cancer varies across the world; the 
highest incidence rates are observed in countries in North America, Europe, North Africa 
and Middle East, while the lowest incidence rates are found within countries of Southeast 






Source: Globocan 2012. Available from: http://globocan.iarc.fr/Pages/Map.aspx 
 
 
Figure 1.3 Age-standardised Global incidence rates of bladder cancer per 100,000 
men per year in 2012 
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Figure 1.4  Age-standardised Global incidence rates of bladder cancer per 100,000 
men per year in 2012 
 
 




In developed countries particularly North America and Southern and Western Europe, the 
incidence of bladder cancer is much higher (5.5 and 20.7 per 100,000 per year in women 
and men, respectively) when compared to Asia and West African countries (1.3 and 3.8 per 
100,000 per year in women and men, respectively). In Europe and North America bladder 
cancer is the fourth most common cancer in men and ninth in women (Figure 1.5).  
Figure 1.5 Age-standardised (world) incidence and mortality rates for bladder cancer 




Source: Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. GLOBOCAN 
2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, 





The current estimated global prevalence of bladder cancer is 2.7 million cases.33 The 
prevalence of bladder cancer is also the highest of all urological cancers, with the 
prevalence of individuals who have survival at least 5 years from diagnosis bladder 
cancer.33  
Due to smoking cessation and reduction in occupational exposures to carcinogenic 
chemicals, the mortality rate of bladder cancer has declined in most European countries 
since the 1900’s.34 The mortality rate is stable in men currently, but has reduced 
considerably in women from 1997 through 2006 in the United States.35 As of 2012, 
mortality rates were lower compared to incidence rates; the highest age standardised 
mortality rates was observed in Western Asia (mortality rate approximately 8.4 per 
100,000 per year for men and 1.6 per 100,000 per year for women).32 
1.9.2 Incidence of bladder cancer according to gender 
Bladder cancer is the seventh most frequent cancer in men and 17th most frequent cancer in 
women worldwide. Globally, bladder cancer is three times more frequent in men than in 
women with an estimated male-female ratio of 3.8:1.0. In different geographical areas the 
male-female ratio of bladder cancer varies considerably: 5.1:1.0 in Southern Europe, 
5.0:1.0 in North America, 1.1:1.0 in Eastern Africa and 2.1:1.0 in South Africa.36 Although 
men are more likely to develop bladder cancer, women generally have worse prognosis and 
survival rates.37 
1.9.3 Incidence of bladder cancer according to age 
Bladder cancer is more common in older people. Globally, the median age of developing 
bladder cancer for men is 69 years and 70 years for women.38 Approximately 90% of 
bladder cancer cases occur in people who are over 55 years of age.33 The incidence rate of 
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bladder cancer increases with increasing age. The incidence rate increases from 142 and 33 
per 100,000 men and women per year, respectively aged 65-69 years, to 296 and 74 per 
100,000 men and women per year, respectively aged 85 years and older, worldwide.37 
In the United Kingdom, for both men and women, the age-specific incidence rate increases 
gradually from the age of 50-54 years with a sharp increase beyond the age 60-64 years. 
The highest incidence is observed for the age group of 85 years and older (Figure 1.6).39 








1.9.4 Incidence of bladder cancer according to ethnicity 
The incidence and mortality rate of bladder cancer varies considerably according to 
ethnicity.40 For example, the age standardised incidence rates is higher amongst the 
Caucasian population (19.9-20.5 per 100,000 per year in men and 5.7-6.0 per 100,000 per 
yearin women) in comparison to the black population (5.6-9.6 per 100,000 per year in men 
and 1.5–3.7 per 100,000 per year in women). However, it was reported that the black 
population have a higher mortality rate.41 
1.10 The health and economic burden of bladder cancer 
Bladder cancer remains a great challenge for clinicians because patients diagnosed with 
Ta/T1 bladder tumours have a recurrence rate of approximately 75%. Patients diagnosed 
with metastatic bladder cancer have a very poor prognosis with a median survival rate of 
approximately 12-15 months.42 Bladder cancer is the most expensive cancer in terms of 
healthcare expenditure per patient because of lifetime ongoing cystoscopies and recurrent 
treatment episodes.43 In developed countries like the USA, the annual cost of healthcare for 
patients with muscle invasive bladder cancer can surpass $35 million.43 
1.11 Risk factors of bladder cancer 
Environmental factors (such as tobacco, infectious organisms) and internal factors (such as 
inherited mutations, hormones, etc.) can cause cancer. The established environmental  risk 
factors for bladder cancer include smoking, specific occupational exposures (e.g. aromatic 





Tobacco smoking is the principal risk factor of bladder cancer. Smoke from tobacco 
consists of different carcinogenic compounds such as arylamines, especially the 
carcinogenic agent 4-aminobiphenyl (4-ABP), N-nitroso mixes, heterocyclic amines, 
polycyclic aromatic hydrocarbons (PAHs), and epoxides.45 It has been reported that the 
population attributable risk of bladder cancer for tobacco smoking in men is approximately 
50-65% and 20-30% in women, since cigarette smoking is more common in men than in 
women.46 The risk of developing bladder cancer increases with duration of smoking, 
number of cigarettes smoked per day, and extent of inhalation.47  Long term exposure and 
high amount of smoking tobacco have been associated with the development of more 
aggressive tumours that can negatively affect prognosis.29 The risk of developing bladder 
cancer can be reduced by 40% through smoking cessation.48  
1.11.2 Occupational exposure 
Occupational exposure to carcinogenic chemicals is a major risk factor of bladder cancer. 
Previous studies indicate that approximately 20% of bladder cancer cases are due to work 
related exposure to carcinogens.49 Occupations such as industrial work in dye, rubber, 
textiles, paints, or leather factories have been indisputably associated with increased risk of 
developing bladder cancer.50 Exposure to chemicals such as benzenes and arylamines 
typically used in these occupations might increase the risk of developing bladder cancer. 
Other chemicals associated with an increased risk of developing bladder cancer are 
polycyclic aromatic hydrocarbons (PAHs) used in manufacturing industries for the 




1.11.3 Schistosomiasis of the bladder 
Schistosomiasis is caused by infection with a parasite known as Schistosoma haematobium 
and chronic infection can result in squamous cell carcinoma of the bladder. Chronic 
infection with Schistosoma haematobium is endemic in the Middle East and countries in 
North Africa with the highest prevalence in Egypt.51 Previous studies conducted in Africa 
reported that a high prevalence of infection with schistosoma haematobium is associated 
with a high incidence of squamous cell carcinoma of the bladder in Egypt compared to 
areas with low prevalence. Approximately 31% of bladder cancer incidences in Egypt are 
squamous cell carcinoma of which approximately 90% are muscle invasive.52 Squamous 
cell carcinoma is common in young and middle aged adults. 
1.11.4 Other risk factors   
There are other risks factors that might increase the risk of developing bladder cancer 
including family history of bladder cancer, treatment of prior tumours with chemotherapy 
and radiotherapy, and long-term or recurrent infections of the urinary tract.53 Additionally, 
it has been reported that diet may be a potential risk factor however, there is need for 
further research to be conducted as previous results have been inconsistent. 
1.12 Dietary consumption, fluid consumption and risk of developing bladder cancer 
Research has suggested that diet may influence the risk of developing bladder cancer since 
most compounds ingested through most food are excreted via the urinary tract which might 
come in contact with the urothelium of the bladder.49 A report from the International 
Agency for Research on Cancer (IARC) classified specific chemical compounds such as 
acrylamide,54 which can be found in starchy foods (e.g. potato crisp, crisp bread), and 
39 
 
heterocyclic amines55 found in cooked meat and fish, as potential human carcinogens. 
Total fluid consumption has been hypothesised to influence the risk of developing bladder. 
High consumption of total fluid may decrease the risk by diluting the urine and thereby 
reducing the time of exposure of carcinogens with the urothelium of the bladder through 
increased frequency of urination.56 On the other hand, a high total fluid consumption of 
specific fluid items such as alcohol or chlorinated tap water may elevate the risk of 
developing bladder cancer because these fluids may contain compounds that are known to 
have carcinogenic properties, for example, acetaldehyde and trihalomethanes (THM).57 
Findings from previous epidemiologic studies on the association between dietary 
consumption or fluid consumption in relation to bladder cancer risk have largely been 
inconsistent. Some studies reported that dietary factors or fluid consumption, such as 
higher consumption of meat or coffee, could increase the risk of developing bladder 
cancer,58-62 but other studies have demonstrated that fruit or vegetables or tea consumption 
could have a protective effect.63-67 
1.12.1 Meat consumption 
The result of a recent systematic review showed that higher consumption of pork, 
barbecued meat, and canned meat were associated with increased risk of bladder cancer.68 
The pooled results of a meta-analysis on meat consumption and bladder cancer risk 
suggested a significant increased bladder cancer risk with high consumption of red or 
processed meat.69 
1.12.2 Vegetables and fruits consumption 
 The effect of vegetable and fruit consumption on the risk of bladder cancer were 
summarised in systematic reviews and meta-analysis. 
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The results of a systematic review indicated that dietary consumption of carrots and 
cruciferous vegetables for example cauliflower, brocolli were associated with a decreased 
risk of bladder cancer.70 A meta-analysis exploring the effect of consumption of vegetables 
such as cruciferous vegetables in relation to bladder cancer, found that consumption of 
cruciferous vegetables can reduce the risk of bladder cancer.71 
1.12.3 Total fluid consumption 
A pooled analysis of  six case-control studies found that total fluid intake may also be 
associated with an increased risk of bladder cancer in men only.72 In a recent meta-analysis 
of 17 case-control studies and four cohort studies, an odds ratio (OR) of 1.06 (95 
confidence interval [95% CI]: 0.88-1.27) was found. In the Harvard Health Professional 
study, an inverse association between total fluid consumption and risk of developing 
bladder cancer was found. Only a few studies have investigated the effect of total fluid 
consumption on bladder cancer according to smoking; hence there is need to investigate 
this topic more comprehensively. 
1.12.4 Dairy products consumption 
Some studies have suggested that the consumption of skimmed milk is associated with a 
significantly reduced risk of bladder cancer,73 but others have suggested that the 
consumption of fermented milk products, such as yoghurt and sour milk may play a role in 
reducing the risk of developing bladder cancer as these products contains lactic acid 
bacteria.63, 74, 75 A recent meta-analysis suggested that high consumption of milk was 
significantly associated with a decreased risk of developing bladder cancer. However, in 
another meta-analysis it was reported that consumption of milk is not significantly 
associated with the risk of developing bladder cancer.76
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1.12.5 Alcohol drinking 
Studies that evaluated the association between alcohol consumption and risk of developing 
bladder cancer generally reported no significant association; some studies found positive  
associations whilst other studies found  inverse associations.77 A meta-analysis of 19 
studies found no significant association between overall alcohol consumption and the risk 
of bladder cancer (OR=1.00, 95% CI: 0.89-1.10). However, when consumption of specific 
alcoholic drinks were investigated, beer consumption was inversely associated with the 
risk of developing bladder cancer (OR=0.86, 95% CI: 0.76-0.96) and the summary OR was 
0.89 (95% CI: 0.71-1.00) for wine consumption.   
1.12.6 Coffee consumption 
A review on coffee consumption and risk of developing bladder cancer found that a 
moderately high relative risk was observed in coffee drinkers in comparison to non-
drinkers.77 In a dose-response meta-analysis it was reported that subjects who consumed 4 
cups/day of coffee had an OR of 1.2 (95% CI: 1.12-1.48) when compared to non-drinkers 
of coffee.78 
1.12.7 Water consumption 
Consumption of chlorinated drinking water has been linked to bladder cancer risk. For 
example, tap water contains substances such as THM, which are known to have 
carcinogenic properties. A meta-analysis of eight studies found an elevated risk between 
consumption of chlorinated water and bladder cancer risk in men (summary OR=1.4, 95% 




1.12.8 Tea consumption 
A recent meta-analysis based on 24 studies reported a decreased risk of bladder cancer 
with high tea consumption in females (summary OR=0.61, 95% CI: 0.38-0.98).80 Another 
study found no significant association between tea consumption and bladder cancer risk, 
however, consumption of specific infusion drinks such as green tea showed a protective 
effect on bladder cancer.81 
1.13 Justification for this research project 
Previous research has suggested that 30% of all cancers could be prevented by dietary 
modifications.82 Therefore, there is need for continuous research to understand potential 
risk factors such as dietary and fluid intake in order to prevent and reduce morbidity and 
mortality of bladder cancer. It is important to focus in detail on the effect of specific food 
groups in relation to bladder cancer to better understand the role dietary and fluid 
consumption has in the aetiology of bladder cancer. 
The incidence of bladder cancer is much lower in China (1.5 and 3.6 per 100,000 in 
women and men, respectively) compared to developed countries in Europe and North 
America. The low incidence of bladder cancer observed in China relative to developed 
countries may be due to differences in dietary factors since the Chinese population 
generally has a different dietary pattern compared to the Western Caucasian population. 
The Western diet is known as the “meat-sweet diet” which typically comprises red meat, 
fried food and desserts compared with the Chinese diet which consists mainly of cooked 
vegetables, noodles, fruits and small amounts of meat. In spite of the potential effect of 




Previous epidemiological studies have reported inconsistent results regarding the 
relationship between diet and fluid consumption and risk of developing bladder cancer. 
The limitation of most previous individual studies has been the lack of statistical power to 
satisfactorily address the association between specific foods items and the risk of bladder 
cancer. There is a need to further conduct a comprehensive analysis to investigate the 
potential effect of dietary consumption and risk of developing bladder cancer. 
1.14 PhD project work 
The current thesis focuses on three different parts: (1) an analyses of dietary consumption, 
diet diversity and risk of developing bladder cancer within a case-control study in China, 
(2) a dose-response meta-analysis on the association between total fluid consumption and 
bladder cancer, and (3) a pooled analysis on fluid consumption and risk of developing 
bladder cancer using individual patient data from the Bladder Cancer Epidemiology and 
Nutritional Determinant consortium. 
1.15 Aims 
The principal aim of this thesis is to conduct a comprehensive investigation into the 
association between dietary consumption, fluid consumption and risk of developing 
bladder cancer. 
1.15.1 Objectives 
The specific objectives of the thesis were: 
• To investigate the role of dietary consumption and diet diversity on the risk of 
developing bladder cancer in a Chinese population 
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• To provide an update of previously published reviews and to perform a dose-
response meta-analysis summarizing the results from epidemiological studies on 
the association between total fluid consumption and risk of developing bladder 
cancer 
• To use individual patient data from previous studies to investigate the association 
between fluid consumption and risk of developing bladder cancer 
 
1.16 Outline of the thesis 
After the general introduction, the second chapter reports on the results of the analyses of a 
case-control study on the association between dietary consumption, diet diversity and 
bladder cancer risk in China. The third chapter reports on a dose-response meta-analysis on 
fluid intake and risk of developing bladder cancer. Chapter four describes the Bladder 
cancer Epidemiology and Nutritional Determinant (BLEND) consortium and describes the 
methods used for collection of individual patient data (IPD) on dietary intake from studies 
participating in BLEND. The fifth chapter describes a pooled analysis of individual patient 
data on fluid consumption and the risk of developing bladder cancer using data from the 
BLEND consortium. The final chapter provides an overall discussion of the main findings 
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Background - The epidemiologic evidence on the role of dietary consumption on the risk 
of bladder cancer in the Chinese population is limited. We investigated the role of dietary 
consumption and diet diversity on the risk of developing bladder cancer within a Chinese 
population. 
Method - A case-control study of 487 cases and 469 controls was conducted in four 
hospitals in China. A food frequency questionnaire was used to gather information on the 
consumption of 35 food items. Unconditional logistic regression models were used to 
derive odds ratios (OR) and corresponding 95% confidence intervals (95% CI) for the 
relationship between dietary factors, dietary diversity scores and bladder cancer. 
Results - The OR of bladder cancer for red meat (OR=1.8, 95%CI: 1.1-3.0; Ptrend=0.01), 
organ meat (OR=1.6, 95%CI: 0.9-2.9; Ptrend=0.04), leafy vegetables (OR=2.9, 95%CI: 1.6-
5.4; Ptrend=0.003), bulb vegetables (OR=2.3, 95%CI: 1.3-4.0; Ptrend=0.003) and preserved 
vegetables (OR=2.3, 95%CI: 1.2-4.2; Ptrend=0.02) were significantly increased when 
comparing the highest to lowest level of consumption. The OR for white fresh fish 
(OR=0.5, 95%CI: 0.3-0.9; Ptrend=0.004), citrus fruits (OR=0.4, 95%CI: 0.3-0.8; 
Ptrend=0.007), stone fruits (OR=0.4, 95%CI: 0.2-0.6; Ptrend<0.001), vine fruits (OR=0.5, 
95%CI: 0.2-1.0; Ptrend=0.02), flower vegetables (OR=0.3, 95%CI: 0.2-0.6; Ptrend<0.001), 
potatoes (OR=0.4, 95%CI: 0.2-0.9; Ptrend=0.005) or dairy products (OR=0.4, 95%CI: 0.3-
0.7; Ptrend<0.001) were significantly decreased when comparing the highest to lowest level 
of consumption. Subjects with the highest total diet diversity (OR=0.4, 95%CI: 0.2-1.1; 
Ptrend=0.02) and fruit diversity (OR=0.1, 95%CI: 0.0-0.3; Ptrend<0.001) had reduced OR 
compared to subjects with the lowest diversity. 
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Conclusion - Our results indicate that a diet with higher total diet diversity and in 




Bladder cancer is the ninth most common cancer globally1 accounting for approximately 
386,000 new cases and 150,200 deaths worldwide in 2008.2 The incidence of bladder 
cancer varies considerably across continents and countries. The age standardized incident 
rate of bladder cancer in China is lower (1.5 and 3.6 per 100,000 in females and males 
respectively) compared to Western regions such as Southern Europe and Northern America 
(6.4-4.1 and 27.1-24.1 per 100,000 in females and males, respectively).3 
Established risk factors for bladder cancer include tobacco smoking, specific occupational 
exposures (e.g. aromatic amines) and infection with Schistosoma haematobium.4 Diet may 
also influence the risk of developing bladder cancer since potential carcinogenic food 
compounds are metabolized and excreted as waste products through the urinary tract.5 
The World Cancer Research Fund (WCRF) reported in 2007 that findings from previous 
epidemiologic studies on the association between diet and bladder cancer have been largely 
inconsistent.6 Some epidemiologic studies reported that high intake of specific dietary 
factors such as meat (e.g. pork, processed meat),7-8 egg,9 or soy10 increases the risk of 
developing bladder cancer. It has been suggested that specific dietary factors such as 
fruit,11-12 vegetables,11, 13 fish,11 cereals,14 and yoghurt15 have a protective effect, whereas 
other studies reported no association.16-20 
To our knowledge, the epidemiologic evidence on the role of dietary consumption and the 
risk of bladder cancer in the Chinese population is limited.10, 21 Although some studies 
investigated the role of frequencies and quantities of dietary components and risk of 
developing bladder cancer in the Chinese population, to our knowledge, only one previous 
study investigated diet diversity22 and none have examined the potential role of diet 




The Chinese diet mainly consists of vegetables, noodles and fruits combined with small 
amounts of meat, whereas the Western diet mainly consists of red meat, fried food and 
desserts. Diet diversity may be a useful indicator of nutrient adequacy and has been 
associated with several cancers23 including those of the colon/rectum,24 oesophagus,25 and 
gastric,26 oral and pharynx27 areas. The principal aim of this study was to investigate the 






2.3.1 The South and East China case-control study 
We carried out a case-control study on bladder cancer between October 2005 and June 
2008 in four large public hospitals in South and East China. Each of the four hospitals 
provides services to large geographical areas-including metropolitan and rural regions. The 
methods of this study have been described in detail elsewhere.28 All incident bladder 
cancer cases (ICD-10 C67) admitted to the hospitals were approached for inclusion into the 
study. Eligible cases were frequency matched on sex and age (5-year age bands) to eligible 
controls. The hospital controls were selected from patients whose main diagnosis excluded 
the risk factors like smoking which is associated with bladder cancer risk. Therefore, 
controls had to be admitted to the same hospital for non-urological, non-cancerous and 
non-smoking related diseases (Table 1). The cases were treated the same as controls, cases 
with smoking related co-morbidity were excluded to minimize bias. The hospital controls 
were selected from patients whose main diagnosis excluded the risk factors like smoking 
which is associated with bladder cancer risk. In total, 541 incident bladder cancer cases 
fulfilled the inclusion criteria. Of these, 12 (2%) refused to participate and 42 (8%) were 
excluded because of insufficient amount of data available for analyses resulting in a total 
of 487 (90% response rate) bladder cancer cases. In total, 585 controls fulfilled the 
inclusion criteria. Of these 5 (<1%) refused to participate and 111 (19%) were excluded 
due to insufficient amount of data for analyses resulting in a total of 469 controls (80% 
response rate) available for analyses. Urothelial carcinoma was the most common type of 
bladder cancer (94%) followed by adenocarcinoma (3%) and squamous cell carcinoma 
(2%). Two cases had another type of bladder cancer. The study was approved by the 
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Medical Ethics Committee of each participating hospital and the Medicine Information 
Profession Committee of China (中国医药信息专业委员会).
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2.3.2 Method of dietary assessment  
Trained interviewers who were aware of the case-control status of the subjects used a food 
frequency questionnaire to gather information on the consumption of 35 specific food 
items within eight food groups. The eight food groups were (specific food items in 
brackets): dairy products (cheese and yoghurt), egg (preserved egg, eggs), fish (dark fish, 
white fresh fish, sea food, river fish, preserved fish), fruit (citrus fruits, stone fruits, soft 
fruits, fleshy fruits and vine fruits), grain (rice, noodles, pasta, bread), meat (meat, organ 
meat, chicken, other poultry, preserved meat), soy (soybean, soymilk, other soy products) 
and vegetable (sweet corn, potato, fruit vegetable, flower vegetable, leafy vegetable, stem 
vegetable, mushroom, root vegetable, garlic, onions, preserved vegetables). The questions 
about dietary consumption reflected the period of one year before the interview. The 
dietary intake of each food item was categorised into six levels: no intake or < 1 a month; 
1-3 times a month; once a week; 2-4 times a week, 5-6 times a week; or ≥ once a day.  
To derive the total number of food items consumed at least once a week, the diet diversity 
score was calculated as the sum of the total number of different food groups consumed, 
and the variety within a specific food group at least once a week.24, 26,22 Diversity within 
the food items was calculated for each food group with five or more food items with 
different nutritional components. In this calculation we considered a consumption of less 
than once a week as “nil” and a consumption of at least once a week as “one”. Thus, five 
different diversity scores were calculated: total diet diversity score (range 0-35), which 
counts the total number of different food items consumed at least once in a week; diet 
diversity score for fruit (range 0-5), which counts the total number of different fruit 
subgroups consumed at least once in a week; diet diversity score for fish (range 0-5), 
which counts the total number of different fish subgroups consumed at least once in a 
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week; diet diversity score for meat (range 0-5), which counts the total number of different 
meat subgroups consumed at least once in a week; and diet diversity score for vegetable 
(0-11), which counts the total number of different vegetable subgroups consumed at least 
once in a week. In addition, data were collected on socio-economic status (including level 
of education, income and occupation), lifestyle factors (including smoking and physical 
activity), medical history and demographic factors. 
 
2.4 Statistical analysis 
Unconditional logistic regression models were used to derive odds ratios (OR) and 
corresponding 95% confidence intervals (95% CI) for the relationship between dietary 
factors, dietary diversity scores and bladder cancer. Adjustments were made for the 
potential confounding effects of: gender, age, smoking status (never, former, current 
smoking), smoking duration (continuous variable), smoking frequency (continuous 
variable) and other food groups. The variables level of education, income source and total 
calorie were initially included in all models, but since results were unchanged, these 
variables were not included in the final models. All covariates were included as categorical 
variables except for smoking duration and smoking frequency which were included as 
continuous variables. The data on food items and diversity score were analysed using cut 
off points to create categories for different levels of consumption for each food item. Each 
category consisted of at least 20 cases and 20 controls. The reference category for all ORs 
was the lowest consumption category. 
For food items where the levels had ordinal properties, a likelihood-ratio test was used to 
derive a P-value for linear trend. To test for heterogeneity in the ORs across the four 
different hospitals, we also analysed the data using a random effects logistic regression 
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model. Similar results were obtained compared to the standard logistic regression model 
and therefore we only provide results relating to the standard logistic regression. Stata 
statistical software release 11 was used for all analyses.29 Statistical significance was 




2.5.1 Case and control characteristics 
The majority of the cases were male (80.7%) (Table 2.1). The mean age at recruitment was 
63.5 years for both cases and controls. Most of the cases (50.5%) and controls (56.9%) 
were within the age range of 60-79 years. Cases were more likely to be current smokers 
(40.2%) than controls (27.1%). Cases smoked cigarettes more often than controls and also 
smoked more cigarettes per day for more years than controls. The proportion of cases and 
controls was similar for each level of education although a slightly greater proportion of 
cases (32.8%) than controls (30.6%) had a primary school education. The proportion of 
controls was slightly higher compared to cases for each level of the variable “income 
source”, although a slightly greater proportion of cases (33.4%) than controls (26.1%) had 
pension as source of income.
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  No % No % Pvalue 
       
Sex Male 393 80.7 369 78.7  
 Female 94 19.3  100 21.3 0.45 
       
City of residence Guangzhou 215 44.1 223 47.4  
 Wuhan  71 14.6 105 22.3  
 Changsha 139 28.5 79 16.8  
 Hangzhou 62 12.7 63 13.4 <0.001 
       
Age (years)a <40 32 6.5 21 4.5  
 40-59 161 33.1 133 28.3  
 60-79 246  50.5 264 56.2  
 ≥80 48 9.9 46 9.8 0.79 
       
Smoking status Non smoker 179 36.8 219 46.7  
 Former smoker 112 23.0 123 26.2  
 Current smoker 196   
40.2 
   
127 
27.1 <0.001 
       
Smoking  durationb  Never 179 36.8 219 46.6  
(years) <20 38 7.8 31 6.6  
 20-39 130 26.7 107 22.8  
 ≥40 140 28.7 113 24.0 0.02 
       
Amount of cigarettes None 179 36.8 219 46.6  
(per day) 1-9  69 14.2 67 14.3  
 10-19  176 36.1 147 31.3  
 ≥20  63 12.9 37 7.9 0.004 
       
Educationc No formal schooling 22 4.5 42 8.9  
 Primary school 159 32.6 144 30.6  
 Junior school 120 24.6 123 26.2  
 Technical 104 21.4 85 18.1  
 Senior technical 36 7.4 41 8.7  
 University  44 9.0  34 7.2 0.07 
       
Control admitted Disease of circulatory 
system 
  67 14.3  
to hospital for Disease of digestive 
system 
  147 31.3  
 Disease of 
musculoskeletal system 
  41 8.7  
 Disease of respiratory 
system 
  31 6.6  
 Other disease   184 39.1  
       
Income Source Pension 154 33.4 122 26.1  
 Salary 58 12.6 44 9.4  
 Savings 31 6.7 43 9.2  
 Contributions from family 174 37.7 197 42.1  
 Other benefits 44 9.5 62 13.2 0.02 
       
adata on age was missing for 5 controls  
bdata on smoking duration was missing for 5 controls 
cdata on education level was missing for 2 controls 
ddata on income source was missing for 1 control 
62 
 
2.5.2 Meat, fish and egg products 
The OR of developing bladder cancer increased significantly with increasing consumption 
of red meat (Ptrend=0.01) and organ meat (Ptrend=0.04) (Table 2.2). Subjects who consumed 
red meat at least five times a week had a 2-fold increased OR compared to subjects who 
consumed meat less than once a week (OR=1.8, 95%CI: 1.1-3.0). Similarly, subjects who 
consumed organ meat at least three times a month or more had a nearly 2-fold increased 
OR of developing bladder cancer compared to subjects who never consumed organ meat 
(OR=1.6, 95%CI: 0.9-2.9). The consumption of white fresh fish was significantly 
associated with a decreased OR of bladder cancer (Ptrend=0.004). Subjects who consumed 
white fresh fish had 40% lower odds of developing bladder cancer compared to those who 
never consumed white fish (OR=0.6, 95%CI: 0.3-0.9).   
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TABLE 2. 2: Odds ratios and 95% confidence intervals of bladder cancer for meat, 
fish, and egg products consumption 
FOOD ITEM FREQUENCY NCASE/CONTROL ORa (95%CI) Ptrend 
Red meat  ≤1/week  67/71 1.0 (ref.)  
 2-4/week 260/270 1.2 (0.9-2.1)  
 ≥5/week 160/128 1.8 (1.1-3.0) 0.01 
     
Organ meat Never 55/73 1.0 (ref.)  
 <1/month 236/225 1.3 (0.8-1.9)  
 1-3/month 196/171 1.9 (1.1-3.1)  
 ≥1/week 61/60 1.6(0.9-2.9) 0.04 
     
Preserved meat Never 42/55 1.0 (ref.)  
 <1/month 313/281 1.6 (1.0-2.8)  
 1-3/month 131/133    1.7 (0.9-3.1)  
 1/week 37/38 2.2 (1.0-4.7) 0.09 
     
Chicken  <1/month    118/85 1.0 (ref.)  
 1-3/month 239/238 0.7 (0.5-1.2)  
 ≥1/week 129/146 0.9 (0.5-1.4) 0.69 
     
Other Poultry Never 20/24 1.0 (ref.)  
 <1/month 246/221 1.7 (0.9-3.6)  
 1-3/month 161/151 1.8 (0.8-3.9)  
 ≥1/week 60/73 1.1 (0.5-2.5) 0.53 
     
Dark fishb Never 253/220   1.0 (ref.)  
 <1/month 121/124 1.2 (0.8-1.8)  
 1-3/month 40/46   1.2 (0.6-2.2)  
 ≥1/week 72/79 1.2 (0.7-2.0) 0.51 
     
White fresh fishc Never 332/270 1.0 (ref.)  
 <1/month 105/125 0.6 (0.4-0.9)  
 ≥3/month 49/74 0.5 (0.3-0.9) 0.004 
     
Sea foodd Never 142/114  1.0 (ref.)  
 <1/month 217/201 1.0 (0.7-1.4)  
 1-3/month 122/96 0.8 (0.5-1.2)  
 ≥1/week 30/31 1.1(0.5-2.2) 0.49 
     
River fish ≤1 /week 243/237 1.0 (ref.)  
 ≥2-4/week 242/232 1.2 (0.9-1.6) 0.27 
     
Preserved fish Never 47/60 1.0 (ref.)  
 <1/month 309/260 1.7 (1.0-2.7)  
 1-3/month 109/87 1.1 (0.6-2.0)  
 ≥1/week 40/43 1.6 (0.9-1.6) 0.72 
     
Preserved egg Never 75/66 1.0 (ref.)  
 <1/month 296/269   1.2 (0.8-1.9)  
 1-3/month 84/90      1.2 (0.7-2.1)  
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   ≥1/week 31/44 0.9 (0.5-1.8) 0.932 
     
Egg 1/week 178/140 1.0 (ref.)  
 2-4/week 243/247 0.8 (0.6-1.2)  
 ≥5/week 66/82 0.6 (0.4-1.0) 0.06 
     
OR=odds ratio; ref=reference group; CI=confidence interval  
aadjusted for sex, age (categorical), smoking status (categorical), smoking duration (continuous), smoking 
amount (continuous) and other food groups 
be.g. mackerel, salmon, and tuna 
ce.g. carp, cod, and eel 
de.g. crab, cockles, lobster, octopus, prawn, and squid 
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2.5.3 Fruit products 
Significant inverse associations between bladder cancer and consumption of citrus fruits 
(Ptrend=0.007), stone fruits (Ptrend<0.001) and vine fruits (Ptrend=0.02) were observed (Table 
2.3). Subjects who consumed citrus fruits or stone fruits at least twice a week had a 60% 
reduction in the OR of bladder cancer relative to subjects who consumed citrus and stone 
fruits less than once a month (citrus fruits OR=0.4, 95%CI: 0.3-0.8; stone fruits OR=0.4, 
95%CI: 0.2-0.6). Subjects who consumed vine fruits at least five times a week had a 50% 
reduction in the OR of bladder cancer relative to subjects who consumed vine fruits less 
than once a month (OR=0.5, 95%CI: 0.2-1.0). 
TABLE 2.3: Odds ratios and 95% confidence interval of bladder cancer for fruit intake 
FOOD ITEM FREQUENCY NCASE/CONTROL OR a(95%CI) Ptrend 
Citrus fruitb <1/month 106/48 1.0 (ref.)  
 1-3/months 212/198 0.6 (0.4-1.0)  
 1/week 75/76 0.7 (0.4-1.3)  
 ≥2/week 92/147 0.4 (0.3-0.8) 0.007 
     
Stone fruitc ≤1/month 168/90 1.0 (ref.)  
 1-3/months 210/194 0.8 (0.5-1.2)  
 1/week 57/65 0.6 (0.4-1.1)  
 ≥2/week 51/120 0.4 (0.2-0.6) <0.001 
     
Vine fruitd ≤1/month 58/30 1.0 (ref.)  
 1-3/month 136/101 0.8 (0.4-1.4)  
 ≤4/week 234/257 0.6 (0.3-1.0)  
 ≥5/week 57/79 0.5 (0.2-1.0) 0.02 
     
Soft fruite Never 231/175 1.0 (ref.)  
 <1/month 148/152 0.9 (0.6-1.3)  
 1-3/months 75/83 0.9 (0.6-1.5)  
 ≥1/week 30/59 0.8 (0.4-1.4) 0.47 
     
Fleshy fruitf ≤1/month 47/28 1.0 (ref.)  
 1-3/month 161/137 1.6 (0.8-3.2)  
 1/week 50/66 0.8 (0.4-1.8)  
 2-4/week 194/187 1.8 (0.9-3.6)  
 ≥5/week 34/50 1.1 (0.5-2.5) 0.46 
     
OR=odds ratio; ref=reference group; CI=confidence interval  
aadjusted for sex, age (categorical), smoking status (categorical), smoking duration (continuous), smoking amount 
(continuous) and other food groups 
be.g. orange, lime, and grapefruit. 
ce.g. apricot, peach, lychee, cherry, and mango. 
de.g. raspberry, blueberry, and strawberry. 
ee.g. apple, papaya, pineapple, pear, and banana 
fe.g. grape and watermelon 
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2.5.4 Vegetable products 
The OR of developing bladder cancer decreased significantly with increasing consumption 
of flower vegetables (Ptrend<0.001) and potatoes (Ptrend=0.005) (Table 2.4). Subjects who 
consumed flower vegetables once or more per week had a 70% decreased OR of bladder 
cancer (OR=0.3, 95%CI: 0.2-0.6) compared to those who rarely consumed flower 
vegetables. The OR for subjects who consumed potatoes at least twice per week was 0.4 
(95% CI: 0.2-0.9) relative to those who consumed less than once a month or never 
consumed potatoes. However, the OR of developing bladder cancer increased significantly 
with increasing consumption of leafy vegetables (Ptrend=0.003), bulb vegetables 
(Ptrend=0.003) and preserved vegetables (Ptrend=0.02). The OR of bladder cancer for the 
highest category were 2.9 (95%CI: 1.6-5.4) for leafy vegetables, 2.3 (95%CI: 1.3-4.0) for 
bulb vegetables and 2.3 (95%CI: 1.2-4.2) for preserved vegetables.  
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TABLE 2.4: Odds ratios and 95% confidence interval of bladder cancer for vegetable intake 
FOOD ITEM FREQUENCY NCASE/CONTROL OR a(95%CI) Ptrend 
Sweet corn ≤1/month 180/156   1.0 (ref.)  
 1-3/month 244/226 1.5 (0.9-2.4)  
 ≥1/week 63/87 0.9 (0.5-1.6) 0.94 
     
Flower vegetablesb <1/month 101/38 1.0 (ref.)  
 1-3/month 227/231 0.4 (0.2-0.8)  
 ≥1/week  158/199 0.3 (0.2-0.6) <0.001 
     
Fruit vegetablesc ≤3/months 212/208 1.0 (ref.)  
 1/week  62/49 1.3 (0.7-2.3)  
 2-4/week 155/144 1.0 (0.6-1.7)  
 ≥5/week 57/68      0.9 (0.5-1.8) 0.72 
     
Leafy vegetablesd ≤3/months 191/214 1.0 (ref.)  
 1-4/week 151/132 2.8 (1.6-5.0)  
 ≥5/week 142/123 2.9 (1.6-5.4) 0.003 
     
Stem vegetablese Never 121/110 1.0 (ref.)  
 <1/month 136/99 1.0 (0.6-1.5)  
 1-3/month 107/119 0.7 (0.5-1.2)  
 ≥1/week 122/141 0.8 (0.4-1.3) 0.17 
     
Mushroom  <1/month 115/85      1.0 (ref.)  
 1-3/month 227/211 1.3 (0.8-2.1)  
 1/week 105/100  1.3 (0.8-2.3)  
 ≥4/week 39/73 0.7 (0.4-1.3) 0.56 
     
Rootsf <1/month  95/56 1.0 (ref.)  
 1-3/month 226/209 1.0 (0.6-1.6)  
 ≥1/week 163/204 0.8 (0.5-1.4) 0.44 
     
Garlic ≤1/week 138/118 1.0 (ref.)  
 2-6/week 94/104 0.8 (0.5-1.3)  
 1/day 253/247 0.9 (0.5-1.4) 0.50 
     
Bulb vegetablesg <1/month 124/120 1.0 (ref.)  
 1-3/month 210/203 1.4 (0.9-2.2)  
 1/week 70/69      1.5 (0.9-2.5)  
 ≥2/week 82/77  2.3 (1.3-4.0) 0.003 
     
Preserved vegetables Never 49/78 1.0 (ref.)  
 <1/month 267/243  2.0 (1.2-3.2)  
 1-3/month 77/93 2.2 (1.2-4.0)  
 ≥1/week  71/77 2.3 (1.2-4.2) 0.02 






























































 1-3/month 282/262 1.3 (0.7-2.2)  
 1/week 53/65      0.8 (0.4-1.5)  
 ≥2/week 36/69 0.4 (0.2-0.9) 0.005 
     
OR=odds ratio; ref=reference group; CI=confidence interval  
aadjusted for sex, age (categorical), smoking status (categorical), smoking duration (continuous), smoking amount 
(continuous) and other food groups 
be.g. broccoli and cauliflower 
ce.g. cucumber and tomato 
de.g. cabbage, lettuce, and spinach 
ee.g. asparagus and celery 
fe.g. carrot and radish 




2.5.5 Grain, soy and dairy products 
A significant inverse association was observed between increasing consumption of 
dairy products and bladder cancer (Ptrend<0.001) (Table 2.5). Subjects who consumed 
dairy products at least once a week had a 60% reduction in the OR of bladder cancer 
compared to subjects who never consumed dairy products (OR=0.4, 95%CI: 0.3-0.7).  
 
TABLE 2.5: Odds ratios and  95% confidence interval of bladder cancer for 
grain, soy, and dairy products consumption. 
FOOD ITEM  FREQUENCY NCASE/CONTR
OL 
ORa (95%CI) Ptrend 
Rice noodle <1/day 39/29 1.0 (ref.)  
  1/day 447/440 0.7 (0.4-1.3) 0.29 
     
Pasta Never 422/401    1.0 (ref.)  
 Consumption 65/68  1.1 (0.7-1.7) 0.59 
     
Bread Never 96/75      1.0 (ref.)  
 <1/month 97/75 1.2 (0.7-1.9)  
 ≤1/week 96/98     0.8 (0.5-1.3)  
 ≥4/week 198/221   0.7 (0.5-1.2) 0.12 
     
Soy bean curd <1/month 62/34      1.0 (ref.)  
 1-3/month 229/241 0.5 (0.3-1.0)  
 1/week 66/82 0.6 (0.3-1.4)  
 ≥2-4/week 129/112 0.7 (0.3-1.7) 0.82 
     
Soy bean milk <1/month 178/122 1.0 (ref.)  
  1-3/month 219/236 0.7 (0.4-1.3)  
 ≥1/week 89/111 0.5 (0.3-1.0) 0.13 
     
Dairy Products Never 87/66 1.0 (ref.)  
 <1/month 87/47 1.4 (0.8-2.4)  
 1/week 137/108 1.0 (0.7-1.7)  
 2-4/week 116/119 0.9 (0.6-1.5)  
 ≥ 1/week 63/129 0.5 (0.3-0.7) <0.001 
     
OR=odds ratio; ref=reference group; CI=confidence interval  
aadjusted for sex, age (categorical), smoking status (categorical), smoking duration 




2.5.6 Diet Diversity  
After adjustment for other food groups consumed, a strong inversely significant 
association was found between bladder cancer and total diet diversity (Ptrend=0.02) and 
bladder cancer and fruit diversity (Ptrend<0.001). Subjects who consumed at least 20 
different food items a week had a 60% reduction in OR of bladder cancer compared to 
subjects who consumed at least four different food items a week (OR=0.4, 95%CI: 0.2-
1.1). The OR of developing bladder cancer decreased substantially for subjects who 
consumed at least five different fruit items per week (OR=0.1, 95%CI: 0.0-0.3) (Table 
2.6). 
 
TABLE 2.6: Odds ratios (OR) and 95% confidence interval (95% CI) of bladder cancer in 
relation to cut-off points of diversity scores within specific food groups and total diet 
FOOD ITEM FREQUENCY NCASE/CONTROL ORa (95%CI) Ptrend 
Meat diversity Never 45/38 1.0 (ref.)  
 1/week 273/249 0.5 (0.2-1.0)  
 2/week 93/98 0.5 (0.2-1.1)  
 ≥3/week 74/85 0.3 (0.1-0.8) 0.07 
         
Fish diversity 0/week 149/137 1.0 (ref.)  
 1/week 253/240 1.1 (0.8-1.6)  
 2/week 51/41 1.9 (1.0-3.5)  









147/152 1.0 (ref.) 
 
 2-3/week 85/39 2.0 (1.1-3.6)  
 4-5/week 103/97 0.9 (0.5-1.6)  
 6-7/week 91/98 1.1 (0.5-2.1)  
 ≥8/week 55/83 0.8 (0.4-1.6) 0.21 
     
Fruit diversity  Never 124/83 1.0 (ref.)  
 1/week 97/72 0.7 (0.4-1.2)  
 2/week 98/84 0.4 (0.2-0.8)  
 3/week 94/95 0.3 (0.1-0.6)  
 4/week 55/92 0.2 (0.1-0.4)  
 5/week 14/41 0.1 (0.0-0.3) <0.001 
     
Total diet diversity ≤4/week 138/126 1.0 (ref.)  
     
 5-8/week 95/66 0.9 (0.5-1.5)  
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 9-12/week 98/92 0.6 (0.3-1.1)  
 13-16/week 106/68 0.4 (0.2-0.8)  
 ≥20/week 60/44 0.4 (0.2-1.1) 0.02 
     
OR=odds ratio, ref=reference group; 95%CI=95% confidence interval 
ORa= odds ratio adjusted for sex, age (categorical), smoking status (categorical), smoking 






2.6.1 Main findings 
In this study we found an inverse association between total diet diversity and bladder 
cancer risk and in particular between fruit diversity and bladder cancer. We 
demonstrated that consumption of citrus fruits, stone fruits, vine fruits, flower 
vegetables, white fresh fish, eggs, potatoes and dairy products may decrease the risk of 
bladder cancer in a Chinese population. We also found that consumption of red meat, 
organ meat, leafy vegetables, bulb vegetables and preserved vegetables may increase 
the risk of bladder cancer.  
2.6.2 Comparison with previous studies 
Our finding that diet diversity, and in particular fruit diversity, was associated with a 
lower risk of bladder cancer is in general agreement with the current literature on diet 
diversity and other cancers.24-26 Diet diversity is a combination of different food items 
that contain different food micro nutrients and compounds; for example, carotenoids, 
vitamin C and E, flavonoids and phytosterols are all known to have strong antioxidant 
and anti-carcinogenic properties.30 The only study that looked at the relationship 
between diet diversity, specifically vegetable and fruit diversity, and the risk of 
developing bladder cancer reported that there was no overall relationship between 
vegetable diversity or fruit diversity and risk of developing bladder cancer.22 
The positive association between red meat, organ meat, preserved meat and the risk of 
bladder cancer is consistent with most previous studies.11, 14, 31-33 In a recent meta-
analysis including ten cohort studies and eleven case-control studies, an increased 
bladder cancer risk was observed with high consumption of red and preserved meat.34 
Red and preserved meats contain compounds that are carcinogenic. It has been reported 
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that cooking meat at a high temperature may produce carcinogenic compounds such as 
heterocyclic amines and polycyclic aromatic hydrocarbons.35 Another constituent of red 
meat is heme (iron content) in red meat that produces free radicals in the colon that may 
damage DNA.36 Salt used to process meat contains nitrates/nitrites and amides that 
contribute to the formation of nitrosamines, which are known to be mutagenic and 
carcinogenic in animals.35 
Consistent with the current epidemiologic literature relating to fish consumption and 
bladder cancer risk, we observed a significant inverse association between consumption 
of white fresh fish and the risk of bladder cancer.11,37 However, most previous studies 
did not specify what type of fish was consumed because these studies were not 
primarily designed to examine the effect of fish consumption on bladder cancer risk. 
Fish is the main source of omega-3 fatty acids and has been shown to inhibit tumour 
growth as well as modulate the expression of pro-inflammatory genes.38  
Our findings in relation to fruits were generally consistent with previous studies.14,39-40 
A population-based case-control study of non-Asians in Los Angeles indicated a strong 
inverse association between consumption of citrus fruits and bladder cancer risk.39 
Another case-control study found that moderate consumption of stone fruits and vine 
fruits has a protective effect on bladder cancer risk.14 One prospective study reported 
inverse associations between consumption of carotenoid β-cryptoxanthin (mainly found 
in citrus fruits) and bladder cancer risk.40 In contrast with our findings, three previous 
studies found no association between citrus fruits or stone fruits consumption on 
bladder cancer risk.41-43 Fruits are a rich source of vitamin C, mostly known for its 
antioxidant property. Vitamin C can inhibit nitrosamine formation in vivo, inhibits 
mutagenesis and carcinogenesis in vitro and lowers tumour cell growth and carcinogen-
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induced DNA damage.44 Additionally, other components of fruit include, 
phytochemicals, dietary fibres and carotenoids, which are also known to be 
antioxidants, and have been shown to have anti-carcinogenic effects on bladder 
cancer.45 
Consistent with most previous literature, we observed an inverse association between 
consumption of flower vegetables (cruciferous vegetables) and bladder cancer risk. In a 
recent meta-analysis of five cohort and five case-control studies, a significant decreased 
risk was observed with overall consumption of flower vegetables (cruciferous 
vegetables).46 Vegetables are rich sources of isothiocyanates and also other compounds 
such as phytochemicals, dietary fibres and carotenoids. They are known to be 
chemopreventive agents with anticancer mechanisms, including stimulation of 
apoptosis, induction of carcinogen detoxification and arrest of cell cycle progression.47 
Besides flower vegetables, the consumption of potatoes was associated with a decreased 
risk of bladder cancer. The significantly decreased bladder cancer risk for consumption 
of potatoes has not been observed in other studies.41 Some studies detected that 
consumption of fried potatoes was significantly associated with increased risk of 
bladder cancer48 and our study reported a null association.41 
The significant elevated bladder risk for consumption of leafy vegetables in our data has 
not been observed previously.14,49 However, in China, the most common method of 
cooking leafy vegetables is lightly frying in little oil. High consumption of fried leafy 
vegetables has previously been associated with an increased risk of bladder cancer.12,14 
In the current study, subjects consumed leafy vegetables relatively commonly with an 
average consumption of three times a week. In addition, it has been reported that the 
high content of nitrate found in vegetables may play a role in the elevated risk of 
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developing cancer. Ingestion of nitrate compounds can be converted to nitrites via 
symbiotic bacteria of the oral cavity and this enhance the generation of N-nitroso 
compounds (e.g. nitrosamines), which are known to be carcinogenic in animals.50 
Consistent with two previous studies, the consumption of preserved vegetables (pickled 
vegetables) was associated with an increased risk of bladder cancer.12,14 
We found a positive association between consumption of bulb vegetables and bladder 
cancer risk. A case-control study contradicts our findings; this study suggested that 
consumption of bulb vegetables such as leek and onion is inversely associated with risk 
of bladder cancer.51 In another study it was reported that consumption of fried onions 
was positively associated with risk of bladder cancer.14 However, it is possible that 
cooking may destroy or reduce the nutritional components of vegetables.14 
Several studies have examined the relationship between the consumption of dairy 
products and the risk of bladder cancer,28,52,53 but results of these studies were generally 
inconsistent. A recently published meta-analysis of 19 studies examined milk 
consumption and bladder cancer risk and found a decreased risk of bladder cancer in the 
highest category compared with the lowest category of milk consumption. Several 
mechanisms could explain the inverse association observed in our study. Dairy products 
are the main source of dietary calcium and it has been reported that the reduced risk of 
cancer is partly associated with consumption of calcium.54 Another possible mechanism 
is that fermented dairy products contain lactic acid bacteria, which have been shown to 
suppress bladder cancer carcinogenesis.55 
2.6.3 Strengths and Limitations 
The strengths of this study include; a relatively large sample size and high response rate. 
To reduce interviewer bias, interviewers were rigorously trained in their interview 
76 
 
skills. An additional strength of our study was that we were able to control for potential 
confounders, such as smoking, that are known to influence bladder cancer risk. We 
cannot, however, entirely rule out the possibility of selection and non-response bias. 
However, since both the cases and controls came from the same underlying source 
population any selection bias should have been minimal. In fact, it is actually not 
necessary for cases and controls included in a case-control study to be representative of 
the general population as long as the controls represent the underlying source 
population that gave rise to the cases.56 Also, if any selection bias would have been 
introduced, the fact that we controlled for attained age, sex and smoking in our 
regression models, should have minimised any potential effect of such selection bias. 
The 81% response rate among the controls is not uncommon among similar case-control 
studies investigating dietary factors and risk of cancer. There is no reason to assume that 
the 19% of the controls that refused to participate are systematically different, in terms 
of the exposure under investigation and/or potential unmeasured confounding factors, 
from those who actually participated. Unfortunately, we do not have more detailed 
information on the cases and controls that refused to participate, but we did record 
reasons for non-participation. The most common reasons that subjects gave for not 
participating were: no direct benefit; not being in the mood; duration of interview was 
too long; worries about privacy; and wanting to receive results. None of these reasons 
are likely to be associated with the exposure under investigation (i.e. dietary factors) 
and thus non-response bias should be minimal. The FFQ contained only 35 food items 
therefore a more detailed analysis was not possible. We cannot rule out the possibility 
of recall bias although we tried to minimize recall bias by asking study subjects about 
their usual food consumption a year before the interview. 
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To investigate the potential bias that could be caused by including hospital controls with 
digestive disease we conducted a sensitivity analysis. No appreciable effect on the OR 
estimates was observed after including or excluding these controls. The interviewers 
were aware of the case-control status of the subjects, but they were not aware of the 
relationship between diet and bladder cancer, thus this is unlikely to have caused bias. 
In addition, the interviewers were trained for patient recruitment, informed consent and 
structured interviews. This training was repeated every six months. 
2.6.4 Conclusion 
To our knowledge, this is the first study to investigate the relationship between diet and 
bladder cancer in detail in China. Our results indicate that higher diet diversity and 
particularly a diet varied in fruit may reduce the risk of developing bladder cancer. 
These findings add to epidemiologic evidence that support the dietary guidelines for a 
more diverse diet.57 In addition, the consumption of citrus fruits, stone fruits, vine fruits, 
flower vegetables, fresh fish, potatoes and dairy products may decrease the risk of 
bladder cancer, whereas the consumption of red meat, organ meat, leafy vegetables, 
bulb vegetables or preserved vegetables may increase the risk of bladder cancer. 
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3.0 CHAPTER THREE 
Total fluid intake and the risk of developing bladder cancer: 
A dose-response meta-analysis 
 





Results from previous epidemiological studies evaluating the association between total 
fluid intake and bladder cancer (BC) risk have been inconsistent. We conducted a dose-
response meta-analysis to investigate the association between total fluid intake and 
bladder cancer risk. Fifteen case-control studies and three cohort studies with a total of 
10,678 BC cases were included. To quantify the dose-response relationship between 
fluid intake and bladder cancer risk, variance-weighted least squares and generalised 
least-squares trend estimation were used. Restricted cubic splines were used to 
investigate potential non-linearity in the dose-response. For men, significant non-
linearity in the dose-response (P<0.001) was found between total fluid intake and BC 
risk. Compared to six cups (250 ml was assumed as a standard metric cup of fluid 
intake) per day, the estimated RRs from the cubic spline model were: 1.06 (95%CI: 
1.03-1.09) for eight cups/day, 1.14 (95%CI: 1.08-1.21) for nine cups, 1.76 (95%CI: 
1.37-2.26) for 12 cups and 1.9 (RR=3.36, 95%CI: 1.90-5.26) for 16 cups. For women, 
no-significant linear relationship was found the overall pooled relative risk of bladder 
cancer for each increment in total fluid intake of 250 ml/day was 1.02 (95%CI: 0.98-
1.06). This meta-analysis suggests that in men the risk of bladder cancer increases 




Bladder cancer is the ninth most common cancer1  worldwide with an estimated 
386,000 incident cases and 150,200 deaths in 2008.2 The incidence rate of bladder 
cancer varies by approximately 10-fold across countries or geographical regions.3 The 
highest incidence rates of bladder cancer are found in developed countries of Southern 
Europe and Northern America compared to less developed regions such as Asia and 
Africa.4 In both Europe and the USA, bladder cancer is the fifth most common cancer.5 
Bladder cancer is three to four times more common among men than in women.6 Of all 
cancers, bladder cancer has the most expensive lifetime treatment per patient.7, 8  
Established risk factors for bladder cancer are tobacco smoking and exposures to 
occupational carcinogens. Tobacco smoking accounts for an estimated 50% of all 
bladder cancer cases.9 Occupational exposure to carcinogens account for an estimated 
20% of all bladder cancer cases.10 Particularly, dye workers, aromatic amines 
manufacturers and rubber workers are at risk of developing bladder cancer.11 Despite 
these established risk factors, the risk of bladder cancer cannot be fully explained; 
hence, it is important to identify additional potential risk factor of which total fluid 
intake is a potential candidate. 
Results from previous epidemiological studies on the association between total fluid 
intake and risk of developing bladder cancer have generally been inconsistent. Several 
possible mechanisms have been suggested by which total fluid intake could affect the 
risk of developing bladder cancer. On one hand, a high total fluid intake may decrease 
the risk by diluting the urine and thereby decreasing the contact time of carcinogens 
with the bladder through increased frequency of urination.12, 13 A high consumption of 
specific fluid items such as tea may also reduce the risk of bladder cancer as tea 
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contains polyphenolic compounds which are believed to have a protective effect.14-16 On 
the other hand, a high total fluid intake of specific fluid items such as alcohol17, 18 or 
chlorinated tap water19 may increase the risk of bladder cancer because these fluids may 
contain compounds like acetaldehyde and trihalomethanes, which are known to have 
carcinogenic properties.20, 21 In addition, high consumption of coffee may also increase 
the risk of bladder cancer as coffee has been classified as a possible carcinogenic agent 
(group 2A).22 In 2008, the WHO consultancy report23 on nutrition, fluid intake and 
bladder cancer concluded that out of 20 studies, six studies14, 19, 20, 24-26 found a 
significantly elevated risk with increasing total fluid intake, four studies12, 27-29 a 
significantly decreased risk, and 10 studies18, 30-38 did not show any significant 
association. Since the consultancy report in 2008, eight more studies investigated the 
relationship between total fluid intake and risk of developing bladder cancer.39-47 To our 
knowledge, the epidemiological evidence on the association between total fluid intake 
and the risk of developing bladder cancer has not been summarised quantitatively. The 
aim of this study was to perform a dose-response meta-analysis summarising the results 





The design, analysis and reporting of this meta-analysis was undertaken according to 
the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines.48 This meta-analysis was registered with the International Prospective 
Register of Systematic Reviews (PROSPERO, Reg no: CRD42012002568). 
3.3.1 Literature Search  
We conducted a systematic literature search to identify relevant epidemiological studies 
on total fluid intake and bladder cancer. We searched the following databases: Medline 
(Ovid/Pubmed) and Embase (Ovid). The time frame for the search was: Medline 1946 
to January 2014; Embase 1974 to January 2014; PubMed up to January 2014. No 
language restrictions were applied. We used the search terms: (Bladder cancer OR 
Bladder carcinoma OR Transitional cell carcinoma OR Urinary bladder neoplasm OR 
Urologic Neoplasm OR Urologic diseases OR Urologic Cancer OR Carcinoma OR 
Cancer OR Tumour) AND (Total fluid consumption OR Fluid consumption OR Total 
Fluid intake OR Fluid intake OR Drinking Behaviour OR Beverage Consumption OR 
Drinking) (Appendix 3.1). We reviewed the reference lists of identified research articles 
to identify other potentially relevant studies. We also searched for conference 
proceedings through the Biomed Central database, but no additional relevant abstracts 
were retrieved. We contacted some authors via email for further information and 




3.3.2 Inclusion and exclusion Criteria 
Studies had to fulfil the following inclusion criteria for inclusion in this meta-analysis: 
a) case-control or cohort study design; b) exposure had to be total fluid consumption; c) 
participants or study population had to be adults of at least 18 years of age; d) the 
primary outcome measure had to be bladder cancer; and e) studies had to report risk 
estimates (e.g. Relative Risk (RR), Hazard Ratio (HR) or Odds Ratio (OR)) with 
corresponding 95% confidence intervals (95% CI) of developing bladder cancer in 
relation to total fluid intake for at least three different categories of total fluid intake. If 
numerous published reports from the same study were obtained, we included only the 
most recent study with the most comprehensive information for total fluid intake and 
bladder cancer risk. 
3.3.3 Data extraction  
A data extraction sheet was developed to extract the following information from each 
study article: first author’s last name, year of publication, continent and country where 
the study was conducted, study design (case-control/cohort), number of cases and 
controls (for case-control studies), age range of subjects, covariates adjusted for in the 
analyses (e.g. smoking), measurement of total fluid intake (e.g. food frequency 
questionnaire), adjusted RR, HR or OR and corresponding 95% CI for the different 
levels of total fluid intake. Where these results were reported for males and females, 
both results were extracted. As bladder cancer is a rare disease, we assumed that ORs 
approximate RRs. Henceforth we used the phrase “relative risk (RR)” to synonymously 
refer to either an odds ratio (OR), hazard ratio (HR) or rate ratio.
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3.4 Statistical analysis 
In most identified study articles, total fluid intake was presented in categories with 
corresponding adjusted RR estimates for the different levels of fluid intake. Since 
various studies used different measurement units to report total fluid intake (e.g. oz, 
glasses, cups etc.) and to facilitate comparison of total fluid intake across studies, we 
converted the reported total fluid intake into millilitres (ml) per day as a standard 
measurement (assuming 250 ml as the standard metric cup) for each study. We then 
calculated the midpoint of the upper and lower boundaries in each category of fluid 
intake within each study. For open-ended categories, we assumed that the boundary had 
the same amplitude as the closest category. We then rescaled the midpoints of total fluid 
intake from millilitres to number of cups per day. 
In order to summarise dose-response data from individual studies, a two-stage approach 
was used. The Variance-Weighted Least Square (VWLS) method49, 50 was used to 
estimate, for each single study, a study specific regression slope through the (adjusted) 
log relative risks corresponding to the different levels of fluid intake, weighted by the 
variance of the log relative risk. At least three different categories of fluid intake were 
required from a single study to calculate a study specific regression slope and associated 
standard error with the VWLS method. The estimated study-specific regression slopes 
were then pooled into one overall slope using a random effects (inverse variance) meta-
analysis model. 
The advantage of the VWLS method is that it only requires adjusted RRs (and standard 
errors) from each study, however it assumes that the log RRs are independent (i.e. that 
the log RRs are not correlated with the reference group). To assess whether the results 
were sensitive to this assumption, we also used the Generalised Least-squares Trend 
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(GLST) estimation method49, 50 in which the correlations between each of the log RRs 
(within each study) are not assumed to be zero. The GLST method requires, in addition 
to the adjusted RRs associated with the midpoints for each category of fluid intake, the 
number of cases in each category of fluid intake and for case-control studies the number 
of control subjects and for cohort studies the person-time. The GLST method estimates 
the study-specific slopes and then combines the study specific slopes into one overall 
slope using a random effects meta-analysis. In the GLST analysis, three studies20, 39, 51 
were excluded due to insufficient data on the number of cases and controls.  
3.4.1 Potential effect modification, sub-group analyses, heterogeneity and 
sensitivity analysis 
Between-study heterogeneity was assessed using the I2 statistic, which quantifies the 
degree of variation attributable to between-studies. Sources of potential between-study 
heterogeneity were explored by stratifying analyses by gender, study design (i.e. case-
control/cohort) and whether the control ascertainment source was hospital-based or 
population-based. In addition, heterogeneity by factors such as continent, types of 
questionnaire and year of publication, and methods of adjustment of smoking status in 
primary studies in four groups (i.e. never smoked/former smoker/current smoker, never 
smoked/former smoker/current smoker (pack years), never smoked/former 
smoker/current smoker (smoking duration and smoking frequency) and pack years) 




3.4.2 Sensitivity analysis 
A sensitivity analysis was conducted by excluding the study of Pohlabeln et al.28 
because in this study 89.6% of the cases were diagnosed with urinary bladder cancer 
and the remaining patients were diagnosed with cancer of other sites of the genito-
urinary tract (ureter [n=3, 1.0%]; renal pelvis [n=11, 3.7%], urethra [n=5, 1.7%] and 
multiple localisations [n=12, 4.0%]). 
 
 3.4.3 Non-linearity in dose-response 
Potential non-linearity in the dose-response relationship of total fluid intake and risk of 
bladder cancer was explored by applying a restricted cubic spline with four knots 
located at the 5th, 35th, 65th and 95th percentile of the distribution of total fluid intake 
derived from the GLST method. Deviations from non-linearity were tested using a 
Wald-test comparing the model with the restricted cubic spline to a model assuming a 
linear dose-response relationship (i.e. null model). The Food Standards Agency (FSA) 
recommended that, in terms of climate, people who live in countries such as the United 
Kingdom and other countries with similar climate should consume 6 to 8 glasses of 
fluid every day,52 so we therefore used 6 cups (250ml) of fluid intake per day as the 
reference category. 
3.4.3 Publication bias 
Egger’s regression test on the slopes derived from the VWLS method was used to 
assess potential publication bias.53 All statistical analyses were conducted using Stata 
(version 12).54For the Egger’s test, a two-sided P-value of 0.10 was considered 
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statistically significant since the Egger’s test has low power; for all other tests a two-




3.5.1   Study selection  
Using the search strategy described, a total of 2,016 published articles were identified 
(Figure 3.1). Of these, 777 duplicate publications were excluded. The remaining 1,239 
articles were reviewed and 43 articles were retrieved based on title and abstract. Full 
texts were retrieved for all 43 articles and of these, 17 articles were excluded for the 
following reasons: two articles55, 56 were letters to a journal editor, six articles18, 23, 38, 40, 
57, 58 were systematic reviews, one article was a pooled analysis of six case-control 
studies19, six articles reported no information on total fluid intake and risk of developing 
bladder cancer,31, 59-62 and one article63 was a duplicate of another study. The population 




Figure 3.1: Flow chart for study selection for the dose-response meta-analysis on 
fluid intake and risk of developing bladder cancer  
Records identified through   
Medline, EMBASE, Pubmed 
(n = 2012)
Additional records identified 
through reference lists 
(n = 4)
Records before duplicates removed (n 
=2016) Duplicates removed (n=777)
Records screened (n= 1239) Records excluded (n =1196) based on title and abstract
Full-text articles assessed for eligibility 
(n= 43) 
Full-text articles excluded 
(n=17)
Reasons: Letters (n=2), not case-
control or cohort study (n=7), no 
information on total fluid intake (n=5), 
study abstract is the same with 
another study (n=1), updated study 
available (n=1)
Studies included in qualitative synthesis 
(n = 26)
Records excluded (n =8)
Reasons: insufficient information on 
RR estimates and total fluid 
consumption for different category  
Studies included in quantitative 
synthesis (dose-response meta-
analysis) 
(n = 18)  
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3.5.2 Characteristics of included studies 
We identified 26 published studies14, 20, 24, 26-37, 39, 41-47, 64 that assessed the relationship 
between total fluid intake and risk of developing bladder cancer. After examination, 
eight studies29-31, 34, 35, 37, 44, 45 were excluded because data on RR estimates and the total 
fluid intake at different categories was not available for pooling. Of the 18 included 
studies, three were cohort studies33, 39, 43 and 15 case-control studies.14, 20, 24-28, 32, 36, 41, 42, 
46, 47, 51, 64 Of the 15 case-control studies, seven were hospital-based26-28, 42, 47, 51, 64 and 
eight population-based.14, 20, 24, 25, 32, 36, 41, 46 Eight studies25-28, 33, 39, 51, 64 were conducted 
in Europe, eight studies14, 20, 24, 32, 36, 41, 43, 47 in USA and two studies in Asia42, 46 (Table 
1). One study46 was published in Chinese only; a native speaker  translated the article 
into English. Ten studies24-26, 28, 36, 39, 41, 42, 51, 64 reported the association between total 
fluid intake and risk of developing bladder cancer for men and women separately, and 
two studies20, 44 reported the association for men only.  
Table 3.1 shows the selected basic characteristics of the included studies. A total of 
10,678 bladder cancer cases were included in the current study. There were four times 
more male (n=8,740) bladder cancer patients than female (n=1,938) patients. In the 
included studies, total fluid intake comprised of consumption of various specific fluid 
items such as coffee, alcohol, juice, soft drinks etc. and varied across studies. Total fluid 
intake was generally higher in men than in women. All included studies controlled for 
the known risk factors tobacco smoking and age. Other confounders were adjusted for, 










































































Total fluid intake includes 
coffee, tea, beer, wine 
and high-proof spirits 
Smoking history: never smoked/ 
ever smoked (pack years) 


















































Total fluid intake includes 
coffee, tea, beer, soft 
drinks. 
Age, sex, smoking history: ever 

































Total fluid intake was 
calculated by adding 
together fluids from all 
sources 
Age, sex, smoking history: 
Never smoked/ex-
smoker/current smoker 
(pack years), history of diabetes 
and bladder cancer infections 









































Total fluid intake includes 
all non-alcoholic and 
alcoholic beverages. 
Smoking history: Never 
smoked/ ex-smoker/current 

















































351 855 35-90 Food 
frequency 
questionnaire 









Total fluid  intake includes 
all alcoholic beverages, 
bottled beverages, soda, 
milk coffee, tea, all juices 
and glasses of tap water 
Age, education, smoking 
history: pack years, coffee 













































Total fluid intake includes 
water, coffee, 
decaffeinated coffee, tea, 
diet, soft drinks, regular 
soft drinks, beer, wine and 
hard liquor 
Age, county and smoking 
history: never smoked/ ex-
smoker/ current smoker(pack 
years) 
































2.08 to <2.72 






2.08 to <2.72 













Total fluid intake includes 
beverages using tap 
water (water per se, 
coffee, hot and iced tea, 
reconstituted fruit juices, 
fruit drinks from powdered 
mixes and soups from 
concentrate or dry mix) 
and other beverages 
Age, sex, smoking history: 
never smoked/ ex-smoker/ 
current smoker(smoking 
frequency and smoking 
duration), study period, 











































Total fluid intake includes 
coffee, tea, beer, wine, 
water and other 
beverages 
Matched evaluation (sex,  age 
±5 year, area 1of residence), 
smoking history: never smoked/ 


















































































Total fluid intake includes 
water, coffee, tea, fruit 
juices/drinks, soups, milk, 
soft drinks, and alcoholic 
beverages. Non-drinking 
water items 
(i.e., milk, soft drinks, and 
alcoholic beverages) 
Age, smoking history: never 
smoked/ ex-smoker / current 
smoker (pack-years), education 
(<high school, high school, 
>high school),  
family history of bladder cancer, 
high risk occupation, 
years of chlorinated surface 
water, vegetable and coffee 
consumption 
10.Geoffroy-























































Total fluid intake includes 
non-alcoholic drinks such 
as tap water, coffee, tea, 
bottled water, juice, milk 
and alcoholic beverages 
such as wine and beer 
Age, centre, and place of 
residence and smoking history: 
never smoked/ ex-
smoker/current smoker (pack 
years) 
11.Zeegers et 
al . (2001) 
Europe The 
Netherlands 


















Total fluid intake includes 
fluids from 19 specific 
beverages 
Age, sex, smoking history: 
never smoked/ ex-smoker/ 
current smoker(smoking 
duration and smoking 
frequency), coffee 
consumption(ml/day), and tea 
consumption(ml/day) 
12.Michaud et 







397 664 20-80 Food 
frequency 
questionnaire 










Total fluid intake includes 
beverages- coffee, beer, 
wine, liquor, champagne, 
soda, juices, tea, milk, 
and water 
Age, sex, region, smoking 
history: never smoked/ ex-
smoker/ current smoker / 
occasional smoker, high-risk 
occupation, night time urination 
frequency, THM levels, and 
non-tap fluid for water intake 




































Total fluid intake includes 
water, coffee, tea, alcohol, 
milk, juice, hot chocolate 
and soda 
Matching factor(age sex and 
race), smoking history: never 
smoked/ ever smoked(smoking 
duration and smoking 


























































use of NSAIDs, intake of 















































Total fluid intake includes 
six non-alcoholic drinks 
were covered: black tea 
(fermented tea), green tea 
(non-fermented tea), fruit 
juice, milk, soft drinks and 
water. Three alcoholic 
drinks were covered: 




Age, sex, smoking history: 
never smoked/ ex-smoker/ 
current smoker (smoking 
frequency and smoking 
duration), level of education 
 
15.Zhang et 
al.  (2010) 
Asia China Case-
control 






Total fluid intake includes  
coffee, tea, sparkling 
water, plain water, beer, 
cider and chinese liquor 
Age, gender, smoking history: 
never smoked/ ever smoked, 
history of occupation with high 
risk, history of bladder 
infections, body mass index and 
alcohol intake 










































Total fluid intake includes 
the specific fluid variables 
(alcoholic beverages, milk 
and other dairy 
beverages, coffee, tea, 
herbal tea, water, fruit and 
vegetable juices and soft 
drinks) 
Age, sex, smoking history: 
never smoked/ ex-smoker/ 
current smoker (smoking 
frequency and smoking 
duration),centre, energy intake 
from fat and non-fat sources 







Cohort 823 N.A 40–75 Food 
frequency 
questionnaire 





1.37 (1.01, 1.85) 
1.16 (0.84-1.59) 
1.27 (0.92- 1.74) 
Total fluid intake includes 
22 beverage items 
Age, smoking history: never 
smoked/ ever smoked (pack 
years), geographic region, total 













































1.34 (0.96-1.87) intake, and intake of fruit and 
vegetables. 








1007 1299 N.D Food 
frequency 
questionnaire 









Total fluid intake includes 
water, decaffeinated tea, 
black tea, green tea, other 
herbal tea, soft drinks, 
coffee, alcoholic beverage 
Age, sex, smoking history: 
never smoked/ ex-smoker/ 
current smoker, ethnicity, 
energy intake 
N.A ─ Not applicable 




3.5.3 Dose-response meta-analysis 
We compared the results of the two the methods: Generalised Least-squares Trend 
(GLST) estimation method and Variance-Weighted Least Square (VWLS) method used 
for conducting this dose-response meta-analysis and since results were similar, we 
report the results from the VWLS method only. 
 
3.5.3.1 Overall analysis 
Fifteen studies14, 24-28, 32, 33, 39, 41, 42, 46, 47, 51, 64 reported the relative risks of bladder cancer 
for all subjects combined (i.e. males and females). Overall, a total of 10,678 bladder 
cancer cases were included in this dose-response meta-analysis. When we assumed that 
the relationship between fluid intake and bladder cancer was linear, but this was non-
significant. The overall pooled RR of bladder cancer for each increment in total fluid 
intake of 250 ml/day was 1.02 (95% CI: 1.00-1.04; Pvalue=0.12) (Figure 3.2); i.e., the 
risk of developing bladder cancer increased by 2% for each additional 250 ml of total 






Figure 3.2 Forest plot of relative risks (RRs) of bladder cancer for each 250 ml/day increase in total fluid 
intake for men and women combined. Squares represent the relative risk estimates for each study; the area of 
squares reflects the weight of the study i.e., the inverse variance; horizontal lines through each square represent the 
95% CI. The last columns include the estimated RRs and corresponding 95% CIs pooled across the levels of fluid 
intake estimated using VWLS (Variance-Weighted Least Square) method and their weights. The diamond represents 
the pooled RRs and 95% CI estimated using the random effects meta-analysis. 
 
3.5.3.2 Subgroup analyses 
Twelve studies20, 24-26, 28, 36, 39, 41-43, 51, 64 investigated the association between total fluid 
intake and risk of developing bladder cancer for men separately. For men, the pooled 
RR of bladder cancer for each 250 ml/day increase of fluid intake was 1.03 (95% CI: 
1.00-1.06; Pvalue=0.05) (Figure 3.3 (a)); i.e., the risk of developing bladder cancer 
increased by 3% for each additional 250 ml of total fluid intake per day. Ten studies24-26, 
28, 36, 39, 41, 42, 51, 64 examined the association between total fluid intake and risk of 
developing bladder cancer for women separately. The overall pooled RR of bladder 
cancer for women for each increase of 250 ml/day of fluid intake was 1.02 (95% CI: 
0.98-1.06; Pvalue=0.23) (Figure 3.3 (b)), but this relationship was not significant. 
NOTE: Weights are from random effects analysis 

































1.02 (1.00, 1.04) 
1.02 (0.99, 1.05) 
1.02 (0.98, 1.06) 
1.05 (0.99, 1.12) 
0.99 (0.96, 1.02) 
0.97 (0.90, 1.04) 
1.01 (0.99, 1.03) 
0.87 (0.80, 0.94) 
RR (95% CI) 
1.00 (0.95, 1.04) 
1.01 (0.99, 1.03) 
1.10 (1.06, 1.14) 
1.05 (1.03, 1.07) 
1.02 (0.98, 1.06) 
0.92 (0.88, 0.96) 
1.05 (1.02, 1.08) 






























Figure 3.3 A) Forest plot of RRs of bladder cancer for each 250ml/day increases in total fluid intake in men. 
B) Forest plot of RRs of bladder cancer for a 250 ml/day increase in total fluid intake in women. Squares 
represent the relative risk estimates for each study; the area of squares reflects the weight of the study i.e., the 
inverse variance; horizontal lines through each square represent the 95% CI. The last columns include the estimated 
RRs and corresponding 95% CIs pooled across the levels of fluid intake estimated using VWLS (Variance-Weighted 
Least Square) method and their weights. The diamond represents the pooled RRs and 95% CI estimated using the 
random effects meta-analysis. 
NOTE: Weights are from random effects analysis 
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In subgroup analyses by study design, we observed a significant increase in bladder 
cancer risk for population-based case-control studies (RR=1.03, 95%CI: 1.01-1.05, 
Pvalue=0.016), but no significant association for hospital-based case-control studies 
(RR=1.01, 95%CI: 0.95-1.07, Pvalue=0.708) or cohort studies (RR=1.00, 95%CI: 0.97-
1.03, Pvalue=0.877). 
In subgroup analyses by study continent, we observed a significant increase in bladder 
cancer risk for North America (RR=1.03, 95%CI: 1.01-1.05, Pvalue=0.002), but no 
significant association for Europe (RR=1.03, 95%CI: 0.99-1.07, Pvalue=0.203) or Asia 







Figure 3.4   A) Subgroup analysis according to study design (hospital based and population based case-
control studies, and cohort studies)—Relative risks (RRs) of bladder cancer for each 250ml/day increase in 
total fluid intake for men and women combined. Squares represent the relative risk estimates for each study; the 
area of squares reflects the weight of the study i.e., the inverse variance; horizontal lines through each square 
represent the 95% CI. The last columns include the estimated RRs and corresponding 95% CIs pooled across the 
levels of fluid intake estimated using VWLS (Variance-Weighted Least Square) method and their weights. The 
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Figure 3.4  B) Subgroup analysis according to continent (Europe, North America and Asia) —Relative risks 
(RRs) of bladder cancer for each 250ml/day increase in total fluid intake for men and women combined. 
Squares represent the relative risk estimates for each study; the area of squares reflects the weight of the study i.e., 
the inverse variance; horizontal lines through each square represent the 95% CI. The last columns include the 
estimated RRs and corresponding 95% CIs pooled across the levels of fluid intake estimated using VWLS (Variance-
Weighted Least Square) method and their weights. The diamond represents the pooled RRs and 95% CI estimated 
using the random effects meta-analysis. 
 
3.5.3.3 Sensitivity analysis 
We conducted a separate analysis excluding the study by Pohlabeln et al.28 because in 
this study 89.6% of the cases were diagnosed with urinary bladder cancer and the 
remaining patients were diagnosed with cancer of other sites of the genito-urinary tract. 
Excluding this study did not affect the RR of developing bladder cancer appreciably 
(RR=1.02, 95%CI: 1.00-1.05; Pvalue=0.11).
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 3.5.4 Meta-regression 
In meta-regression analysis, the association between total fluid intake and bladder 
cancer risk did not vary significantly when year of publication, method of fluid intake 
assessment, continent, study design and method of adjustment for smoking status in 
individual studies (i.e. never smoked/former smoker/current smoker, never 
smoked/former smoker/current smoker (pack years), never smoked/former 
smoker/current smoker (smoking duration and smoking frequency) and pack years) 
were explored by fitting these factors into a meta-regression model as effect modifiers 
(I2=88.28%) (See Appendix 3.2). 
3.5.5 Non-linear relationship between total fluid intake and bladder cancer risk 
When investigating potential non-linearity in the dose-response relationship between 
total fluid intake and risk of developing bladder cancer, we observed a J-shaped 
association between total fluid intake and bladder cancer risk in men (Figure 3.5). The 
P-value for the non-linear dose-response model was significant for men (P<0.001). The 
cubic spline model suggested that for very low fluid intake (<five cups a day) the RR 
was slightly increased compared to six cups of fluid intake per day, and that men who 
consumed eight or more cups of total fluid intake per day, had a higher risk of 
developing bladder cancer compared to six cups a day. Compared to six cups per day, 
the estimated RRs from the cubic spline model were: 1.06 (95%CI: 1.03-1.09) for eight 
cups/day, 1.14 (95%CI: 1.08-1.21) for nine cups/day, 1.76 (95%CI: 1.37-2.26) for 12 
cups/day, and 3.36 (95%CI: 1.90-5.26) for 16 cups/day. The non-linear dose-response 
relationship was not significant in women (Pvalue=0.260) (Figure 3.5). We did not 
examine the non-linear relationship in all subjects combined because seven studies did 
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not provide sufficient data such as the number of cases in each category of fluid intake, 








Figure 3.5 A) Dose-response modelled relationship between total fluid intake and risk of developing bladder cancer 
risk in women. B) Dose-response modelled relationship between total fluid intake and risk of developing bladder 
cancer risk in men. Total fluid intake was coded using restricted cubic spline with knots located at 5th, 35th, 65th and 
95th percentiles of the distribution of total fluid intake. The solid line represents the RR estimate of the association 
between total fluid intake and risk of developing bladder cancer; long dashed line represents 95% CI; Short dashed 
line represents best fitting cubic spline. We used 6 cups (250ml) of fluid intake per day as the reference category. 
The Pvalue for non-linear dose-response model for women was 0.260. The Pvalue for non-linear dose-response model 
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3.5.6 Publication bias 
There was no strong evidence of publication bias; Pvalues of Egger’s regression 





 3.6   Discussion  
In this dose-response meta-analysis we investigated the association between total fluid 
intake and risk of developing bladder cancer based on 10,678 bladder cancer cases. Our 
result suggests a non-linear relationship between total fluid intake and bladder cancer 
risk in men. The lowest risk appears to be in those who consume about six cups (of 250 
ml each) per day and the risk increases when fluid intake exceeds eight cups per day.  
3.6.1 Summary of results of included studies  
Several studies have suggested that total fluid intake is associated with increased risk of 
developing bladder cancer in men.14, 20, 25, 26, 47, 51 The result from the EPIC study 
reported  a slightly increased risk for each increase of 100 ml/day of total fluid intake 
per day which was slightly stronger in men than in women (HR=1.01, 95%CI: 1.00–
1.02) , although the results were not statistically significant.39 A previous pooled 
analysis of six case-control studies suggested that total fluid intake was associated with 
an elevated bladder cancer risk in men; the adjusted OR for one litre/day increase of 
intake was 1.08 (1.03-1.14).19 In 2008, the WHO consultancy report concluded that 
there may be an association between total fluid intake and bladder cancer risk, but it was 
unclear on the direction of the association and for which gender.23 All of the above 
mentioned previous studies are in agreement with the result of our meta-analysis 
although our meta-analysis is more up-to-date and no previous study explored potential 
non-linearity of the association.  
To our knowledge, this study is the first meta-analysis that examined the non-linear 
relationship between total fluid intake and bladder cancer risk in men. We found a 
significant non-linear relationship between total fluid intake and bladder cancer risk in 
men. We also noted that in most studies included in this analysis, men consumed more 
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fluid than women. The recommendation for daily total fluid intake varies across 
continents and countries. The European Food Safety Authority proposed that women 
should consume 1.6 litres (about six cups) of fluid per day and men should consume 2.0 
litres (eight cups) of fluid per day.65 The Food Standards Agency (FSA) recommended 
that, in terms of climate, people who live in countries such as the United Kingdom and 
other countries with similar climate should consume six to eight glasses of fluid every 
day.52 Whilst our work does not offer sufficient robust results to challenge these 
recommendations, it does suggest that further research is required before accepting that 
increasing fluid intake is part of healthy lifestyle advice. 
3.6.2 Biological mechanisms 
Our results should be interpreted cautiously; total fluid intake includes different fluid 
items such as water, alcohol, coffee, tea, soft drinks etc. Depending on what is 
contained in the fluid, it is difficult to pinpoint the carcinogenic role of total fluid intake 
on the risk of developing bladder cancer. Specific fluid items may contain different 
carcinogens and have different biological mechanisms that may play a role in the 
development of bladder cancer. Since the majority of carcinogens bind to DNA,66 it is 
possible that exposure of the bladder wall to carcinogens lead to binding with epithelial 
DNA which forms DNA adducts that initiate carcinogenesis. 
High intake of fluid has been hypothesised to increase the risk of bladder cancer by 
exposing the bladder to fluid items that have carcinogenic effects.13, 27 For example, 
depending on the source of water, tap water contains chemical pollutants such as 
trihalomethanes. It was found in a prior study that tap water may contain carcinogens 
such as disinfection by-products and arsenic in drinking water.20, 21, 27 High alcohol 
consumption might increase the risk of developing bladder cancer. Earlier studies 
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included in this meta-analysis have reported that high consumption of beer and coffee 
was associated with elevated bladder cancer risk.26, 51 Alcoholic drinks contain 
compounds such as acetaldehyde that has been classified as a carcinogen as it has been 
shown to cause damage to DNA.21, 67 Coffee contains compounds such as caffeine and it 
has been reported in animal studies that caffeine can stimulate or suppress tumours 
depending on the species and stages of administration.68                               
There are numerous plausible reasons for the stronger association between fluid intake 
and bladder cancer risk observed in men. Women are more likely to consume less fluid 
than men. The possible explanation for the observed J-shaped association between total 
fluid intake and bladder cancer in men may be due to the difference in the levels of 
drinking; men are more likely to drink more alcoholic drinks as compared to women.69 
The difference in gender may also be due to a lack of adequate data on total fluid intake 
and bladder cancer risk in women to establish an association.  
3.6.3 Strengths and limitations 
To conduct this dose-response meta-analysis, midpoints were assigned for each 
category of fluid intake within each study. It has been recommended by researchers that 
midpoints are the appropriate technique available for assigning exposure levels.70 It has 
however been proposed by Shi and Copas (2004), that a dose value based on dose 
distribution (normal) should be assigned rather than the midpoints.71 However, whilst 
potentially promising these methods are not without their drawbacks, primarily the 
assumption of normal distribution of the dose is untestifiable. These methods have not 
been adopted widely in applied applications (in part because they are not readily 
implementable in standard statistical packages). 
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The results between studies included in this dose-response analysis were heterogeneous 
and might not have been appropriate to pool in the overall analysis (even when using 
random effects analysis). The heterogeneity observed may be due to differences in 
population, geographical locations (USA, Europe and Asia), study designs, assessment 
method for smoking status and methods of fluid intake assessment. The different 
methods of fluid intake assessment used in most of the included studies were: food 
frequency questionnaire, standard questionnaire, semi-quantitative questionnaire, 
interviews and in-person interviews.  Different measurement units were also used to 
report total fluid intake in various studies. For all studies, total fluid intake was 
converted into ml/day as the standard measurement to facilitate comparison between 
studies. A meta-regression was conducted to explore the effect of study design, method 
of adjustment of smoking status in primary studies, year of publication, geographical 
location and various methods of total fluid assessment on heterogeneity. However, none 
of these potential confounding factors could explain the variation observed. The 
presence of heterogeneity might be due to unknown confounders that were not adjusted 
for in the individual studies; for example, genetic susceptibility, energy intake, 
measurement error, and cultural and lifestyle differences in different populations. On 
the positive side, we found that the I2 decreased in the subgroup analyses for women 
only, population case-control study only, cohort study only and studies conducted in 
North America only.  It is possible that publication bias may have occurred however the 
results from Egger’s test showed no strong evidence of publication bias.  
The observed association between total fluid intake and bladder cancer risk may be 
affected by methodological biases. Such biases may also account for the inconsistencies 
observed between the hospital-based and population-based case-control studies, and 
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case-control studies and cohort studies. Recall bias may be a potential drawback in case-
control studies; cases might tend to recall their fluid consumption differently compared 
to controls that are disease free and this may potentially bias the results of this study.  
However, it is unlikely that cases were aware or had knowledge about the hypothesis on 
the relationship between fluid intake and bladder cancer risk, hence any recall bias 
should have been minimal. Sensitivity analyses were also conducted; the use of hospital 
controls did not make any considerable variation on the odds ratios observed.  
In general, more studies have reported that fluid intake was associated with an elevated 
bladder cancer risk in men and not in women. However, one study that was conducted 
in China reported a decreased bladder cancer risk in men and not in women. This may 
reflect a true inversion of the association, or it may be due to some sort of bias.71 The 
quality of epidemiological studies has changed over time; therefore, it is possible that 
earlier studies might have poorer quality compared to recent studies. Also, the non-
linear relationship observed in men might be due to other residual factors or other risk 
factors that were not adjusted for in individual studies. On the other hand, we found that 
the I2 value decreased when the analysis included women only, population based case-
control studies only, cohort studies only and North American studies only.    
3.6.4 Conclusion  
In conclusion, we found a positive association between total fluid intake and risk of 
bladder cancer in men. In men, whilst low to moderate fluid intake was not associated 
with an increased risk, fluid intake exceeding eight cups per day increases the risk 
substantially. To our knowledge our study is the first study to observe the non-linear 
relationship between total fluid intake and bladder cancer risk in men.
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 4.0 CHAPTER FOUR 
The methodology of the BLadder cancer Epidemiology and 

























4.1 BLadder cancer Epidemiology and Nutritional Determinant (BLEND) 
Consortium  
 
The BLadder cancer Epidemiology and Nutritional Determinant (BLEND) study is the 
world’s largest consortium on dietary factors and risk of developing bladder cancer. 
This consortium promotes collaborative research by bringing together researchers with a 
background in bladder cancer and epidemiology from different parts of the world. The 
purpose of the consortium was to investigate comprehensively, the relationship between 
dietary factors and the risk of developing bladder cancer. 
 
The main objectives of the BLEND consortium were to: 
• pool individual patient data from previous observational studies on dietary 
nutritional factors and the risk of developing bladder cancer 
• create a database on dietary, nutritional factors and the risk of developing 
bladder cancer that will act as a resource for potential future studies 
• conduct comprehensive investigations into associations between dietary and 
nutritional factors and the risk of developing bladder cancer with the maximum 
amount of statistical power as is practically feasible 
 
This chapter describes the steps undertaken to set up the BLEND consortium. The steps 
were: 
• identifying available studies on dietary factors and bladder cancer 
• contacting other international consortia 
• define eligibility criteria for consortium participation 
•    identify potentially relevant studies and contact principal investigators 
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•     organise transfer of data  
•     create a code book 
•     harmonisation of data 
•     combining data sets to form a single master data set 
 
4.2 Identifying available studies on dietary factors and bladder cancer risk 
A computerised search through Pubmed (National Library of Medicine, Bethesda, 
Maryland) (1966–Sept 2009), and Embase (Elsevier B. V., Amderstam, the Netherlands 
(1974–Sept 2009), was conducted to identify published epidemiologic studies related to 
diet and bladder cancer. The search terms used to identify relevant articles were:  
(Bladder cancer OR Bladder carcinoma OR Transitional cell carcinoma OR Urinary 
bladder neoplasm OR Urologic Neoplasm OR Urologic diseases OR Urologic Cancer 
OR Carcinoma OR Cancer OR Tumour) AND (Dietary/diet consumption OR Total 
fluid consumption OR Fluid consumption OR Fruit consumption OR Vegetable 
consumption OR Fish consumption OR Fat or oil consumption OR Drinking behaviour 
OR Milk consumption OR Risk factors). 
Researchers were contacted in networks such as the International Bladder Cancer 
Network (IBCN) and the US National Cancer Institute initiated International 
consortium on bladder cancer (ICBC) to help identify additional studies conducted on 
diet and bladder cancer.
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4.3 Eligibility criteria for selection of studies 
To be included in the BLEND consortium, studies had to meet the following criteria: a) 
the study design had to be case-control or cohort study; b) cases had to be bladder 
cancer patients; c) the source from which controls were ascertained had to be 
population-based or hospital-based for case-control studies only; d) hospital controls 
had to be free from bladder cancer; e) have reported data on dietary consumption; and f) 
subjects included had to be 18 years or over.   
 
Figure 4.1 Flow diagram for relevant studies for the BLEND consortium 
Studies excluded (n=15) 
-10 case-control studies agreed to participate at the start 
and afterwards lost contacts  
- 5 cohort studies agreed to participate at the start and 
afterwards lost contacts  
 











   
     
Studies excluded pooled analysis (n = 28) 
Reasons for not participating 
-No contact information of investigators (n=15) 
-No funding to support this study to help translation of 
studies(n=2) 
-Not enough resources to do the work(n=6) 
-Studies with less than 40 cases were excluded from the study 
(n=5) 
 
Studies identified to include in the pooled analysis  
(n = 67) 
 
 
 19 case-control studies and 5 cohort studies agreed to transfer 








4.4 Study identification and contacting of principal investigators 
 
A total of 67 studies were identified that examined the association between dietary 
factors and the risk of developing bladder cancer. The Principal Investigator of each 
potentially eligible study was invited to participate in the BLEND consortium and was 
asked to provide relevant data, study questionnaires and codebooks. Investigators of 39 
studies agreed to participate, of which investigators of 24 studies provided complete 
data. Reasons why some investigators did not participate were: some investigators 
mentioned that their workload was already too high and with other investigators after 
the initial contact the communication was lost. (See appendix 4.1 for the list of  studies 
not included in the BLEND consortium)   
4.4.1 Participating studies 
In total, investigators of 24 studies agreed to participate in the BLEND consortium, 12 
studies1-12  were from Europe, eight10,13-19  from the USA and Canada, and four 20-22 
from Asia. Six studies2,5,8,13,16,17 have a population-based case-control design, 12 studies 
14,4,6,9-11,15,18,20-23 have a hospital-based case-control design, and six 1,3,11,12,19,24 a 
population-based cohort design. The list of participating studies, location of studies, 
period of recruitment, study design, number of cases and control (for case-control 





TABLE 4.1: Summary of participating studies in BLEND consortium 
Participating Study Country Recruitment 
Period 








In data  each data set 
1.Swedish Mammography Cohort (SMC) 
& the Cohort of Swedish Men 1 
Sweden 1997-2008 Population based cohort 688 Non cases 96 
2.Los-Angeles bladder cancer Case-
control study 13 





3.Roswell Park Cancer Institute 14 USA 1982-1998 Hospital-based case-control 275 (25) 
 
825(75) 44 
4.Belgian Case-control study on bladder 
cancer 2 
Belgium 1999-2004 Population based case-control 200 (34)  384 (66) 788 
5.Netherlands Cohort Study on diet and 
cancer 3 
The Netherlands 1986-2003 Population based cohort 941 Non cases 150 
6.Aichi Prefecture Case-control study 20 Japan 1996-1999 Hospital-based case-control 40 (7) 568 (93) 
 
107 
7.Kaohsiung Study 21 Taiwan 1996-1997 Hospital-based case-control 40 (20) 160 (80) 41 
8.Hessen Case-control study on bladder 
cancer 4 
Germany 1989-1992 Hospital-based case-control 300 (50) 300 (50) 26 
9.Stockholm Case-control study 5 Sweden 1985-1987 Population based case-control 273 (33) 553 (67) 188 
10.Roswell Park Memorial Institute Case-
control study on bladder cancer 15 
USA 1957-1965 Hospital-based case-control 585  
(6) 
8460 (94) 64 
11.Reina Sofia University 23 Spain 1997 Hospital-based case-control 85  
(40) 
130 (60) 17 
12.New England bladder cancer study 16 USA 1994-2001 Population based case-control 398 (55) 326 (45) 121 
13.Italian Case-control study on bladder 
cancer 6 
Italy 1985-1992 Hospital-based case-control 727 (41) 1067 (59) 21 
14.Brescia bladder cancer study 7 Italy 1992-1993 Hospital-based case-control 200 (48) 214 (52) 40 
15.North Rhine Westphalia study 8 Germany 1992-1995 Population based case-control 194 (45) 238 (55) 3 
16.National Enhanced Cancer 
Surveillance System (NESCC) 17 
Canada 1994-1997 Population based case-control 1028 (17) 5030 (83) 69 
17. Multicentre French case-control study France 1984-1987 Hospital-based case-control 201 326 2 
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9 (38) (62) 
18.South and East China Case-control 
study on bladder and prostate cancer 22 
China 2005-2008 Hospital-based case-control 483 (51) 464 (49) 52 
19.Molecular Epidemiology of Bladder 
Cancer and Prostate Cancer 18 
USA 1993-1997 Hospital-based case-control 197 (39) 314 (61)  90 
20.North Carolina case control study 10 USA 1987-1991 Hospital-based case-control 245 (53) 215 (47) 9 
21.Women's Lifestyle and Health Study 11 Norway, Sweden 1991-2006 Population based cohort 49 Non cases 98 
22.RERF atomic bomb survivors 24 Japan 1950-2000 Population based cohort 311 Non cases 102 
23.Vital study 19 USA 2000-2008 Population based cohort 330 Non cases 126 
24.European Prospective Investigation 
into Cancer and Nutrition (EPIC) 12 
Multiple centres in 
Europe 





4.5 Brief description of each participating study 
This section gives a brief description of the 24 participating studies. 
Swedish Mammography Cohort (SMC) & the Cohort of Swedish Men (COSM) (Swedish 
study) 
Subjects were recruited from the Swedish Mammography Cohort and Cohort of Swedish 
Men. In 1997, men and women between the ages of 45-85 years residing in central Sweden 
were asked to fill in a 96-item food frequency questionnaire. A total of 82,002 Swedish 
men and women who were cancer disease free were followed up for an average of 9.4 
years and 485 incident bladder cancer cases were identified form the Swedish Cancer 
Registries. The Regional Ethics Committee of Karolinska Institute gave ethical approval to 
conduct the Swedish study.1 
Los-Angeles bladder cancer case-control study  
The Los-Angeles bladder cancer study was a population-based case-control study 
conducted from 1987 to 1999. The study involved a total of 1,660 cases and 1,586 controls 
The cases were newly histologically confirmed bladder cancer patients amongst non-
Asians that were diagnosed between 1987 and 1999. The cases were selected from the Los 
Angeles County Cancer Surveillance Epidemiology and End Results Program (SEER 
registry). Controls were recruited from the same area of residence as the cases at the point 
in time when the cases were diagnosed with bladder cancer. Controls were frequency 
matched with cases based on gender, age (five year bands) and ethnicity (non-Hispanic 




Roswell Park Cancer Institute bladder cancer study 
The Roswell Park Cancer Institute study was a hospital-based case-control study involving 
275 incident bladder cancer cases and 825 controls. The cases were selected through the 
Roswell Park Center Institute Tumour Registry and 95% were transitional cell carcinoma 
and the remaining 5% were squamous cell carcinoma or adenocarcinoma. Controls 
subjects who were free from neoplastic conditions and treated for other diseases such as  
diseases of the circulatory system (12%), infectious and parasitic diseases (20%), disease 
of the genitourinary system (13%), ill-defined signs and symptoms (17%), benign 
neoplasms (8%), and other various conditions (28%), were recruited from the Roswell Park 
Cancer Institute. The participants were aged between 25-86 years and mostly Caucasians. 
To assess information about dietary intake, a 44-food frequency questionnaire was used.14 
Belgian case-control study  
The Belgian case-control study on bladder cancer was a population based unmatched case-
control study carried out in the Belgian Province of Limburg and included 200 cases and 
385 controls. Eligible cases were histologically confirmed with transitional cell carcinoma 
of the bladder between 1999 and 2004. The cases were identified from the Limburg Cancer 
Registry (LIKAR) and were contacted through general practitioners and urologists. To 
assess dietary consumption, a standard 788-item food frequency questionnaire was used.2 
Netherlands cohort Study  
The Netherlands cohort study was established in 1986 and included 120,852 men and 
women between the ages of 55-69 years who were followed up for 9.3 years (follow-up 
completeness was more than 95%). A total of 995 incident bladder cancer cases were 
identified through the cancer registries and the Dutch national database of pathology 
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reports (PALGA). Study participants were asked about their dietary consumption using a 
validated 150-item food frequency questionnaire.3 
Aichi Cancer Centre Japan Case-control study  
The Aichi cancer centre hospital case-control study was conducted in Japan between 1994 
and 2000. The study included 124 histologically confirmed urinary tract cancers, of which 
113 had cancer of the bladder, five renal pelvic cancer and six ureter cancer. A total of 620 
controls that were cancer free were frequency matched to cases on age (five year bands) 
and sex. A food frequency questionnaire was used to obtain information about participant 
food consumption.20 
Kaohsiung Taiwan study 
The Kaohsiung study in Taiwan was a hospital-based case-control study conducted 
between 1997 and 1998. This study involved 103 eligible patients with histologically 
confirmed bladder cancer. One hundred and three ophthalmic patients free from non-
neoplastic, non-urological renal and liver function diseases were recruited as controls. A 
structured questionnaire was used by trained interviewers to obtain information about 
dietary consumption.21 
Hessen case-control study  
The Hessen case-control study was a hospital-based case-control study carried out in 
Hessen, Germany, in 1989 to 1992. It involved 300 cases (61 females and 239 males) with 
histologically confirmed cancer of the lower urinary tract. The study included 300 controls 
that were matched with the cases based on sex, age and area of residence. Dietary 
consumption was measured using a food frequency questionnaire.4 
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Stockholm case-control study  
The Stockholm case-control study was a population-based case-control study conducted in 
Stockholm, Sweden between 1985 and 1987. Eligible subjects were individuals with no 
history of neoplastic disease of the urothelium before the study was initiated. Four hundred 
and eighteen cases were histologically confirmed with the lower urinary tract cancer 
(bladder, renal pelvis, ureter and urethra) at the beginning of the study. Cases were 
ascertained from the regional cancer registry and urologic departments in the county of 
Stockholm. Controls were selected from a computerised registry in the same population 
using random sampling. A 56-item food frequency questionnaire was used to assess dietary 
consumption in this study.5 
Roswell Park Memorial Institute bladder case-control study  
The Roswell park memorial institute study was a hospital-based case-control study 
conducted in New York, USA between 1982 and 1998. Four hundred and ninety-nine 
patients with histologically confirmed bladder cancer and 1,922 control subjects matched 
for age were included. The controls were admitted for non-cancerous diseases of the 
digestive system, genitourinary system, respiratory system and circulatory system. The 
subjects were mainly Caucasians and aged between 19-94 years. A 29-item food frequency 
questionnaire was used to assess dietary consumption of the subjects a year before 
diagnoses.15 
Reina Sofia University study 
Reina Sofia University study was a hospital-based case-control study among men 
conducted in Corboda, Spain. It involved 74 bladder cancer patients and 89 controls 
subjects admitted for non-urological diseases. An administered interview questionnaire 
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was used to assess dietary consumption.23 
New England bladder cancer study  
This study was a population-based case-control study conducted in New Hampshire, USA 
between 1994 and 2004. A total of 857 newly diagnosed bladder cancer patients, aged 25 
to 70 years were selected from the New Hampshire State Cancer Registry.  Controls were 
matched with the cases based on sex and age. The controls were recruited from centres for 
medical services and the department of transport in New Hampshire.16 
Milan and Pordenone case-control study  
The Milan and Pordenone case-control study was a hospital-based case-control study 
conducted in Italy between 1985 and 1992. Cases were recruited from two areas in Italy: 
greater Milan and province of Pordenone. It involved 727 histologically confirmed bladder 
cancer patients and 1,067 controls treated for non-neoplastic conditions or urological 
diseases, aged between 25-79 years. A structured questionnaire was used by trained 
interviewers to assess the information on dietary consumption.6 
Brescia bladder cancer study  
The Brescia bladder cancer study was conducted in Italy between 1992 and 1993. A total 
of 934 subjects were recruited from the same hospital: 355 were histologically confirmed 
bladder cancer patients and 599 control subjects were admitted for non-neoplastic diseases. 
Dietary consumption of participants was assessed using a structured questionnaire.7
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North Rhine Westphalia study  
This was a case-control study carried out in North Rhine Westphalia, Germany between 
1992 and 1995. Eligible participants were residents of North Rhine Westphalia, patients 
diagnosed with bladder cancer or prostate cancer, patients diagnosed before 1988 and with 
a specified year of first diagnosis. The cases were histologically confirmed bladder cancer 
patients (n=156) and the controls were prostate cancer patients who asked for after-care 
treatment (n=336).8 
National Enhanced Cancer Surveillance System (NESCC) Study 
The National Enhanced Cancer Surveillance System (NESCC) study was a population-
based case-control study conducted in Canada between 1994 and 1997. The participants 
were recruited from seven provinces: Newfoundland, Manitoba, Alberta, Nova Scotia, 
Saskatchewan, Prince Edward Island, and British Columbia. A total of 887 incident cases 
histologically confirmed with bladder cancer aged between 20-74 years were included in 
this study. From the same provinces random sampling was used to select controls and 
frequency matched cases based on age and gender (n=2,897). Physician consent was 
obtained before contacting patients.17 
 
Multicentre French case-control study  
The Multicentre French study was a hospital case-control study conducted in France 
between 1984 and 1987. This study involved 690 incident histologically confirmed bladder 




South and East China Case-control study on bladder and prostate cancer  
This South and East China case-control study was between 2005 and 2008. Participants 
were recruited in four hospitals: the first affiliated hospital in Hangzhou, Second Xiangya 
hospital in Changsha, the first municipal hospital Guangzhou and the Tongji hospital in 
Wuhan. This study recruited 432 cases histologically confirmed with bladder cancer aged 
40 years and over. Three hundred and ninety-two controls were recruited and frequency 
matched to cases by age and sex. Information on dietary consumption was ascertained by 
trained interviewers using a computerised questionnaire.25 
Molecular Epidemiology of Bladder Cancer and Prostate Cancer study 
The Molecular Epidemiology of Bladder Cancer and Prostate Cancer  was conducted in 
Memorial Sloan-Kettering Cancer Center (MSKCC) between 1994 and 1997 and was a 
hospital case-control study of 145 cases diagnosed with bladder cancer and 170 controls 
that were cancer free.  A standardised questionnaire was used to measure food 
consumption.18 
Duke University Medical Centre and University of North Carolina case-control study  
The Duke University Medical Centre and University of North Carolina case-control study 
was conducted between 1987 and 1991. Two hundred thirty cases and 203 frequency 
matched controls based on sex and age were enrolled in this study. The controls had no 
history of cancer except for non-melanoma skin cancer.10
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Women's Lifestyle and Health Study 
The women’s Lifestyle and Health Study was conducted in Sweden between 1991 and 
2006. This study included 47,921 women between the ages of 30-49 years. The cohort 
members were followed up for 16 years.11 
Atomic bomb survivors’ cancer study 
This was a cohort study of 120,321 participants that has been initiated since 1950 in Japan 
to examine the effect of atomic bomb radiation amongst survivors of atomic bombings. 
The participants were followed up and a total of 311 incident cases were identified.24 
Vital cohort study  
The Vital cohort study was conducted in Washington between 2000 and 2002. It involved 
77,719 participants between the ages of 50-76 years recruited from 13 counties. A total 330 
incident urothelial carcinoma cases were selected by SEER registry. A self-administered 
questionnaire was used to measure dietary consumption. The study was approved by the 
institutional review board of the Fred Hutchinson Cancer Research Center.26 
 
European Prospective Investigation into Cancer and Nutrition (EPIC)  
The European Prospective Investigation into Cancer and Nutrition study was a cohort 
study conducted in 23 centres in Europe. The centres were in 10 European countries: 
Denmark, France, Germany, Greece, Italy, The Netherlands, Norway, Spain, Sweden, and 
the United Kingdom. A total of 521,448 participants aged between 25-70 years were 
recruited in the study. The participants were followed for 9.3 years and 513 cases were 
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newly diagnosed with urothelial cell carcinoma. A 24 hour diet recall questionnaire was 
used to measure dietary consumption.27    
4.6 Data transfer 
The process of contacting principal investigators to obtain individual patient data from 
participating studies commenced in March 2009 (to date).  
The Principal Investigator (PI) of each potentially eligible study was invited to participate 
in the BLEND consortium and asked to provide relevant individual patient data, study 
questionnaires and codebooks for their study. To ensure secure data transfer and 
compliance with data protection, principal investigators were asked to sign a data release 
agreement form. After signing of the agreement form by the principal investigator of each 
study, the electronic data files including data sets, codebooks, data dictionaries and 
questionnaires were received by the BLEND team. A database was then set up to collate all 
data sets received from principal investigators. Each data set included anonymous 
information on bladder cancer patients (case-control status for case-control study), age of 
participants, demographics (such as age, sex, ethnicity, smoking history of subjects), 
family history of bladder cancer patients and dietary consumption. 
 
4.7 Number of cases and controls 
For several studies, the numbers of cases and controls did not completely match those 
reported in the associated publications. In two studies18,20 fewer cases were received, 
respectively 40 and 197 instead of 297 and 229. Four studies10,15,17,23 had more cases 
(respectively 585, 85, 1028 and 245 instead of 569, 74, 887 and 228). Another four 
studies15,17,18,20  received more controls (respectively 568, 8,460, 5,030 and 314 versus 295, 
1,025, 2,847 and 204). One study10 provided fewer controls (215 instead of 232). In total 
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we have 104 fewer cases less and 10,001 controls more compared to the numbers 
mentioned in the articles (Table 4.1). 
4.8 Assessment of dietary/nutritional consumption  
The food items assessed with the food frequency questionnaires (FFQs) varied widely. 
Whereas two studies8,9 only asked respectively about three and two specific food items, 
others assessed a full dietary assessment of 788 food items. The use of a validated FFQ 
questionnaire was reported in seven studies.1-3,11,12,16,19 Three studies1-3 reported food items 
in a quantitative manner. The EPIC study28 used a 24 hour recall questionnaire. After 
setting up a database, a codebook was developed which was used to help facilitate the 
management of the data sets (Figure 4.1). 
4.9 Codebook 
The codebook contained a list of variables such as study identification number, study 
design (cohort/case-control), bladder cancer cases-control status (for case-control studies), 
TNM classification of malignant tumour, gender, age at diagnosis of the participants, 
ethnicity, smoking status, smoking frequency and smoking duration, family history of 
bladder cancer patients and dietary consumption. All specific food (e.g. milk, egg, meat, 
fish, grains) and fluid (e.g. water, alcohol) items were categorised and coded based on the 
hierarchical Eurocode 2 Food Coding System which was developed by the project of 
Eurofoods Enfant. The Eurocode 2 Food Coding System was developed to serve as a 
standard instrument for nutritional surveys which improves comparability and quality in 
dietary consumption in Europe and studies on diet.  
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The codebook gives the description of what information is contained in the data sets. To 
combine and make the data sets in the database comparable, the codebook contained 
unique codes, and all data sets were re-coded based on the unique codes of the codebook.  
The codebook was created in an excel spread sheet and consisted of columns containing: a 
variable name, variable code, variable label and value label. A variable name was assigned 
to each variable with a variable label which shows the description of the variable and the 
content of each variable. For example, table 4.2 below shows the variable name was 
smoking with a unique variable code D01. The value label for D01 was tobacco smoking 
status, which was a categorical variable. Tobacco smoking had three value labels, 
1=current tobacco smoker, 2=former smoker and 3=never smoked. For more clarity and 
completeness of the codebook, missing and unknown data were assigned a value label, e.g. 
for missing and unknown data on tobacco smoking “.a” and “.b” was assigned, 
respectively. 





VARIABLE LABEL CODE  VALUE LABEL 
SMOKING D01 Tobacco smoking 
status 
1 Current tobacco smoker 
      2 Former tobacco smoker 
      3 Never tobacco smoker 
      .b Not known - data not 
asked 
      .a Missing data 
  D02 Cigarette smoking 
status 
1 Current cigarette smoker 
      2 Former cigarette smoker 
      3 Never cigarette smoker 
      .b Not known - data not 
asked 





The food items were grouped into 12 food categories in the Eurocode 2 food classification 
system:  
• Milk and  milk products 
• Egg and egg products 
• Meat and meat products 
• Fish and fish products 
• Fats and oils 
• Grain and grain products 
• Pulses, seeds, kernels and nuts products 
• Vegetables 
• Fruit and fruit products 
• Sugar and sugar products 
• Beverages (except milk) 
• Miscellaneous (includes soups and sauces) 
In the food classification system, each food group was further divided into subgroups and 
the subgroups into specific food items.  
In the codebook food items, food subgroup and food group were recorded in a similar 
manner as in the Eurocode codebook, for example, milk products: 
The food group was – milk and milk products 
Subgroup – liquid milk 
Food item – milk > 4% fat (whole milk) 
For example, in table 4.3 below, the food group is milk and milk products and subgroup is 
liquid milk and food item whole milk has a unique variable code, variable label and value 
label in portions, grammes, millilitres per week. Then, for each food group, subgroup and 
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food item, the unique variable code was assigned which starts with two letters “EC 
(Eurocode)” and six numeric values and ended with a “P (portion)” or   (grammes) or ML 
(millilitres). For example, the unique variable code for the food group milk and milk 
products was EC010000P (Milk and milk products in portions), EC010000G (Milk and milk 
products in grammes), EC010000P (Milk and milk products in millilitres). 
Food items that were not in the codebook were indicated as a miscellaneous food item and 
were coded slightly differently with an extra letter “X (miscellaneous)” before the letter 
“P” or “G” or “ML”. For example, miscellaneous milk items were coded as EC010100XP. 
The codebook is documented in appendix 2. 
 
 





VARIABLE LABEL   VALUE LABEL 
Milk and milk 
products 
EC010000P Milk and milk products in portions   Portions per week 
  EC010000G Milk and milk products in 
grammes 
  Grammes per week 
  EC010000ML Milk and milk products in 
millilitres 
  Millilitres per week 
  EC010100P Liquid milks in portions   Portions per week 
  EC010100ML Liquid milks in millilitres   Millilitres per week 
  EC010100XP Liquid milks-MISCELLANEOUS- 
in portions 
  Portions per week 
  EC010100XML Liquid milks-MISCELLANEOUS- 
in millilitres 
  Millilitres per week 
  EC010110P Milk >4% fat in portions   Portions per week 
  EC010110ML Milk >4% fat in millilitres   Millilitres per week 
                    
 
 
4.10 Harmonization of data (Quality control and data cleaning) 
After creating a codebook, the next step was carrying out harmonisation of data. The 
purpose of harmonisation of data was to improve comparability of different data collected 
from different independent sources to enable pooling of data. 
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The following steps were involved in harmonisation of data: quality control and data 
cleaning. All data management and cleaning was carried out using Stata software. 
 
4.10.1 Quality control 
Quality control is an important part in collaborative research; it is a process were data sets 
from each study are checked, monitored and maintained before the data sets are merged 
together into a single data set. Each data set was checked carefully and underwent 
extensive quality control to ensure that the data recorded are meaningful and reflect the 
actual details. The steps involved in quality control were: translations of data sets into 
English, decisions on missing or unknown values and data checking for errors. 
 
4.10.1.1 Translations data questionnaire into English 
A few data sets or questionnaire were not in English. The Reina Sofia University study 
reported the data set in Spanish; the principal investigator was contacted to help translate 
the data. The questionnaire of the Kaohsiung study in Taiwan was reported in Chinese; a 
native Chinese speaker was asked to translate the questionnaire to enable better 
understanding of the data.
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4.10.1.2 Decisions on missing and unknown values 
The data sets were checked to ensure completeness of values recorded. Missing and 
unknown data were occasionally missing in some data sets discussed with the BLEND 
team and principal investigators, and the data was updated accordingly for example in the 
Los Angeles Bladder Cancer Case-control Study the  number “8” was coded as unknown 
and number “99” was coded as missing . Missing values were agreed by the BLEND team 
to be coded as “.a”, unknown values “.b” and not applicable “.c” in all data sets. All these 
are Stata missing values in Stata. 
 
4.10.1.3 Data checking 
All data sets were double checked for possible coding errors. In two data sets, North Rhine 
Westphalia study and South and East China Case-control study two control subjects had 
data on bladder cancer staging, so it might have been actual bladder cancer cases. It was 
decided by the BLEND team to drop these controls from the data sets. Each data set and 
questionnaire was examined for inconsistencies, for example, the Multicentre French Case-
control study coding was not consistent with the data dictionary. 
4.10.2 Data cleaning 
Data cleaning was carried out after each data set had undergone extensive quality control. 
The do file is a Stata program which contains syntax code. First, do files for each study 
were created and ensured that all variables were re-coded based on the codes in the 
BLEND codebook. Within each do file all the variables were re-coded, labelled and the 
food items were converted into portions per week, if necessary. Then, checks were 
conducted using specific Stata commands such as “assert” to verify the codes and true 
values of each variable (See full details of all do files in appendix 4.2).
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 4.11 Combining / appending data sets  
Finally, all data sets that underwent extensive data cleaning and logical checks were 
merged into a single data set. The data set included data on 28,396 subjects where of which 
7,514 were cases and 28,396 were non-cases.   
4.12 BLEND team 
Three reseachers were working on the BLEND study: Mieke Goossens, Fatima Isa and 
Anke Wesselius. 
Mieke Goossens role was contacting the primary investigators for the transfer of individual 
patient data. My role (Fatima Isa) in the BLEND team was to help in creating the 
codebook and carrying out harmonisation of data for 19 case-control studies. I was 
involved in the day to day management of the data sets of the BLEND study.  I made sure 
all 19 case-control studies underwent thorough quality control, data cleaning and combined 
data sets into a single data set. For quality control, I checked all data sets and 
questionniares for inconsistencies to ensure that the data set transferred to the BLEND 
study was accurate. I contacted native speakers to translate the questionnaires written in 
other languages to English. Finally, I combined the re-coded data sets into a single data set.  




4.13 Part of my PhD Project work on BLEND study 
For the purpose of this PhD I focused on conducting a pooled analysis of 19 case-control 
studies. Therefore, the next chapter will focus on  the investigation on the  association 
between fluid consumption and risk of developing bladder cancer using data from the 
BLEND consortium. Also, only case-control studies have been included in this pooled 
analysis because individual patient data from cohort studies are still yet to be transferred 
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5.0 CHAPTER FIVE 
Fluid consumption and risk of developing bladder cancer: an 
international pooled analysis of case-control studies 
The Bladder Cancer Epidemiology and Nutritional 






In terms of cancer incidence, bladder cancer is the ninth most frequently diagnosed 
cancer worldwide.1 The main established risk factors for bladder cancer include 
smoking, specific occupational exposures (e.g. aromatic amines) and Schistosoma 
haematobium,2 although it has been postulated that fluid consumption may also be a 
possible risk factor implicated in the development of bladder cancer.3 Beverages such as 
alcohol, coffee and hot mate tea have been classified as potential carcinogenic agents 
(group1, group 2A and group 2B).4  
Findings from previous epidemiological studies that investigated the relationship 
between specific fluids or total fluid intake and the risk of bladder cancer have largely 
been inconsistent. In some studies, fluid consumption was associated with an elevated 
risk of bladder cancer;5-19 despite the overall elevated risk, not all previous studies 
showed a clear dose-response relationship, and the risk in women remains unclear. 
However, in other studies fluid intake was associated with a decreased risk of bladder 
cancer20-30 and some studies showed no significant association.31-37  
A pooled analysis of six previous case-control studies demonstrated that total fluid 
intake may be associated with an increased risk of bladder cancer but in men only.38 
Another systematic review could not identify any significant association between total 
fluid intake and risk of bladder cancer.39 However, in a recent updated systematic 
review and dose-response meta-analysis, it was concluded that the risk of bladder 
cancer is increased in men if total fluid intake exceeds eight cups per day. 40 
 
In most reviews and pooled analyses conducted to date, specific fluids such as coffee 





bladder cancer, although some studies did find that heavy consumption of coffee (more 
than five or 10 cups of coffee per day) modestly increased the risk of bladder cancer.41-
43 In another meta-analysis, no significant association between overall alcohol 
consumption and bladder cancer risk was found, although consumption of wine and 
beer significantly decreased the risk of bladder cancer.44 
Some pooled analysis tends to have high statistical power and allows for subgroup 
analyses to be performed which would otherwise not be possible in individual studies. It 
also allows investigation of consumption of specific fluid items that cannot be 
investigated in individual studies. 
The Bladder Epidemiology and Nutritional Determinant (BLEND) study was 
established to comprehensively investigate the association between dietary intake and 
the risk of developing bladder cancer. The Principal Investigators of 19 individual case-
control studies provided individual patient data and one study was excluded from the 
analysis because there was no data on fluid consumption. Therefore, the principal aim 
of the current study was to characterise the association between fluid intake and risk of 
developing bladder cancer by pooling individual patient data on 7,514 bladder cancer 
patients and 20,882 controls from the BLEND study. The study pooled individual 





5.2   Methods and materials 
5.2.1 The Bladder Cancer Epidemiology and Nutritional Determinant (BLEND) 
Study 
A systematic literature search was conducted to identify observational studies on dietary 
intake and risk of bladder cancer and potential for participation in the BLEND study. 
The databases Medline (National Library of Medicine, Bethesda, Maryland) (1966–Sept 
2009), and Embase (Elsevier B. V., Amderstam, the Netherlands (1974–Sept 2009) 
were searched. The search terms used to identify relevant articles were:  
(Bladder cancer OR Bladder carcinoma OR Transitional cell carcinoma OR Urinary 
bladder neoplasm OR Urologic Neoplasm OR Urologic diseases OR Urologic Cancer 
OR Carcinoma OR Cancer OR Tumour) AND (Dietary/diet consumption OR Total 
fluid consumption OR Fluid consumption OR Fruit consumption OR Vegetable 
consumption OR Fish consumption OR Fat or oil consumption OR Drinking behaviour 
OR Milk consumption OR Risk factors). 
 Additionally, researchers were contacted via the personal contacts in existing bladder 
cancer consortia such as the International Bladder Cancer Network and US National 
Cancer Institute led consortium of molecular case-control studies on bladder cancer. 
For inclusion in the BLEND consortium, studies had to meet the following inclusion 
criteria: a) case-control design, b) cases had to be incident bladder cancer patients, c) the 
source from which controls were ascertained had to be population-based or hospital-
based, d) hospital controls should be free from bladder cancer, e) reported data on 






The Principal Investigator (PI) of each potentially eligible study was invited to 
participate in the BLEND consortium and asked to provide relevant individual patient 
data, study questionnaires and codebooks for their study. To ensure secure data transfer 
and compliance with data protection, principal investigators were asked to sign a data 
release agreement form.  
 
5.2.2   Fluid intake assessment 
In all studies, a food frequency questionnaire (FFQ) was used to collect information on 
fluid intake. The fluid items assessed varied widely across studies. For each study, total 
fluid intake was calculated as the total sum of all different fluid items assessed. 
Additional information on socio-demographic variables, such as age, gender, smoking 
history (smoking status, smoking duration and smoking frequency) was obtained from 
each study if available. To standardise measures of fluid intake across studies, all fluid 
items were converted from the portion size used (e.g. cup, pint) in each study to 
millilitres. A standard cup of a non-alcoholic beverage such as coffee, tea or a glass of 
soft drink (e.g. cola) was considered to be 250 millilitres. Alcoholic drinks such as a 
pint of beer was measured as 360 millilitres, a glass of wine as 120 millilitres and a 
glass of liquor as 45 millilitres. Missing and unknown data were discussed with the 
BLEND team and principal investigators, and the data were updated accordingly. After 
satisfactory quality control, data cleaning and checking errors and inconsistencies, the 





5.2.3 Statistical analysis 
Fluid intake was originally measured as a continuous variable. It was subsequently 
transformed into easy interpretable cut-off points. The lowest category was used as the 
reference group in all analyses. A multilevel mixed-effects logistic regression model 
was used to calculate odds ratios (OR) and corresponding 95% confidence intervals 
(CIs) for the association between fluid intake and risk of developing bladder cancer.45 
This model was used because of the hierarchical structure of the pooled data set, 
therefore both variations between studies and clustering within studies was examined. 
The data set consists of two clusters: the first hierarchy of clustering is the individual 
studies included in the pooled data set. The second hierarchy is the centres or hospitals 
where cases and controls were recruited from within each study. Additionally, an 
interaction between the clustered variable and exposure variable (fluid consumption) as 
a random effect (i.e. random slope) was included in the model to allow the potential for 
variation in ORs between studies. Potential confounders such as smoking status (non-
smoker, former smoker and current smoker), age (continuous, in years), and gender 
were included in the logistic regression model for all analyses unless otherwise 
specified. To test for linear trend, a Wald-test was used to derive a p-value for trend by 
including fluid intake as a non-negative consecutive integer variable in each model.  
Subgroup analyses were conducted stratifying by gender and smoking status of case and 
control population. 
All statistical analyses were conducted using Stata version 13 and a two-sided p-value 






The Principal Investigators of 19 individual case-control studies agreed to participate, 
and provided individual patient data. One study was excluded from the analysis because 
there was no data on fluid consumption.46 Therefore, individual patient data from 18 
case-control studies were included in this analysis.  
Of the 18 individual case-control studies in the BLEND study, six studies were 
population-based and 12 were hospital based. The studies were conducted between the 
periods of 1957-2008 in twelve different countries: Belgium (1), Canada (1), China (1), 
France (1), Germany (1), Japan (1), Italy (2), USA (6), Spain (1), Sweden (1) and 
Taiwan (1). Studies were from three continents: Europe (8), North America (7) and Asia 
(3) (Table 5.1).  
 
TABLE 5.1: Characteristics of the 18 case-control studies included into the Bladder Cancer Epidemiology 
and Nutritional Determinant (BLEND) study 
First  
author  
Continent Country Recruitment  
Period 




Jiang47 North America USA 1987-1999 Population-based  1660  1586  
Tang48 North America USA 1982-1998 Hospital-based  275  825 
Mettlin49 North America USA 1957-1965 Hospital-based 585  8546 
Wallace50 North America USA 1994-2001 Population based  398  326  
Zhang51 North America USA 1993-1997 Hospital-based  197  314  
Taylor46 North America USA 1987-1991 Hospital-based  245  215  
Gaertner52 North America Canada 1994-1997 Population-based  1028  5039  
Wakai53 Asia Japan 1996-1999 Hospital-based  40  568  
Lu14 Asia Taiwan 1996-1997 Hospital-based  40  160  
Hemelt24 Asia China 2005-2008 Hospital-based  483  469  
Kellen54 Europe Belgium 1999-2004 Population-based  200  384  
Pohlabeln 29 Europe Germany 1989-1992 Hospital-based  300 300  
Steineck55 Europe Sweden 1985-1987 Population-based  273  553  
Randi56 Europe Italy 1985-1992 Hospital-based  727  1067  
Baena6 Europe Spain 1997 Hospital-based  85  130  
Porru57 Europe Italy 1992-1993 Hospital-based  200  214  
Golka58 Europe Germany 1992-1995 Population-based  194  238  
Clavel59 Europe France 1984-1987 Hospital-based  201 326 







Table 5.2 shows a detailed description of the characteristics of cases and control 
subjects in each of the studies included in BLEND study. The master data set comprised 
of 7,514 bladder cancer cases and 20,882 control subjects. Cases were more likely to be 
males; a total of 76.1% of the cases and 54.7% of the controls were male. The mean age 
was 60 years for cases and 57 years for controls. For smoking status, 43.1% cases and 
32.8% of the controls were current smokers and 37.6% of the cases and 27.9% of the 
controls were former smokers. Cases who were smokers or former smokers tend to 

















TABLE 5.2: Characteristics of bladder cancer cases and controls  
from 18 case-control studies included in BLEND study 




  No % No % 
      
Sex Male 5719 76.1 11413 54.7 
 Female 1795 23.9 9469 45.3 
      
Age (years) <40 214 2.8 2947 14.2 
 40-44 252 3.4 1464 7.0 
 45-49 408 5.4 1706 8.2 
 50-54 738 9.8 2104 10.1 
 55-59 1162 15.5 2525 12.2 
 60-64 1471 19.6 2836 13.6 
 65-69 1233 16.4  2907 14.0 
 70-74 1187 15.8 2645 12.7 
 ≥75 846 14.1 1645 7.9 
      
Smoking status Non smoker 1418 19.3 7918 39.4 
 Former smoker 2757 37.6 5612 27.9 
 Current smoker 3160 43.1 6589 32.8 
      
Smoking   <1 1449 20.6 7778 41.0 
Duration 1-9 256 3.6 1477 7.8 
(years) 10-19 554 7.9 2194 11.6 
 20-29 990 14.1 2553 13.4 
 30-39 1467 20.8 2328 12.3 
 40-49 1512 21.5 1691 8.9 
 ≥50 817 11.6 964 5.1 
      
Amount of  <1 1727 24.6 9547 49.5 
Cigarettes 1-4 273 3.9 646 3.3 
(per day) 5-14 1242 17.7 4255 22.1 
 15-24 2031 28.9 2536 13.1 
 25-34 841 12.0 1498 7.8 
 35-44 588 8.4 582 3.0 
 ≥45 322 4.6 229 1.2 





Table 5.3 presents median fluid consumption of controls and cases within each 
individual study. Fluid consumption varied across studies, with coffee as the major 
contributor of fluid consumption in almost all studies, particularly those studies 
conducted in Europe and America. The second source of fluid consumption was water 
in all studies, although in studies conducted in Asia the major source of fluid 





Table 5.3: Fluid consumption for controls and cases by studies included in the BLEND study  
 Controls  Cases 
  consumption (ml/week)  consumption (ml/week) 
1st Author 
(Location)  
Total Fluid Intake  
includes: Mean Median 
(25th-75th) 
Percentiles  Mean Median (25
th-75th) 
Jiang Coffee 5514 3600  (1680-6720)  6426 5040 (3360- 8400) 
(USA) Tea (miscel.) 1339 0  (0-1680)  1414 0 (0- 1680) 
 Soda water 1866 720  (0- 1680)  2398 960 (0- 3360) 
 Tomato juice 168 55  (2-240)  180 28 (0-166) 
 Orange juice 699 480  (111- 1200)  602 240 (55- 960) 
 Grape fruit juice 167 28 (0-111)  145 9 (0-111) 
 Fruit juice 866 591  (231-1551)  747 480 (111-1200) 
 Other fruit juice 90 0  (0-9)  117 0 (0-5) 
 Beer 2577 360  (0-2160)  2861 0 (0-2160) 
 Wine 379 0  (0-240)  291 0 (0-120) 
 Liquor 245 0  (0-180)  357 0 (0-270) 
 Water 5284 5040  (1680-6720)  4903 3360 (1680-6720) 
         
         
Tang  Coffee 5234 4375 (2188-7437.5)  5562 4375 (2188-7438) 
(USA) Tea (miscel.) 1715 875 (438-1750)  1426 438  (438-1750)     
 Herbal tea 786 438 (438-438)  533.75   438 (438- 438) 
 Carbonated soft drink 1301 438  (0-875)       1515 438  (0-1750)   
 Beer 513 360 (0-720)  940 360 (0-1080) 
 Wine 110 120 (0- 240)  164 0 (0-120) 
 Liquor 62 45 (0-90)  103 45 (0-90) 
         
         
Stieneck Lemonade 371 63 (63-500)  520 63 (63- 500) 
(Europe) Fruit Juices 478 125 (63-500)  556 125 (63-1125) 
 Carbonated soft drinks 584 188 (125-563)  717 188 (125-1000) 
 Beer 1638 1080 (360-2520)  1987 1800 (720- 2520) 
 Wine 424 360 (120-480)  517 360 (240-720) 
 Beverages (miscel.) 979 500 (250-1250)  1182 750 (500-1750) 
 Coffee 5073 4667 (3208-6417)  5727 5250 (3500- 7583) 
 Tea (miscel.) 1455 1167 (292-1750)  1308 875 (0-1750) 
         
         
Wallace Carbonated soft drinks 1737    625 (438-1750)  2038   1063  (438-2813)   
(USA) Apple juice 158     60 (60-120)  211 60  (60-120)   
 Liquor 82  11  (11- 23)  86 11 (11-23) 
 Wine 321    60 (60-150)  207 60   (60- 90) 
 Beer 620      90 (90-180)  750    90  (90-180) 
 Tea (miscel.) 1006     125 (63-750)  703 63 (63-250) 
 Coffee 3832  4125 (844 -5313)  3995 2625   (1436- 5313) 
 Punch drinks 216   63   (63-125)  356 63 (63-125) 
 Tomato juice 153 63 (63-125)  185 63 (63-125) 
 Other fruit 464  63 (63-250)  493   63 (63- 250) 
 Grape juice 184  63 (63- 63)  170 63 (63- 63) 
 Orange juice 1061 250 (63-2500)  805 125 (63-1375) 
         
Zhang Coffee 5496 5250 (1750-7000)  5620 3500 (1750-7000) 
(USA) Tea (miscel.) 2793 1750  (1750- 3500)  2746 1750 (750-3500) 
 Orange Juice 1555 1750  (500-1750)  1366 1750 (500-1750) 
 Grape Juice 763 500  (250- 750)  754 500 (63-1750) 
 Tomato Juice 498 188 (65-500)  492 135 (63-500) 
 Fruit Juice 1426 1250  (500-1750)  1446 875 (375-1750) 
 Carbonated soft drink 1620 1000  (500-1750) 
 1385  1250 (438-1750) 
 Beer  1322 720  (270-1440)  1065 360 (90-1080) 
 Wine 284 180  (60-360)  352 150 (30-600) 
 Liquor 106 45 (11-135)  135 90 (6-225) 
         
         
Randi  Coffee 3274 3150 (1575-4725)  3603 3150 (1575-4725) 
(Italy) Tea (miscel.) 384 0 (0-0)  399 0 (0-0) 






Table 5.3:  Fluid consumption for controls and cases by studies included in the BLEND study  (Continued) 
  Controls  Cases 
  consumption (ml/week)  consumption (ml/week) 
1st Author 
(Location)  
Total Fluid Intake  
includes: Mean Median (25
th-75th)  Mean Median (25th-75th) 
Pohlabeln  Coffee 5594 5250 (3500-7000)  4577 3500 (1750-7000) 
(Germany) Tea (miscel.) 2335 1750 (0-3500)  2442 1750 (0-3500) 
 Water 5256 3500 (1750-7000)  5379 5250 (1750- 7000) 
 Beer 1788 0 (0-2520)  1408 0 (0- 2520) 
 Wine 153 0 (0-0)  111 0 (0-0) 
         
         
Kellen  Soft drink 481 37 (0-488)  697 74 (0-1050) 
(Belgium) Coffee 3594 3640 (1820-4633)  3934 3640 (1820- 5460 )  
 Herbal tea 259 0 (0- 96)  174 0 (0-0) 
 Infusion drink 197 0 (0-0)  215 0 (0-0) 
 Tea (miscel.) 383 0 (0- 127)  221 0 (0-0) 
 Water 3546 2998 (1050-4715)  3541 3071 (1050- 5250) 
 Wine 423 245 (0-566)  374 62 (0-368) 
 Liquor 379 0 (0- 37)  310 0 (0-0) 
 Beer 1087 245 (0-1246)  1083 208 (0-1111) 
 Spirits 170 0 (0-0)  60 0 (0-0) 
         
         
Golka Coffee 3275 2250  (2250-2250)  3424 2250  (2250-6300) 
(Germany)         
         
         
Wakai  Coffee  3175 2750   (1750-4500 )   2868 2500  (1750- 3500) 
(Japan) Oolon tea 930 0 (0 – 219)  723 0 (0-0) 
 Beverages (miscel) 4340 2750 (0-6250)  2752 813 (0-4875) 
 Tea (miscel) 7603 5531 (4500 – 10500) 
 6769 5250 (3594-10500) 
 Fruit juice 337 0 (0-188)  248 0 (0-250) 
 Soft drink 242 0 (0-50)  173 0 (0-100) 
 Water 2869 1750 (0-4500)  2991 1563 (0-3500) 
         
         
Lu  Tea (miscel.) 624 0 (0-1750)  836 625 (0-1750) 
(Taiwan) Oolong tea 495 0 (0-1750)  755 63 (0-1750) 
 Wine 104 0 (0-0)  165 0 (0-300) 
         
         
Porru  Coffee 6476 7000  (0-10500)  9104 7000 (3500-10500) 
(Italy) Tea (miscel.) 2100 1750 (1750-1750)  2285 1750 (875-1750) 
 Wine 2590 2352 (1176-3528)  2473 2352 (0-3528) 
 Beer 79 0 (0-0)  103 0 (0-0) 
 Aperitif 16 0 (0-0)  0 0 (0-0) 
 Liquor 66 0 (0-0)  83 0 (0-0) 
 Water 1241 1400 (1050-1400)  1276 1400 (525-1575) 
 Carbonated soft drink 2154 1750 (1750-1750)  2625 1750 (1750-3500) 
         
         
Hemelt Red tea 2038 0 (0- 4667)  2064 153  (0- 4667)   
(China) Green tea 2626 806 (0- 4667)  2604   750   (0- 4667)   
 Water 7111 7000 (3500-11667)  7189.431   7000 (3500-  11667) 
 Fruit juice 118 0 (0-77)  92 0 (0-77) 
 Carbonated soft drink 15 0 (0-0)  63 0   (0-0)   
 Beer 501 0 (0-0)  599 0 (0- 55) 
 Wine 21 0 (0-0)  34 0 (0-0) 
 Liquor 52   0 (0-7)  50 0     (0-0)   
 Beverages (miscel.) 30 0 (0-0)  84 0 (0-0) 
         
         
Clavel Coffee 3276 3500 (1750-3500)  2803 1750 (1750-3500) 









To facilitate interpretation of results of fluid items in relation to bladder cancer risk, 250 
millilitres was assumed as the standard metric cup. 
 
5.3.1 Overall analysis with all subjects combined 
Table 5.4 reports the ORs of developing bladder cancer and corresponding 95% confidence 
intervals in relation to total fluid intake and specific fluid items for all subjects combined. 
A borderline significant association was found between coffee consumption and bladder 
cancer risk for all subjects combined (Ptrend=0.082). Subjects that consumed 10 or more 
cups (≥ 2,500 ml/day) of coffee had an estimated 3-fold increase in ORs (OR=3.0, 95% CI: 
1.3-7.0) compared to subjects who drank one cup (250 ml/day) or less than one cup of 
coffee. 
  
Table 5 3: Fluid consumption for controls and cases by studies included in the BLEND study   (Continued) 
  Controls 
consumption (ml/week) 
 Cases  
consumption (ml/week)    
1st Author 
(Location)  
Total Fluid Intake  
includes: Mean Median 
(25th-75th) 
Percentiles  Mean Median (25
th-75th) 












4754 4500 (1750-8000) 
         
Baena Water 6165 6125 (3500-8750)  6609 6125 (6125-8750) 
(Spain) Coffee 2214 2625 (0-2625)  2666 2625  (0-2625) 
         
         
Taylor Beer 966 0 (0-720)  1064 0 (0-720) 
(USA) Wine 108 0 (0-0)  132 0 (0-0) 
 Liquor 145 0 (0-0)  203 0 (0-0) 
 Coffee 4729 3500 (1750- 7000)  6053 3500 (1750-7000) 
  Tea (miscel.) 1950 1750 (0- 3500)  2257 1750 (0-3500) 
 Carbonated Soft drink 1661 0 (0-1750)  2407 0 (0-1750) 
                  Mettlin Beer 436 90 (0-540)  559   90 (0-540) 
(USA) Wine 45 0 (0-30)  45 0 (0-30) 
 Spirit 38 0 (0-23)  41    0 (0- 23) 
 Tea 1885 1313 (1313-1750)  1695   1313   (1313-1750)   
 Coffee 4376 5250 (1750-7000)  4389   5250  (1750-7000) 
 Alcohol mix 541 147 (0- 898)  415 74  (0-452) 
 Liquor 52   0 (0-7)  50 0   (0-0)   
 Beverages (miscel.) 30 0 (0-0)  84 0  (0-0) 










Table 5.4: Odds ratios (OR) and 95% confidence interval (95% CI) of bladder cancer in relation to  total fluid 
intake for all subjects combined 
Fluid item Cups (250 ml) /day NCASE NCONTROL ORa (95%CI) Ptrend 
      
Total fluid  <1 381 2,067 1.0 (ref.)  
 1 619 2,026 0.8 (0.5-1.4)  
 2-3 1,696 5,353 1.0 (0.6-1.7)  
 4-8 3,042 7,310 1.1 (0.7-1.9)  
 ≥9 1,507 1,402 1.3 (0.8-2.3) 0.142 
      
      
Coffee 0-1 1,940 6,235 1.0 (ref.)  
 2 2,459 6,157 1.1 (0.7-1.8)  
 3-9 1,697 4,428 1.3 (0.7-1.8)  
 ≥10 205 116 3.0 (1.3-7.0) 0.082 
      
      
Water 0 682 678 1.0 (ref.)  
 1-2 1,049 1,130 1.0 (0.7-1.3)  
 3-5 912 1,033 1.0 (0.8-1.4)  
 ≥6 438 452 1.0 (0.7-1.5) 0.757 
      
      
Cola 0 1,351  2,028 1.0 (ref.)  
 1 158  219 0.8 (0.5-1.3)  
 3  35  35 0.9 (0.4-1.8)  
 ≥4 39 47 1.0 (0.5-1.9) 0.838 
      
      
Tea 0 2924 7253 1.0 (ref.)  
 1-2 899 2660 0.9 (0.8-1.2)  
 3-5 235 889 0.8 (0.6-1.0)  
 ≥6 77 71 0.9 (0.7-1.2) 0.218 
      
      
Green tea 0 286 295 1.0 (ref.)  
 1-2 77 59 0.9 (0.4-1.8)  
 3-5 75 84 1.2 (0.6-2.5)  
 ≥6 27 23 0.9 (0.6-1.5) 0.897 
      
      
Liquor 0 1,953 2,116 1.0 (ref.)  
 ½  76 66 0.8 (0.4-1.3)  
 ≥1 62 34 1.3 (0.7-2.5) 0.735 
      
      
Beer 0 3,066 7,501 1.0 (ref.)  
 ¼ 246 1,112 0.8 (0.6-1.0)  
 ½ 224 621 0.7 (0.6-1.0)  
 1 446 1,198 0.8 (0.6-1.1)  
 ≥2 505 545 1.1 (0.8-1.4) 0.798 
      
      
Wine 0 3,398 9,287 1.0 (ref.)  
 ¼ 203 574 0.7 (0.5-0.9)  
 ½ 140 218 0.8 (0.6-1.2)  
 1 152 216 0.9 (0.6-1.3)  
 ≥2 628 846 1.0 (0.7-1.5) 0.687 
OR=odds ratio  from model with random effect and random slope, ref=reference group; CI=confidence interval 







5.3.2   Subgroup analysis according to gender 
The association between coffee consumption and bladder cancer risk varied amongst 
gender. A significant increased association between coffee consumption and the risk of 
developing bladder cancer was observed (Ptrend= 0.030) when the analyses was restricted 
to men only. Men that consumed 10 or more cups (≥ 2,500 ml/day) of coffee per day 
had an estimated 3-fold increased OR of developing bladder cancer (RR=2.9, 95% CI: 
1.2-6.9) compared to men who drank one cup (250 ml/day) or less than one cup of 
coffee (Table 5.5). For women, the OR of drinking at least six or more cups (≥ 1,500 
ml/day) of coffee was 0.9 (95% CI: 0.5-1.8; Ptrend=0.867) when compared to women 






Table 5.4: Odds ratios (OR) and 95% confidence interval (95% CI) of bladder cancer in relation to  total fluid intake for 
all subjects combined  (Continued) 
Fluid item Cups (250 ml) /day NCASE NCONTROL ORa (95%CI) Ptrend 
      
Soda water  0 826 1082 1.0(ref.)  
 1-2 299 295 1.0(0.9-1.3)  
 3-5 95 96 1.0(0.8-1.4)  
 ≥6 71 37 1.5(0.9-2.2) 0.167 
      
Carbonated soft drinks 0 2,924 7,253 1.0(ref.)  
 1-2 899 2660 0.9(0.8-1.2)  
 3-4 204 845 0.8(0.6-1.0)  
 ≥5 108 115 0.9(0.7-1.2) 0.210 
      
Fruit juice 0 2508 2534 1.0(ref)  
 1-2 527 591 0.9(0.7-1.2)  
 ≥3 29 31 0.8(0.4-1.4) 0.291 
OR=odds ratio  from model with random effect and random slope, ref=reference group; CI=confidence interval 






  OR=odds ratio from model with random effect and random slope, ref=reference group; CI=confidence interval  
    aadjusted for age (continuous), smoking status(categorical), smoking duration(continuous), cigarette amount (continuous)
Table 5.5: Odds ratios (OR) and 95% confidence interval (95% CI) of bladder cancer in relation to fluid intake for 
males only   
Fluid item Cups (250 ml) /day NCASE/ NCONTROL ORa (95%CI) Ptrend 
      
Total fluid  <1 215 1,011 1.0 (ref.)  
 1-2 813 2,484 1.1 (0.7-1.7)  
 3-5 1,593 3,346 1.3 (0.8-2.1)  
 6-8 1,291 1,724 1.2 (0.8-1.9)  
 ≥9 1,396 1,376 1.4 (0.8-2.3) 0.200 
      
      
Coffee 0-1 1,408 3,394 1.0 (ref.)  
 2-3 1,909 3,480 1.2 (0.8-1.8)  
 4-9 1,328 2,419 1.3 (0.9-2.0)  
 ≥10 172 98 2.9 (1.2-6.9) 0.030 
      
      
Water 0 560 569 1.0 (ref.)  
 1 425  430 1.1 (0.8-1.5)  
 2 416 421 1.1 (0.8-1.6)  
 3-5 756  769 1.2 (0.9-1.7)  
 ≥6 331 338 1.2 (0.8-1.9) 0.184 
      
      
Cola 0 995 1,380 1.0 (ref.)  
 1 92 144 0.7 (0.4-1.2)  
 ≥3 42  46 1.0 (0.5-1.8) 0.597 
      
      
Tea <1 2,282  4,137 1.0 (ref.)  
 1-2 638  1,291 0.9 (0.8-1.2)  
 3-4 196 378 0.8 (0.6-1.1)  
 ≥5 225 243 0.9 (0.6-1.2) 0.227 
      
      
Green tea 0 175  168 1.0 (ref.)  
 ½ 45 52 1.1 (0.4-3.3)  
 1 31 23 1.1 (0.4-2.7)  
 2 34  25 1.1 (0.4-2.8)  
 3 90   89 0.8 (0.4-1.7) 0.601 
      
      
Beer 0 2,225 3,475 1.0 (ref.)  
 ¼ 215  706 0.8 (0.5-1.1)  
 ½ 189 1461 0.7 (0.5-0.9)  
 1 395 957 0.7 (0.5-1.0)  
 ≥2 469 506 1.0(0.7-1.4) 0.492 
      
      
Carbonated soft drink 0 2,282  4,137 1.0 (ref.)  
 1-2 638 1,291 0.9 (0.8-1.2)  
 3-4 196  378 0.8 (0.6-1.1)  
 ≥5 225  243 0.9 (0.6-1.2) 0.227 
  
 
   
  
 
   
Wine 0 2,523 4,816 1.0 (ref.)  
 ¼ 154  368 0.6 (0.4-0.9)  
 ½ 115 156 0.9 (0.6-1.3)  





   OR=odds ratio from model with random effect and random slope, ref=reference group; CI=confidence interval  
    aadjusted for age (continuous), smoking status(categorical), smoking duration(continuous), cigarette amount (continuous)
Table 5.6: Odds ratios (OR) and 95% confidence interval (95% CI) of bladder cancer in relation to  total fluid intake for 
females only 
Fluid item Cups (250 ml) /day NCASE NCONTROL ORa (95%CI) Ptrend 
      
Total fluid  <1 123 988 1.0 (ref.)  
 1 109 767 0.9 (0.4-1.8)  
 2-3 420 2,392 1.2 (0.6-2.2)  
 4-8 696 3,286 1.1 (0.6-2.2)  
 ≥9 276 282 1.3 (0.6-2.8) 0.389 
      
      
Coffee <1 273 1,547 1.0 (ref.)  
 1 259 1,294 0.9 (0.5-1.6)  
 2-3 550 2,677 1.0 (0.6-1.7)  
 4-5 257 1,791 0.9 (0.5-1.7)  
 ≥6 145 236 0.9 (0.5-1.8) 0.867 
    
 
 
    
 
 
Water 0 121 105 1.0 (ref.)  
 1-2 208 278 0.7 (0.4-1.1)  
 3-5 156 263 0.6 (0.4-1.0)  
 ≥6 107 114 0.8 (0.5-1.3) 0.323 
      
      
Cola 0 353 647 1.0 (ref.)  
 1-2 66 75 0.7 (0.4-1.2)  
 ≥3 32  36 1.0 (0.5-1.8) 0.597 
      
      
Tea <1 594 2,988 1.0 (ref.)  
 1-2 275 1,366 1.1 (0.7-1.5)  
 3-4 75  517 0.8 (0.5-1.2)  
 ≥5 68  68 1.3 (0.7-2.2) 0.891 
      
      
Beer < ¼ 841  4,026 1.0 (ref)  
 ¼ 31 406 0.7 (0.4-1.3)  
 ½ 35 160 0.9 (0.5-1.7)  
 1 87 281 1.3 (0.8-2.1) 0.473 
      
      
Carbonated soft drink 0 594 2,988 1.0 (ref.)  
 1-2 275 1,366 1.1 (0.7-1.5)  
 3-4 75 517 0.8 (0.5-1.2)  











Wine 0 875 875/4,471 1.0 (ref.)  
 ¼ 49 49/207 0.8 (0.5-1.3)  
 ½ 25 25/62 0.7 (0.3-1.3)  
 ≥1 75 75/202 1.2 (0.6-2.2) 0.793 
    
 
 
Soda water <1 187 377 1.0 (ref.)  
 1 42 56 0.8 (0.6-1.1)  





5.3.3   Subgroup analysis according to smoking status 
The association between total fluid intake or specific fluid items and bladder risk among 
men according to smoking status was examined. A borderline significant association 
was found between coffee consumption and bladder cancer risk for all subjects who 
were ever smokers (Ptrend=0.063). Ever smokers who consumed 10 or more cups (≥ 
2,500 ml/day) of coffee had an estimated 2.6 increased ORs (OR=2.6, 95% CI: 1.1-5.9) 
compared to subjects who drank one cup (250 ml/day) or less than one cup of coffee. 
A significant positive association was observed between coffee consumption and 
bladder cancer risk amongst men who were ever smokers (Ptrend=0.043). Men who were 
ever smokers who consumed at least 10 or more cups (≥2,500 ml/day) of coffee per day 
had a 2.5 increased OR of developing bladder cancer (OR=2.5, 95% CI: 1.1-5.8) 
compared to men who were ever smokers and drank one cup (250 ml/day) or less than 
one cup of coffee (Table 5.8). In addition, no evidence of interaction between smoking 
and coffee consumption effect on the risk of developing bladder cancer.(Pvalue=0.614)  
For men who were never smokers and drank at least six or more cups (1,500 ml/day) of 
coffee per day had an estimated 50% increased risk of developing bladder cancer 
(OR=1.5, 95% CI: 0.8-2.5) compared to men who were never smokers and never drank 









Table 5.7: Odds ratios (OR) and 95% confidence interval (95% CI) of bladder cancer in relation to fluid intake for  ever 
smokers only   
Fluid item Cups (250 ml) /day NCASE NCONTROL ORa (95%CI) Ptrend 
      
Total fluid  <1 230 894 1.0 (ref.)  
 1-2 239 850 0.8 (0.4-1.4)  
 3-5 1,088 2,783 1.0 (0.6-1.8)  
 6-8 2,573 5,012 1.0 (0.6-1.7)  
 ≥9 1,465 1,275 1.3 (0.7-2.3) 0.293 
      
      
Coffee 0-1 1,421 3,207 1.0 (ref.)  
 2-3 2,047 3,808 1.1 (0.7-1.7)  
 4-9 1,529 3,334 1.2 (0.8-1.9)  
 ≥10 198 105 2.6 (1.1-5.9) 0.063 
      
      
Water 0 566 490 1.0 (ref.)  
 1-2 865 707 1.1 (0.8-1.5)  
 3-5 700 673 1.0 (0.8-1.4)  
 ≥6 336 260 1.3 (0.8-1.9) 0.379 
      
      
Cola 0 1,116 1,258 1.0 (ref.)  
 1-2 124 136 0.9 (0.6-1.4)  
 3 33 25 1.0 (0.5-1.9)  
 ≥4 32 32 1.0 (0.5-1.8) 0.861 
      
      
Tea <1 4559 2345 1.0 (ref.)  
 1-2 1,452 1,721 1.0 (0.8-1.1)  
 3-4 504 209 0.8 (0.6-1.0)  
 ≥5 225 242 0.9 (0.7-1.2) 0.214 
      
      
Green tea 0 111 131 1.0 (ref.)  
 ½ 42 39 1.1 (0.4-3.0)  
 ≥1 125 92 1.1 (0.5-2.2) 0.848 
      
      
Beer 0 2,544  4,781 1.0 (ref.)  
 ¼ 191   459 0.8 (0.6-1.1)  
 ½ 388   973 0.8 (0.6-1.1)  
 1 149 176 0.9 (0.7-1.3)  
 ≥2 315  274 1.2 (0.9-1.7) 0.461 
      
      
Wine 0 2,804  5,874 1.0 (ref.)  
 ¼ 118  153 0.8 (0.6-1.2)  
 ½ 119 119 0.8 (0.5-1.3)  
 1 157 157 1.3 (0.8-2.2)  
 ≥2 404 404 1.0 (0.6-1.6) 0.761 
      
      
Liquor 0 1,407 1,212 1.0 (ref.)  
 ¼ 107   72 1.1 (0.8-1.7)  
 ½ 72  61 0.9 (0.6-1.4)  





OR=odds ratio from model with random effect and random slope, ref=reference group; CI= confidence interval 
aadjusted for sex, age (continuous),smoking duration(continuous), cigarette amount (continuous)
Table 5.7 Odds ratios (OR) and 95% confidence interval (95% CI) of bladder cancer in relation to fluid intake for  ever 
smokers only   (Continued) 
Fluid item Cups (250 ml) /day NCASE NCONTROL ORa (95%CI) Ptrend 
      
Fruit juice 0 1,754 1,422 1.0 (ref.)  
 ½ 253  210 0.9 (0.7-1.3)  
 1 385  331 0.9 (0.7-1.2)  
 2 56  48 0.8 (0.5-1.2) 0.243 
      
      
Carbonated soft drink 0 2,345 4,559 1.0 (ref.)  
 1-2 721 1,452 1.0 (0.8-1.1)  
 3-4 209 504 0.8 (0.6-1.0)  
 ≥5 242 225 0.9 (0.7-1.2) 0.214 
      
      
Soda water <1 679 658 1.0 (ref.)  
 1-2 249 204 1.0 (0.8-1.3)  
 3-5 73 53 1.1 (0.8-1.6)  





Table 5.8: Odds ratios (OR) and 95% confidence interval (95% CI) of bladder cancer in relation to fluid intake for 
ever smokers in males only   
Fluid item Cups (250 ml) /day NCASE NCONTROL ORa (95%CI) Ptrend 
      
Total fluid  <1 169 575 1.0 (ref.)  
 1-2 674 1,800 1.1 (0.7-1.8)  
 3-5 1,348  2,640 1.2 (0.7-2.0)  
 6-8 1,137  1,302 1.2 (0.7-1.9)  
 ≥9 1,272  1,131 1.4 (0.8-2.4) 0.251 
      
      
Coffee 0-1 1,148 2,250 1.0 (1.0-1.0)  
 2-3 1,687 2,705 1.1 (0.8-1.7)  
 4-9 1,232 2,074 1.3 (0.9-2.0)  
 ≥10 167 90 2.5 (1.1-5.8) 0.043 
      
      
Water 0 497  442 1.0 (ref.)  
 1 382 311 1.2 (0.8-1.6)  
 2 348   290 1.1 (0.8-1.6)  
 3-5 623   567 1.1 (0.8-1.5)  
 ≥6 284   222 1.3 (0.9-2.0) 0.234 
      
      
Cola 0 878 999 1.0 (ref.)  
 1 72   94 0.7 (0.4-1.2)  
 ≥3 35 33 0.9 (0.4-1.8) 0.429 
      
      
Tea <1 1,967 3,209 1.0 (ref.)  
 1-2 557  966 1.0 (0.8-1.2)  
 3-4 163  299 0.8 (0.6-1.0)  
 ≥5 214  202 1.0 (0.7-1.4) 0.480 
      
      
Green tea 0 126 106 1.0 (ref.)  
 ½ 41 37 1.0 (0.3-3.6)  
 1 89 122 1.0 (0.4-2.4) 0.971 
      
      
Beer 0 1,870 2,445 1.0 (ref.)  
 ¼ 185  580 0.8 (0.5-1.1)  
 ½ 165 367 0.7 (0.5-1.0)  
 1 348 824 0.7 (0.5-1.0)  
 2 43  422 1.0 (0.7-1.4) 0.481 
      
Wine 0 2,123  3,642 1.0 (ref.)  
 ¼ 133/ 281 133/ 281 0.7 (0.5-1.0)  
 ½ 99/114 99/114 0.9 (0.6-1.3)  

































OR=odds ratio from model with random effect and random slope, ref=reference group, CI= confidence interval 
aadjusted for age (continuous), smoking duration(continuous), cigarette amount (continuous)
Table 5.8: Odds ratios (OR) and 95% confidence interval (95% CI) of bladder cancer in relation to fluid intake 
for ever smokers in males only (Continued)   
Fluid item Cups (250 ml) /day NCASE NCONTROL ORa (95%CI) Ptrend 
Liquor 0 1,100  926 1.0 (ref.)  
 ¼ 77 60 0.8 (0.4-1.4)  
 ½ 57 46 0.7 (0.4-1.4)  
 1 47  24 1.1 (0.5-2.3) 0.619 
      
Carbonated soft drink 0 1,967 3,209 1.0 (ref.)  
 1-2 557  966 1.0 (0.8-1.2)  
 3-4 163  299 0.8 (0.6-1.0)  
 ≥5 214  202 1.0 (0.7-1.4) 0.480 
      
Fruit juice  0 1,476 1,171 1.0 (ref.)  
 ½ 198 164 1.0 (0.7-1.4)  
 1 312  252 1.0 (0.7-1.4)  
 2 42   34 0.8 (0.5-1.3) 0.602 
      
Soda water 0 449  411 1.0 (ref.)  
 ½ 83  73 1.0 (0.7-1.5)  
 1 124 112 0.9 (0.7-1.2)  





Table 5.9: Odds ratios (OR) and 95% confidence interval (95% CI) of bladder cancer in relation to fluid intake 
for never smokers in males only   
Fluid item Cups (250 ml) /day NCASE NCONTROL ORa (95%CI) Ptrend 
      
Total fluid  <1   46 436 1.0 (1.0-1.0)  
 1-2 139 684 1.5 (0.9-2.5)  
 3-5 245 706 2.1 (1.2-3.7)  
 6-8 154  422 1.7 (0.9-3.0)  
 ≥9 124 245 1.9 (1.0-3.5) 0.098 
      
Coffee 0 134 706 1.0 (ref.)  
 1 126 438 1.3 (0.8-2.0)  
 2-3 146  561 1.5 (1.0-2.3)  
 4-5 130 431 1.4 (0.9-2.3)  
 ≥6 47 136 1.5 (0.8-2.6) 0.089 
      
Water 0 63 127 1.0 (ref.)  
 1 43 119 0.7 (0.5-1.2)  
 2 68 131 0.9 (0.6-1.4)  
 3-5 133  202 1.2 (0.8-1.8)  
 ≥6 47  116 0.6 (0.4-1.0) 0.796 
      
Tea <1 315 928 1.0(ref.)  
 1 54 208 0.8(0.5-1.2)  
 2 27 117 0.7(0.4-1.2)  
 ≥3 44 120 0.9(0.5-1.6) 0.468 
      
Beer 0 355 1,030 1.0 (ref.)  
 ¼ 30 126 0.8 (0.5-1.5)  
 ½ 24 94 0.6 (0.3-1.2)  
 1 47 133 1.0 (0.6-1.7)  
 ≥2 38 84 1.1 (0.6-2.1) 0.884 
      
Carbonated soft drink 0 315 928 1.0(ref.)  
 1 54 208 0.8(0.5-1.2)  
 2 27 117 0.7(0.4-1.2)  
 ≥3 44 120 0.9(0.5-1.6) 0.468 
      
Wine 0 400 1,174 1.0(ref.)  
 ¼ 21 87 0.6(0.3-1.2)  
 ≥½ 82 230 1.0(0.5-1.9) 0.693 
      
Fruit juice 0 247 446 1.0(ref.)  
 ½ 73 48 1.0(0.6-1.9)  
 ≥1 139 81 0.9(0.5-1.6) 0.762 
      
Soda water 0 84/186 84/186 1.0 (1.0-1.0)  
 ½ 23/35 23/35 1.4 (0.7-2.7)  
 1 21/51 21/51 0.9 (0.4-1.9)  
 ≥2 36/52 36/52 1.4 (0.8-2.7) 0.361 
OR=odds ratio from model with random effect and random slope, ref=reference group, CI=Confidence interval 






5.4   Discussion 
5.4.1 Summary of key findings  
To my knowledge, this is the largest ever pooled analysis to date to comprehensively 
investigate the association between total fluid intake and risk of developing bladder 
cancer with a total of 7,514 bladder cancer cases and 20,882 control subjects. The result 
of this study shows a 3-fold increased risk of developing bladder cancer in men who 
consumed at least 10 or more cups (≥2500 ml/day) of coffee per day. In addition, the 
positive association between coffee consumption and bladder cancer risk in men was 
observed both in ever smokers, after adjusting for amount of cigarettes smoked and 
smoking duration, and never smokers.  
 
5.4.2 Comparison findings with previous studies  
A previous pooled analysis of 10 European case-control studies involving a total of 564 
cases and 2,929 controls suggested that never smokers who consumed 10 or more cups 
of coffee per day had an excess significant risk of developing bladder cancer (RR=1.80, 
95% CI: 1.00-3.30) compared to those who never drank coffee.60 These results are 
consistent with our findings, but our analysis included 10 times the number of cases and 
takes into account clustering within the dataset. Another previous pooled analysis of six 
case-control studies consisting of 2,729 bladder cancer cases and 5,150 control subjects 
have showed that heavy consumption of coffee i.e. more than five cups of coffee per 
day increased the risk of developing bladder cancer, mainly in ever smokers.61 
Additionally, the pooled analysis of six case-control studies also suggested that total 





controlling for confounders the OR for 1 litre/day increased consumption was 1.08 
(95%CI: 1.03-1.14). Results of a previous cohort study conducted in the Netherlands 
indicated that there may be a positive association between high coffee consumption and 
bladder cancer risk in men.62 Another prospective study conducted in Japan has 
suggested that high coffee consumption increases the risk of developing bladder cancer 
in never or former smokers (RR=2.24, 95% CI: 1.21-4.16; or RR=2.05, 95% CI: 1.15-
3.65).63 
 
5.4.3 Biological mechanisms 
There are plausible biological mechanisms that have been suggested by researchers for 
the association of coffee on cancer development. Coffee is amongst the most widely 
consumed beverages in the world. It is one of the main sources of caffeine in the 
western diet and has been reported to be potentially carcinogenic. Caffeine may induce 
the production of cytochrome P450 enzymes that promote carcinogenesis.64 In addition, 
caffeine can inhibit DNA repair and stimulate cell division before DNA replication is 
completed. 
Researchers have evaluated the effect of coffee consumption and on health and other 
forms of cancers such as lung cancer. Some studies have shown that caffeine inhibits 
genes, for example, the tumour suppressor gene P53 and ataxia telangiectasia mutated 
(ATM) genes that respond to DNA damage. These genes have been associated with 
increased risk of developing childhood leukaemia65 and lung cancer.66 Furthermore, 
higher consumption of caffeine has been associated with low birth weight or 





5.4.4 Implication for practice 
Despite the limitation of this study, findings from this study are consistent with previous 
research which shows that higher consumption of coffee may increase the risk of 
developing bladder cancer in men.  Furthermore, there are possible mechanisms 
suggesting that caffeine may have carcinogenic properties at higher levels of 
consumption. Therefore, based on these findings it is useful to refine and improve 
dietary guidance on higher coffee consumption and bladder cancer risk. Also, 
individuals should be aware that excessive consumption of coffee might have an impact 
on the development of bladder cancer. However, to my knowledge dietary guidelines on 
coffee consumption advised that pregnant women should consume 200mg per day of 
caffeine (that is 2 cups of coffee per day) based on the Food standard agency.68 
 
5.4.5 Study strengths and limitations 
The large sample size is one of the strengths of this study. Individual studies used food 
frequency questionnaires (FFQ) to record how often the subjects consume fluid intake 
over a period of time. FFQ has been demonstrated to be reliable and easy to complete 
for subjects in a large population setting. All datasets were re-coded using standard 
rules and fluid items were standardised from portion sizes (e.g. cups, pints) to millilitres 
to ensure consistency across all studies. Adjustment was made for the principal 
confounders such as smoking history (smoking status, smoking duration and smoking 
frequency), age and gender.  
This study may have several limitations, firstly only case-control studies were included 
in this pooled analysis. Case-control study designs are more susceptible to recall bias 





result observed in this study. However to reduce selection bias, for each study the 
controls subjects were selected from the same source population were the cases were 
derived from. Recall bias might be a limitation because subjects with the disease might 
report fluid consumption differently compared to subjects with no disease. However, it 
is unlikely that recall bias can distort the results of this study because cases and controls 
generally were not aware of the association between coffee consumption and bladder 
cancer. 
Studies were conducted in three continents: Europe, North America and Asia. Studies 
conducted in the African continent were not included because of limited evidence on 
bladder cancer risk and dietary consumption.  
None of the included studies in this study provided information on the method of 
preparation or brewing of coffee. In different populations, brewing and method of 
preparation of coffee varies considerably.69 The concentration of coffee consumed or 
exposure of coffee may vary across countries. However, potential variation in exposure 
variable (fluid item) between studies was taken into account by including a random 
slope in the multilevel logistic regression model (an interaction between the cluster 
variable i.e. hospital or centre within the study and fluid item).  
 
Despite the available biological mechanism on the effect of coffee consumption and risk 
of developing bladder cancer, it is possible the results might be confounded by smoking. 
Therefore, in this study, subgroup analysis by smoking status in men was conducted and 
adjustment was made for smoking duration and cigarette smoking per day for ever 
smokers. The result shows a positive association in both ever smokers and never 





consumption effect on the risk of developing bladder cancer. Furthermore, other 
possible unknown confounders that might play a role in bladder cancer risk were not 
adjusted for due to lack of information or data. 
In conclusion, this pooled analysis of 18 individual case-control studies suggests that 
consumption of at least 10 or more cups (≥2500 ml/day) of coffee per day may increase 
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6.0 CHAPTER SIX 







6.1 Principal findings 
 
Chapter 2 focused on investigating the role of dietary consumption and diet diversity on 
the risk of developing bladder cancer in a Chinese population. This thesis showed that a 
high diet diversity— particularly a diet varied in fruit— may reduce the risk of developing 
bladder cancer. The consumption of citrus fruits, stone fruits, vine fruits, flower 
vegetables, fresh fish, potatoes and dairy products may decrease the risk of developing 
bladder cancer, whereas the consumption of red meat, organ meat, leafy vegetables, bulb 
vegetables or preserved vegetables may increase the risk of bladder cancer. 
 
In chapter 3, an update of previous published reviews and a dose-response meta-analysis 
summarizing the results from epidemiological studies on overall fluid consumption and 
risk of developing bladder cancer was presented. The results indicate that low to moderate 
fluid consumption is not associated with an increased risk of developing bladder cancer but 
that fluid consumption exceeding eight cups per day increases the risk of developing 
bladder cancer substantially in men only.  The results of this study suggest a non-linear 
relationship between total fluid intake and bladder cancer risk in men. 
 
In Chapter 5 the association between fluid consumption and risk of developing bladder 
cancer was investigated by pooling individual patient data from the BLEND consortium. A 







The results presented in this thesis suggest that the consumption of 10 or more cups (≥2500 
ml/day) of coffee per day increases the risk of developing bladder cancer by 3-fold in men.  
Additionally, the association between coffee consumption and bladder cancer risk did not 
differ substantially between ever smokers and never smokers in men which suggest that the 
found association is not confounded by smoking.  
6.2 Discussion 
To my knowledge, only chapter two is the second study to examine the association 
between diet diversity and risk of developing bladder cancer.  Contrary to the findings, the 
other previous study that examined fruit and vegetable diversity and risk of developing 
bladder cancer reported that there was no overall relationship between vegetable diversity 
or fruit diversity and risk of developing bladder cancer.1 The inconsistencies observed 
between both studies might be due to differences in methods of dietary assessment. The 
previous study was a multicentre cohort study, consisting of subjects from 23 centres in 10 
European countries.  In the previous study the method of dietary assessment differed 
between countries, for example different questionnaires such as food frequency 
questionnaire, semi quantitative questionnaire and extensive self-administered 
questionnaire. Also, in the dietary questionnaires the number of fruits and vegetables 
consumed differed by country. In the study population of the case-control study conducted 
in this thesis, the study population was from China and a food frequency questionnaire was 
used to obtain information on dietary consumption. Because of the differences in study 
design and methods of dietary assessment it is difficult to compare findings between 
studies.  
Additionally, other studies have investigated the relationship between diet diversity and 





diversity is associated with decrease risk of developing colorectal cancer.2 Another study 
concluded that a diet that is diverse in vegetable and fruit was significantly associated with 
decrease risk of developing pharyngeal cancer.3 All these findings are consistent with the 
findings in this thesis on diet diversity and risk of developing bladder cancer. Also the 
results of this thesis supports the recommended dietary guideline on more varied diet.4 The 
American dietary guideline supports a more diverse diet particularly in fruits and 
vegetables.4 
 
Other findings from chapter 2 confirm the results of previous studies that the consumption 
of citrus fruits, stone fruits, vine fruits, flower vegetables, fresh fish, potatoes and dairy 
products may decrease the risk of developing bladder cancer, whereas the consumption of 
red meat, organ meat, leafy vegetables, bulb vegetables or preserved vegetables may 
increase the risk of bladder cancer. These findings support the World Health Organization 
guidelines which recommend 5 a day, that is, eating 400 grams of fruits and vegetables a 
day to reduce the risk of developing chronic diseases like cancer and diabetes. 5 
 
In chapter 3 and 5, the effect of total fluid consumption on the risk of developing bladder 
cancer was investigated using two different approaches (meta-analysis and pooled 
analysis). The result in both chapters indicated a non-linear relationship between total fluid 
consumption and risk of developing bladder cancer in men. The European Food Safety 
Authority  and Food standard Agency proposed that individuals should consume 6 to 8 
glasses of fluid every day.6,7 In this thesis, it is possible the increased bladder cancer risk  
in relation to total fluid consumption observed might be due high consumption of specific 





coffee, water, tea and soda water etc. The major limitation in the dose response meta-
analysis conducted in this thesis is that only data on total fluid consumption was available 
and further analysis into specific fluid consumption in relation to bladder cancer risk was 
not conducted.  An advantage of using the pooled analysis approach is that specific fluid 
items could be investigated in relation to bladder cancer and subgroup analyses could be 
conducted for smoking and gender. Additionally, the result from chapter 5 suggests that 
excess consumption of coffee may increase the risk of developing bladder cancer by 3 fold 
in men.  This result is consistent with the American medical association council on 
scientific affairs which recommends that 10 cups of coffee per day is excessive and people 
should consume two to three cups of coffee per day.8 Excess consumption of coffee has 
been associated with increased risk of diseases such as osteoporosis, fibrocystic disease.8 
 
6.3 Strengths and Limitations of conducting research on dietary consumption and 
fluid consumption in relation to bladder cancer risk  
6.3.1 Assessment of dietary and fluid consumption 
A challenge in many epidemiological studies that aim to investigate the relationship 
between dietary consumption and fluid consumption and a specific disease is that dietary 
assessment is extremely difficult to measure.9 Usually,  a food frequency questionnaire is 
the tool used in epidemiological studies to measure dietary consumption.10 Other used 





Food frequency questionnaire 
Food frequency questionnaires are used to assess individuals’ habitual food and beverages 
consumption over a given period of time (for example one year).10 The food frequency 
questionnaire (FFQ) is an appropriate tool used for large scale epidemiological studies on 
dietary consumption and disease risk.11 In this thesis, a food frequency questionnaire was 
used in the study conducted in chapter 2 and all case-control studies included in the 
BLEND consortium. In addition, it has been suggested that food frequency questionnaire is 
the most appropriate tool to use for case-control study design because it assess the food 
and drink over a longer period time. The reliability of the FFQ has been tested previously 
and measures the frequency of food consumed in individuals.  However, the FFQ does not 
ask for details on how the food was prepared and the portion size consumed. Other 
alternative methods such as the food diary and 24 hour recall can be used obtain the 
portion size of food consumed. The food frequency questionnaire takes into account the 
day to day variability of food consumed by individuals. The FFQ is relatively less 
expensive tool used in measuring food, nutritional and beverage consumption when 
compared to other alternative methods of food assessment such as 24 hour recall 
questionnaires and food diary.10 Hence, the FFQ in the SEARCH study as described in 
chapter 2. 
 
24 hour recall questionnaire 
The 24 hour recall questionnaire involves trained interviewers asking individuals about 
their food and drink consumption in the preceding 24 hours. This method can be used to 
obtain detailed information of food and drink consumed such as methods of cooking, 





Food diary / record 
This method of dietary assessment requires individuals to record food and drink 
consumption for 3, 4, 5 or 7 days at home in a food diary. The food diary consists of 
coloured photographs of different food items and their portion sizes. One benefit of the 
food diary is that it gives comprehensive information on the food consumed in portion 
sizes and  weight  of food items can be recorded before consumption.12 Furthermore, some 
food items consumed can be eaten raw or cooked for example tomatoes, fish etc. The FFQ 
might not have detailed information on such food items. 
Therefore, future studies on the association between fluid consumption and risk of 
developing bladder cancer should also focus on assessing the quantity or portion sizes of 
food consumed using combination alternative questionnaires such as food diaries, 24 hour 
recall questionnaires. Illustrated in table 6.1 are the advantages and disadvantages of the 
















Table 6.1 Advantages and disadvantages of the commonly used methods of dietary 
assessment  
 
Methods of dietary assessment Advantages Disadvantages 
Food frequency questionnaire  
 
• Does not alter eating 
behaviours 
 
• Captures  frequency or 
usual consumption over 
a long period of time 
 







• Relies on the  recall of 
subjects food or fluid 
consumption  
 
• FFQ does not give precise 
quantity of food 
consumed by subjects 
 
• Dietary pattern cannot be 
recorded  
 
• Cannot be used over short 
period of time 
 
24 hour recall • Consumption is 
measured in portion size 
or weighed, gives more 
detail 
 
• Eating behaviour is not 
altered  
 
• Can be used over a short 
period of time 
 
• Expensive when 
compared to food 
frequency questionnaire 
 
• Rely  on subjects  recall on 
fluid and food 
consumption 
 
• Requires multiple recalls 
over several months to 
capture the usual   
consumption 
 
Food diary / record  • Do not rely on subjects  
recall 
 
• Gives detailed 
information of portion 
size and estimates of 
food and drink eaten 
 
• Suitable for assessment 




• Time consuming 
 




• Individuals might forget to 










A potential issue in the analysis of diet and cancer is extreme correlations, that is 
collinearity, between similar food items complicating determining the net effect of a 
specific food item on an outcome.14  Food items from the same food group might consist of 
similar nutrients, for example citrus fruits such as orange, satsuma and grapefruit might 
have high degree of collinearity. An example of multicollinearity problem is when a 
particular variable is added to a regression model that is correlated with other explanatory 
variables of interest and this will increase the variance.  Therefore, the added variable to 
the regression model do not explain the variation in the outcome variable. In this thesis, to 
detect the degree of multicollinearity of the food items in the case-control study from 
chapter 2, a correlation test was conducted to confirm if two or more food items were 
correlated. 
6.4 Implication of conducting meta-analysis versus pooled analysis in dietary 
consumption and bladder cancer research 
Some individual studies had small sample sizes and lacked statistical power to yield 
conclusive results on the association between fluid consumption and risk of developing 
bladder cancer. In chapter 3 and 5 of this thesis, a meta-analysis and a pooled analysis 
procedure was used to investigate the association between fluid consumption and risk of 
developing bladder cancer. Meta-analysis and  a pooled analysis methods are extensively 
used in epidemiological research when results from individual studies are inconclusive.15 
The meta-analysis required pooling of results of individual studies to produce an overall 
summary effect. The pooled analysis involved pooling individual patient data from prior 





investigated.15  Both a meta-analysis and pooled analysis  methods have usually greater 
statistical power and give more precise estimates when compared to individual studies.16 
 Despite the benefits of using meta-analysis and pooled analysis in term of gaining 
statistical power, both methods have advantages and disadvantages.   In the dose-response 
meta-analysis in this thesis, a subgroup analysis according to smoking could not be 
conducted because most individual studies did not report the association between total 
fluid consumption and risk of developing bladder cancer stratified by smoking. However, 
in the pooled analysis individual patient data was available on smoking history, gender and 
age for studies included in the BLEND consortium.  
Furthermore, the studies included in both the meta-analysis and pooled analysis were 
conducted in different populations, there is a chance that there will be variations between 
studies hence is critically important to choose a model that will take account of these 
variations. The random effect model was used in the dose-response meta-analysis which 
takes into account the variations in terms population across the studies. In the pooled 
analysis a more complex model (multilevel mixed-effects logistic regression model) was 
used which takes into account the variation across the studies but also potential clustering 
within studies. An example of a clustering within a study is when subjects are recruited 
from different centers or hospitals. 
In the meta-analysis, information on the overall total fluid intake was available in the 
relevant articles. Therefore, the pooled analysis was a more appropriate approach to be 
adopted when compared to the meta-analysis because it gave the opportunity to: explore 
variation within study for example clustering and investigate the association between 





bladder cancer. All these analyses were not possible in a meta-analysis because only data 






Table 6.2 Strengths and limitations of meta-analysis and pooled analysis15 
Methods            Strengths              Limitations 
Meta-analysis • Gives a further comprehensive 
summary of literature than 
narrative systematic review 
 
• Gives a precise estimate of the 
average effect from all 
available studies 
 
• Increases statistical power 
 
• Examine between study 
heterogeneity 
• Heterogeneity across included 
studies 
 
• Difficult to examine subgroup 
analyses or conduct stratified 
analysis  
 
• Errors cannot be checked in 
individual studies because of lack 
of availability of individual patient 
data 
Pooled analysis • Increase statistical power 
 
• Permits subgroup analyses 
 
• Allows  better adjustment of 
confounders 
 
• Gives a precise estimates of 
the average effect from all 
available studies 
• Time consuming  
 
• Involves collaboration with many 
principal investigators 
  
• Unavailability of data and some 
principal investigators might not 
be willing to participate 
 
6.5 Case-control studies  
In a case-control study the cases are identified with a particular disease in a given 
population and the controls are generally  free of disease of interest.17  Details on 
exposures are collected retrospectively.  In chapter two of this thesis, a hospital based case-
control design was used to investigate the association between dietary consumption and 
diet diversity and risk of developing bladder cancer. Cases were histologically confirmed 
bladder cancer patient and the controls were recruited from the same hospital as the cases 
and were free from cancer. The case-control design was used in this study because it is 
more appropriate to study diseases that are rare, for example bladder cancer and 





prospective cohort, case-control studies may be subject to recall bias and selection bias.17 
Strengths of case-control studies are: case-control studies are less expensive and quicker to 
conduct compared to other study designs such as cohort study. Also, they are suitable for 
examining rare diseases such as bladder cancer.  Case-control studies can be used to 
investigate multiple risk factors and smaller sample sizes are necessary compared to cohort 
studies.  
Further limitations of case-control studies include: this study design is limited to 
examining one outcome. Also, case-control studies are subject to recall and selection bias, 
and rare exposures are difficult to investigate. In chapter 2, 3, and 5 of this thesis, the 
limitations of recall and selection bias have been discussed for each chapter. 
 
In this study, both hospital and population controls were included and both controls have 
numerous strengths and limitation. Although the hospital controls are not healthy and may 
have diseases with the same risk factors.  In this study controls were hospitalized for 
digestive, cardiovascular and respiratory diseases therefore I conducted a sensitivity 
analysis excluding controls that have digestive problem. No substantial effect on the OR 
estimates was observed after including or excluding these controls. Using hospital controls 
in case-control studies have some advantages for example: the hospital controls are easy to 
find and more co-operative and have similar tendency to remember past exposure and 
other factors (such as ethnic and socioeconomic status). In addition, when hospital controls 
are used, recall bias and selection bias are minimized because the hospital controls are 





6.6 Implication for practice 
According to the findings in this thesis, diet diversity may reduce the risk of developing 
bladder cancer, particularly fruit diversity. Therefore, the policy makers and general public 
should be aware of importance of variety in diet and should be encouraged to consume 
diverse diet particularly a diet diverse in fruit. Although this is the second study on this 
topic area therefore more investigation. The World Health Organization (WHO) dietary 
guidelines advice the general public to increase intake of variety of different foods through 
and within food groups to encourage good health and for consumption of sufficient 
essential nutrients.18 In addition, individuals should be aware that consumption of citrus 
fruits, stone fruits, vine fruits, flower vegetables (broccoli, cauliflower), white fresh fish, 
eggs, potatoes and dairy products could prevent bladder cancer. While high consumption 
of red meat, organ meat, bulb vegetables and preserved vegetables could increase the risk 
of bladder cancer. Also, it has been recommended by experts that diet consisting of low fat 
from meat might reduce the risk of chronic diseases such as cardiovascular diseases.19 The 
World Cancer Research Fund (WCRF)/ American Institute for Cancer Research (AICR) 
suggested that a diverse diet consisting of protein-rich and starch plant based foods might 
be a better diet when compared to diets high in meat, alcohol, fat and sugar.19  
 
The results of this thesis emphasize that eight cups of fluid per day should be consumed; 
this finding is consistent with the normal recommended fluid consumption per day. 
Therefore, general public should be advised by health professionals and doctors to 
consume the recommended 6 cups of total fluid per day and in relation to bladder cancer 
risk. Findings of this thesis suggest that consumption of ten or more cups of coffee is 





should be advised on the effect of excessive consumption of coffee and the risk of 
developing bladder cancer. Although, the relative risk of 2.9 was observed for coffee 
consumption, 3% of cases who consumed 10 or more cups of coffee could be attributed to 
having bladder cancer.  So in essence, a case number of bladder cancers could potentially 
be prevented if people who consume a lot of coffee would decrease their coffee 
consumption. 
6.7 Recommendation for future research on dietary consumption and bladder cancer 
People eat meals consisting of different food groups (for example fish, grains and 
vegetables etc.) with combination of nutrients. To my knowledge, this is the second study 
that explicitly investigated the effect of diet diversity and risk of developing bladder cancer 
risk. Therefore, it is important for researchers to further examine diet diversity and risk of 
developing bladder cancer in detail using combination of alternative tools such as diet 
diversity questionnaire as proposed by Food and Agriculture Organization (FAO) or 24 
hour recall questionnaire. 20 
 
Since most individuals consume different variety of food items and drinks each day, 
therefore, future research should explore the effect of dietary patterns and risk of 
developing bladder cancer. To my knowledge only one study has investigated the 
association between dietary pattern and risk of developing bladder cancer. 21 
 
To date, most epidemiological studies have focused mainly on dietary consumption and 
risk of developing bladder cancer and there is a need to further investigate the prognosis of 
bladder cancer in relation to dietary consumption. Additionally, the effect of dietary 





invasive bladder cancer to muscle invasive bladder cancer should be investigated in detail.  
To my knowledge, only one study investigated the relationship between cruciferous 
vegetables and among bladder cancer survivors. The findings of the study suggest that 
broccoli consumption may reduce bladder cancer mortality. 
 
Most studies conducted on dietary consumption in relation to bladder cancer were 
conducted in Europe, North America and few in Asia. Therefore, results observed in this 
thesis reflect the association between dietary consumption and fluid consumption and risk 
of developing bladder cancer in developed countries.22,23 As a result, well-designed 
epidemiological studies are needed in Africa and Asia to investigate the dietary factors and 
diet diversity and risk of developing bladder cancer.  
 
Future studies should report the different methods of cooking, preservation and processing 
of dietary and fluid items; to better understand the relationship between dietary 
consumption, fluid consumption and risk of developing bladder cancer.  
The association between cooking method or method of food preparation and risk of 
developing bladder cancer was reported in three previous epidemiological studies. 
Findings from two of the previous studies have suggested that food items such as red meat 
when cooked in high temperature forms compounds like heterocycline amines that may 
increase the risk of developing bladder cancer. Another previous study suggested no 
significant association between cooking method and risk of developing bladder cancer. 
Also, deep fried foods are associated with elevated risk of diseases; hence  according to 
World Health Organization (WHO) a safe way of preparation of food to reduce fat is by 





preservation and processing of food and fluid items on the risk of developing cancer are 
limited. 
 
6.8 General conclusion 
 
The general conclusions of this thesis are: higher diet diversity, particularly a diet varied in 
fruit may reduce the risk of developing bladder cancer. A low to moderate fluid 
consumption was not associated with an increased risk of developing bladder cancer; 
although fluid consumption exceeding 8 cups per day increases the risk of developing 
bladder cancer substantially in men.  A J shape association between total fluid intake and 
bladder cancer risk in men was observed.  An increased risk of developing bladder cancer 
by 3 folds in men who consumed at least 10 or more cups (≥2500 ml/day) of coffee per day 
was found. In addition, the positive association between coffee consumption and bladder 
cancer risk in men was observed both in ever smokers— after adjusting for amount of 
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Appendix 2.1: Published Article in Journal of Cancer Causes and Control: Dietary 
consumption and diet diversity and risk of developing bladder cancer: results from the 





Appendix 3.1: Search strategy for dose response meta-analysis on fluid intake and 
risk of developing bladder cancer 
 
Ovid MEDLINE(R) 1946 to November Week 3 2012  
Search Strategy: 
# Searches Results 
1 bladder cancer$.mp. or exp Urinary Bladder Neoplasms/ 43742 
2 ucc.mp. 322 
3 exp Carcinoma, Transitional Cell/ or tcc.mp. 16698 
4 
((bladder or urinary) adj2 (neoplasm$ or cancer$ or carcinoma$)).mp. [mp=title, abstract, original 
title, name of substance word, subject heading word, protocol supplementary concept, rare disease 
supplementary concept, unique identifier] 
45530 
5 or/1-4 50704 
6 
((fluid$ or liquid$ or beverage$) adj2 (intake or consumption)).mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, protocol supplementary concept, rare disease 
supplementary concept, unique identifier] 
4978 
7 drink$.mp. 121247 
8 drinking behavior.mp. or exp Drinking Behavior/ 53693 
9 or/6-8 124064 




Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations January 02, 2013  
Search Strategy: 
# Searches Results 
1 bladder cancer$.mp. or exp Urinary Bladder Neoplasms/ 1313 
2 ucc.mp. 20 
3 tcc.mp. or exp Carcinoma, Transitional Cell/ 243 
4 ((bladder or urinary) adj2 (neoplasm$ or cancer$ or carcinoma$)).mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, protocol supplementary concept, rare disease 
supplementary concept, unique identifier] 
1525 
5 or/1-4 1679 





of substance word, subject heading word, protocol supplementary concept, rare disease supplementary 
concept, unique identifier] 
7 drink$.mp. 4765 
8 drinking behavior.mp. or exp Drinking Behavior/ 399 
9 or/6-8 4955 
10 5 and 9  
 
 
Embase 1974 to 2012 December 19  
Search Strategy: 
# Searches Results 
1 bladder cancer$.mp. or exp bladder cancer/ 45625 
2 ucc.mp. 475 
3 transitional cell carcinoma/ or tcc.mp. 17287 
4 ((bladder or urinary) adj2 (neoplasm$ or cancer$ or carcinoma$)).mp. [mp=title, abstract, subject 
headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device 
trade name, keyword] 
56204 
5 or/1-4 64959 
6 ((fluid$ or liquid$ or beverage$) adj2 (intake or consumption)).mp. [mp=title, abstract, subject headings, 
heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade 
name, keyword] 
18041 
7 drink$.mp. 137681 
8 drinking behavior.mp. or exp drinking behavior/ 33919 
9 or/6-8 150175 




"Urinary Bladder Neoplasms"[Mesh] AND "Beverages"[Mesh] AND (Journal Article[ptyp] AND 











Appendix 3.2: Appendix 3.2: Meta-regression for total fluid intake and risk of 






Appendix 4.1 Studies not included in The Bladder Cancer Epidemiology and 












Year of publication   
Old studies 1.00  
New studies 1.00(0.87-1.14) .05538 
Method of fluid assessment   
Interview and questionnaire 1.00  
Food frequency questionnaire 0.94 (0.82-1.08) .05119 
Type of study design   
Hospital based case-control study 1.00  
Population based case-control study 0.99(0.87-1.12) .04962 
Cohort study 1.08(0.88-1.32) .09035 
Continent    
North America 1.00  
Europe 0.97(0.84-1.11) .05413 
Asia 0.93(0.80-1.08) .05596 
Smoking   
Never smoked/former smoker/current smoker 1.00  
Never smoked/former smoker/current smoker (pack years) 1.03( 0.90-1.20) .06202 
Never smoked/former smoker/current smoker (smoking 
frequency and smoking duration) 
0.96(0.82-1.11) .05745 
   










Sun 1 China 2004 Cohort 61 18244 1986-1989 Shanghai Cohort 
Study 
Sun2  China 2002 Cohort 61 63257 1993-1998 Singapore Chinese  
Health Study 
Serra 3 Spain 2008 Case-
Control 
1219 1271 1998-2001 Spanish Bladder  
Cancer Study 
Ciccone 4 Italy 1988 Case-
Control 
567 794 1978-1983 Turin Study 
Carel 5 Israël 1999 Case-
Control 
92 92 1989-1993 Israël Study 
Lynch 6 USA 1987 Case-
Control 
49 956 N/A Omaha, Nebraska 
 Study 
Schabath 7 USA 2005 Case-
Control 
409 451 1999-2003 The University of  
Texas M.D. Anderson  
Cancer Center 












214 540 2002-2004 Eastern European  
Bladder Cancer Study 
Rohan 9 Canada 2007 Cohort 140 4800 1995-1998 Canadian Study 





1453 6468 1995-2006 Nijmegen Bladder  
Cancer Study 
Baris11 USA 2009 Case-
Control 
1170 1413 2001-2004 New England  
Study 
Radosavljevic12 Serbia  2005 Case-
Control 
130 130 1997-199 Serbia Case-Control  
Study 
Riboli13 Spain 1991 Case-
Control 
432 792 1985-1986 Spanish Multi-centre  
Case-Control  
Study 
Sakauchi Japan 2005 Cohort 123 - 1988-1997 Japan collaborative  
Cohort Study 
Zhao14 USA 2007 Case-
Control 
697 708 1999-2007 The University of  
Texas M.D. Anderson 
 Cancer Centre Study 
Wilkens15 Hawaii 1996 Case-
Control 
261 522 1979-1986 Hawaii Study 
Mucci16 Sweden 2003 Case-
Control 
263 538 1992-1994 Stockholm   
cancer Study 
Aune17 Uraguay 2009 Case-
Control 
254 2117 1996-2004 Uraguay cancer 
 Study 
Balbi 18 Uraguay 2001 Case-
Control 
144 516 1998-1999 Montevideo Study 
Michaud 19 Spain 2007 Case-
Control 
397 664 1998-2001 Bladder cancer 





765 765 1984-1987 France Case-Control  
Study 
Cantor21 USA 1998 Case-
Control 
1452 2434 1986-1989 Iowa Case-Control  
Study 
Brummer22 USA 1996 Case-
Control 
202 220 1987-1990 Western Washington 






Kunze23 Germany 1992 Case-
Control 
491 431 1977-1985 South Lower Saxony  
Case-control Study 
Slattery24 USA 1988 Case-
Control 
419 889 1977-1982 Utah Case-Control  
Study 
Jensen25 Denmark 1986 Case-
Control 
371 771 1979-1981 Cophenghen  
Case-Control Study 
Claude26 Germany 1986 Case-
Control 
431 431 1977-1982 Southern Lower  
Saxony Case-Control  
Study 
Michaud 27 Finland 2002 Cohort 344 - 1985-1998 Alpha-tocopherol 
 beta-carotene  
cancer prevention 
Study 
Michaud 28 USA 2000 Cohort 320 - 1986-
Ongoing  
Health professional 
 follow up study 










1549 - 1986-2003 Netherlands Cohort  
Study on Diet and 
Cancer 
Demiral 31 Turkey 2008 Case-
Control 




Destefani32 Uraguay 2007 Case-
Control 
255 501 1996-2006 Uraguay Bladder 
Cancer  
Case-Control study 
Chyou33 Hawaii 1993 Case-
Control 
96 96 1965-1968 Oahu Hawaii 
 Case-Control Study 
Mills34 USA 1991 Cohort 52 - 1976-1982 Seventh-day  
Adventist Study 
Risch35 Canada 1988 Case-
Control 
826 792 1979-1982 Canada  
Case-Control Study 
Wynder36 USA 1980 Case-
Control 
367 367 1957-1960 New York  
Case-Control Study 
Garcia-closas37 Spain 2007 1219 1219 1271 1998-2001 Spanish Bladder 
Cancer Study 
Dunham38 USA 1968 Case-
Control 
702 NA 1958-1964 New Orleans 
Bladder Cancer 
Study 
Bate39 Argentina 2007 Case-
Control 
114 114 N/A Argentina  
Case-control Study 
Castelao40 America 2004 Case-
Control 
1592 1592 1987-1996 Non-Asians Los 
Angeles Study 
Sacerdote41 Italy 2007 Case-
Control 
266 193 1994-2003 Torino Study 




Texas Cancer Centre 
Study 
Kurashi43 Japan 2009 Cohort 206 - 1990-2005 Japanese bladder 








1. Sun CL, Yuan JM, Wang XL, Gao YT, Ross RK, Yu MC. 
Dietary soy and increased risk of bladder cancer: a prospective cohort 
study of men in Shanghai, China. Int J Cancer. 2004 Nov 1;112(2):319-
23. 
2. Sun CL, Yuan JM, Arakawa K, Low SH, Lee HP, Yu MC. 
Dietary soy and increased risk of bladder cancer: the Singapore Chinese 
Health Study. Cancer Epidemiol Biomarkers Prev. 2002 
Dec;11(12):1674-7. 
3. Serra C, Kogevinas M, Silverman DT, Turuguet D, Tardon A, 
Garcia-Closas R, et al. Work in the textile industry in Spain and bladder 
cancer. Occup Environ Med. 2008 Aug;65(8):552-9. 
4. Ciccone G, Vineis P. Coffee drinking and bladder cancer. Cancer 
Lett. 1988 Jul;41(1):45-52. 
5. Carel R, Levitas-Langman A, Kordysh E, Goldsmith J, Friger M. 
Case-referent study on occupational risk factors for bladder cancer in 
southern Israel. Int Arch Occup Environ Health. 1999 Aug;72(5):304-8. 
6. Lynch HT, Kimberling WJ, Lynch JF, Brennan K. Familial 
bladder cancer in an oncology clinic. Cancer Genet Cytogenet. 1987 
Jul;27(1):161-5. 
7. Schabath MB, Spitz MR, Lerner SP, Pillow PC, Hernandez LM, 
Delclos GL, et al. Case-control analysis of dietary folate and risk of 
bladder cancer. Nutr Cancer. 2005;53(2):144-51. 
8. Kiemeney LA, Thorlacius S, Sulem P, Geller F, Aben KK, Stacey 
SN, et al. Sequence variant on 8q24 confers susceptibility to urinary 
bladder cancer. Nat Genet. 2008 Nov;40(11):1307-12. 
9. Rohan TE, Soskolne CL, Carroll KK, Kreiger N. The Canadian 
Study of Diet, Lifestyle, and Health: design and characteristics of a new 
cohort study of cancer risk. Cancer Detect Prev. 2007;31(1):12-7. 
10. Aben KK, Witjes JA, Schoenberg MP, Hulsbergen-van de Kaa C, 
Verbeek AL, Kiemeney LA. Familial aggregation of urothelial cell 
carcinoma. Int J Cancer. 2002 Mar 10;98(2):274-8. 
11. Baris D, Karagas MR, Verrill C, Johnson A, Andrew AS, Marsit 
CJ, et al. A case-control study of smoking and bladder cancer risk: 
emergent patterns over time. J Natl Cancer Inst. 2009 Nov 
18;101(22):1553-61. 
12. Radosavljevic V, Jankovic S, Marinkovic J, Dokic M. Diet and 
bladder cancer: a case-control study. Int Urol Nephrol. 2005;37(2):283-9. 
13. Riboli E, Gonzalez CA, Lopez-Abente G, Errezola M, Izarzugaza 
I, Escolar A, et al. Diet and bladder cancer in Spain: a multi-centre case-
control study. Int J Cancer. 1991 Sep 9;49(2):214-9. 
14. Zhao H, Lin J, Grossman HB, Hernandez LM, Dinney CP, Wu X. 
Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and 





15. Wilkens LR, Kadir MM, Kolonel LN, Nomura AM, Hankin JH. 
Risk factors for lower urinary tract cancer: the role of total fluid 
consumption, nitrites and nitrosamines, and selected foods. Cancer 
Epidemiol Biomarkers Prev. 1996 Mar;5(3):161-6. 
16. Mucci LA, Dickman PW, Steineck G, Adami HO, Augustsson K. 
Dietary acrylamide and cancer of the large bowel, kidney, and bladder: 
absence of an association in a population-based study in Sweden. Br J 
Cancer. 2003 Jan 13;88(1):84-9. 
17. Aune D, De Stefani E, Ronco A, Boffetta P, Deneo-Pellegrini H, 
Acosta G, et al. Legume intake and the risk of cancer: a multisite case-
control study in Uruguay. Cancer Causes Control. 2009 Nov;20(9):1605-
15. 
18. Balbi JC, Larrinaga MT, De Stefani E, Mendilaharsu M, Ronco 
AL, Boffetta P, et al. Foods and risk of bladder cancer: a case-control 
study in Uruguay. Eur J Cancer Prev. 2001 Oct;10(5):453-8. 
19. Michaud DS, Kogevinas M, Cantor KP, Villanueva CM, Garcia-
Closas M, Rothman N, et al. Total fluid and water consumption and the 
joint effect of exposure to disinfection by-products on risk of bladder 
cancer. Environ Health Perspect. 2007 Nov;115(11):1569-72. 
20. Geoffroy-Perez B, Cordier S. Fluid consumption and the risk of 
bladder cancer: results of a multicenter case-control study. Int J Cancer. 
2001 Sep;93(6):880-7. 
21. Cantor KP, Lynch CF, Hildesheim ME, Dosemeci M, Lubin J, 
Alavanja M, et al. Drinking water source and chlorination byproducts I. 
Risk of bladder cancer. Epidemiology. 1998 January;9 (1):21-8. 
22. Bruemmer B, White E, Vaughan TL, Cheney CL. Nutrient intake 
in relation to bladder cancer among middle-aged men and women. Am J 
Epidemiol. 1996 Sep 1;144(5):485-95. 
23. Kunze E, Chang-Claude J, Frentzel-Beyme R. Life style and 
occupational risk factors for bladder cancer in Germany. A case-control 
study. Cancer. 1992 Apr 1;69(7):1776-90. 
24. Slattery ML, West DW, Robison LM. Fluid intake and bladder 
cancer in Utah. Int J Cancer. 1988 Jul 15;42(1):17-22. 
25. Jensen OM, Wahrendorf J, Knudsen JB, Sorensen BL. The 
Copenhagen case-control study of bladder cancer. II. Effect of coffee and 
other beverages. Int J Cancer. 1986 May 15;37(5):651-7. 
26. Claude J, Kunze E, Frentzel-Beyme R, Paczkowski K, Schneider 
J, Schubert H. Life-style and occupational risk factors in cancer of the 
lower urinary tract. Am J Epidemiol. 1986 Oct;124(4):578-89. 
27. Michaud DS, Pietinen P, Taylor PR, Virtanen M, Virtamo J, 
Albanes D. Intakes of fruits and vegetables, carotenoids and vitamins A, 
E, C in relation to the risk of bladder cancer in the ATBC cohort study. 
Br J Cancer. 2002 Oct 21;87(9):960-5. 
28. Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Willett WC, 
Giovannucci E. Prospective study of dietary supplements, 
macronutrients, micronutrients, and risk of bladder cancer in US men. 





29. La Vecchia C, Negri E, Decarli A, D'Avanzo B, Liberati C, 
Franceschi S. Dietary factors in the risk of bladder cancer. Nutr Cancer. 
1989;12(1):93-101. 
30. Keszei AP, Schouten LJ, Goldbohm RA, van den Brandt PA. 
Dairy intake and the risk of bladder cancer in the Netherlands Cohort 
Study on Diet and Cancer. Am J Epidemiol. 2010 Feb 15;171(4):436-46. 
31. Demirel F, Cakan M, Yalcinkaya F, Topcuoglu M, Altug U. The 
association between personal habits and bladder cancer in Turkey. Int 
Urol Nephrol. 2008;40(3):643-7. 
32. De Stefani E, Boffetta P, Ronco AL, Deneo-Pellegrini H, Acosta 
G, Mendilaharsu M. Dietary patterns and risk of bladder cancer: a factor 
analysis in Uruguay. Cancer Causes Control. 2008 Dec;19(10):1243-9. 
33. Chyou PH, Nomura AM, Stemmermann GN. A prospective study 
of diet, smoking, and lower urinary tract cancer. Ann Epidemiol. 1993 
May;3(3):211-6. 
34. Mills PK, Beeson WL, Phillips RL, Fraser GE. Bladder cancer in 
a low risk population: results from the Adventist Health Study. Am J 
Epidemiol. 1991 Feb 1;133(3):230-9. 
35. Risch HA, Burch JD, Miller AB, Hill GB, Steele R, Howe GR. 
Dietary factors and the incidence of cancer of the urinary bladder. Am J 
Epidemiol. 1988 Jun;127(6):1179-91. 
36. Wynder EL, Stellman SD. Artificial sweetener use and bladder 
cancer: a case-control study. Science. 1980 Mar 14;207(4436):1214-6. 
37. Garcia-Closas R, Garcia-Closas M, Kogevinas M, Malats N, 
Silverman D, Serra C, et al. Food, nutrient and heterocyclic amine intake 
and the risk of bladder cancer. Eur J Cancer. 2007 Jul;43(11):1731-40. 
38. Dunham LJ, Rabson AS, Stewart HL, Frank AS, Young JL. 
Rates, interview, and pathology study of cancer of the urinary bladder in 
New Orleans, Louisiana. J Natl Cancer Inst. 1968 Sep;41(3):683-709. 
39. Bates MN, Hopenhayn C, Rey OA, Moore LE. Bladder cancer 
and mate consumption in Argentina: a case-control study. Cancer Lett. 
2007 Feb 8;246(1-2):268-73. 
40. Castelao JE, Yuan JM, Gago-Dominguez M, Skipper PL, 
Tannenbaum SR, Chan KK, et al. Carotenoids/vitamin C and smoking-
related bladder cancer. Int J Cancer. 2004 Jun 20;110(3):417-23. 
41. Sacerdote C, Matullo G, Polidoro S, Gamberini S, Piazza A, 
Karagas MR, et al. Intake of fruits and vegetables and polymorphisms in 
DNA repair genes in bladder cancer. Mutagenesis. 2007 Jul;22(4):281-5. 
42. Lin J, Kamat A, Gu J, Chen M, Dinney CP, Forman MR, et al. 
Dietary intake of vegetables and fruits and the modification effects of 
GSTM1 and NAT2 genotypes on bladder cancer risk. Cancer Epidemiol 
Biomarkers Prev. 2009 Jul;18(7):2090-7. 
43. Kurahashi N, Inoue M, Iwasaki M, Sasazuki S, Tsugane S. 
Coffee, green tea, and caffeine consumption and subsequent risk of 
bladder cancer in relation to smoking status: a prospective study in Japan. 









Appendix 4.2 The Bladder Cancer Epidemiology and Nutritional 







VARIABLE LABEL  CODE VALUE LABEL 
        
A01 Study ID 101 Cohort of Swedish Men (Larsson et al) 
    102 Jiang et al (Los Angeles) 
    103 Tang et al (New York) 
    104 Spanish Bladder Cancer Study (Garcia-Closas et al) 
    105 Kellen et al (Limberg - Belgium) 
    106 Singapore Chinese Health Study (Sun et al) 
    107 Shanghai Cohort Study (Sun et al) 
    108 Netherlands Cohort Study (Zeegers et al) 
    109 Wakai et al (Japan) 
    110 Lu et al (Taiwan) 
    111 Pohlabeln et al (West Germany - Hessen) 
    112 Hartge et al (US) 
    113 Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study 
(Wright et al) 
    114 - 
    115 Steineck et al (Stockholm) 
    116 Quirk et al (New York) 
    117 Spanish Bladder Cancer Study (Serra et al) 
    118 Baena et al (Spain) 
    119 - 
    120 Turino Bladder Cancer Study (Sacerdote et al) 
    121 Wallace et al (New Hampshire) 
    122 - 
    123 Randi et al (Italy) 
    124 Carel et al (Israel) 
    125 Porru et al 
    126 Lynch et al (Omaha) 
    127 Lutherstadt Wittenberg Bladder Cancer Study (Golka et al) 
    128 Canadian Study (Gaertner et al) 
    129 French Bladder Cancer Study 
    130 SEARCH 
    131 Anderson 
    132 Zhang 
    133 Fletcher 
    134 Cantor 
    135 Bosetti 
    136 Kiemeney 
    137 Taylor 
    138 - 
    139 New England 
    140 Leeds 
    141 Women's Health Study (Zhang et al) 
    142 Swedish Women’s Lifestyle and Health Study (Wiederpass 
et al) 
    143 Canadian Study of Diet, Lifestyle, and Health (Rohan et al) 
    144 Park 





A02 Primary Subject ID   Assigned subject number 
A03 Study Subject ID   Study subject ID 
A04 Study Design 10 Case-Control Study 
    20 Cohort Study 
    21 Retrospective Cohort Study 
    22 Prospective Cohort Study 
    30 Cross-sectional Study 
A05 Assessment Method 10 Questionnaire 
    11 Self-administered questionnaire 
    12 Interview-administered questionnaire 
    20 Registry 




0 usual habit/currently 
    1 habits before current illness 
    2 < 1 year 
    3 >= 1 year 
A07 Country of study 
location 
1 Argentina 
    2 Belgium 
    3 Canada 
    4 China 
    5 Singapore 
    6 Denmark 
    7 France 
    8 Germany 
    9 Greece 
    10 Hawaii 
    11 Israel 
    12 Italy 
    13 Japan 
    14 Lebanon 
    15 Pakistan 
    16 Russia 
    17 Serbia 
    18 Spain 
    19 Sweden 
    20 Taiwan 
    21 The Netherlands 
    22 Tunisia 
    23 Turkey 
    24 UK 
    25 Uruguay 
    26 USA 
A08 Subject Status 1 Case subject 
    2 Control subject 
    3 Cohort Subject 
A09 Cluster 1 First centre or pair 
    2 Second centre or pair 





    4 Fourth centre or pair 
    5 Fifth centre or pair 
    6 Sixth centre or pair 
    7 Seven centre or pair 
    8 Eigth centre or pair 
B01 Age at time of bladder 
cancer diagnosis 
(years) 
  Age in years at time of diagnosis of bladder cancer 
B02 Age at time of 
study/questionnaire 
(years) 
  Age in years at time of questioning/study 
B03 Gender 1 Male 
    2 Female 
    .b Not known - data not asked 
    .a Missing data 
B04 Ethnic group 10 Caucasian 
    20 Mixed 
    21 White and Black Caribbean 
    22 White and Black African 
    23 Any other mixed background 
    30 Asian 
    31 Indian 
    32 Pakistani 
    33 Bangladeshi 
    34 Any other Asian background 
    40 Black 
    41 Caribbean 
    42 African 
    43 Any other Black background 
    50 Chinese 
    60 Any other ethnic group 
    .b Not known - data not asked 
    .a Missing data 
C01 Bladder Cancer Stage 10 Non-muscle invasive 
    11 CIS 
    12 Ta 
    13 T1 
    20 Muscle-invasive 
    21 T2 
    22 T3 
    23 T4 
    .c Not applicable 
    .b Not known - data not asked 
    .a Missing data 
C02 Nodal disease 1 No nodal disease 
    2 Nodal disease 
    .c Not applicable 
    .b Not known - data not asked 
    .a Missing data 
C03 Metastatic disease 1 No metastatic disease 





    .c Not applicable 
    .b Not known - data not asked 
    .a Missing data 
C04 Bladder Cancer Grade 10 Low grade 
    11 G1 
    12 G2 
    20 High grade (G3) 
    .c Not applicable 
    .b Not known - data not asked 
    .a Missing data 
D01 Tobacco smoking 
status 
1 Current tobacco smoker 
    2 Former tobacco smoker 
    3 Never tobacco smoker 
    .b Not known - data not asked 
    .a Missing data 
D02 Cigarette smoking 
status 
1 Current cigarette smoker 
    2 Former cigarette smoker 
    3 Never cigarette smoker 
    .b Not known - data not asked 
    .a Missing data 
D03 Passive smoking 
status 
1 No 
    2 Yes 
    .c Not applicable 
    .b Not known - data not asked 
    .a Missing data 
D04 Length of time 
smoking cigarettes 
(pack years) 
  Smoking pack years 
    .c Not applicable 
    .b Not known - data not asked 
    .a Missing data 
D05 Number of cigarette 
smoked per day 
.b Not known - data not asked 
    .a Missing data 
D06  Number of years of 
smoking cigarettes  
.b Not known - data not asked 
    .a Missing data 
E01 Number of siblings .b Not known - data not asked 
    .a Missing data 
E02 Number of brothers   Brothers 
E03 Number of sisters   Sisters 
E04 Number of offspring .b Not known - data not asked 
    .a Missing data 
E05 Number of sons   Sons 
E06 Number of daughters   Daughters 
F01 1st degree relative 
with bladder cancer 
1 Yes 
    2 No 





    .a Missing data 
F02 No. of 1st degree 
relatives with bladder 
cancer  
  Number of 1st degree relatives with bladder cancer 
F03 Classification of 1st 
degree relative with 
bladder cancer - 
Relative 1 
10 Parent 
    11 Father 
    12 Mother 
    20 Sibling 
    21 Sister 
    22 Brother 
    30 Offspring 
    31 Daughter 
    32 Son 
    .c Not applicable 
    .b Not known - data not asked 
    .a Missing data 
F04 Classification of 1st 
degree relative with 
bladder cancer - 
Relative 2 
10 Parent 
    11 Father 
    12 Mother 
    20 Sibling 
    21 Sister 
    22 Brother 
    30 Offspring 
    31 Daughter 
    32 Son 
    .c Not applicable 
    .b Not known - data not asked 
    .a Missing data 
F05 Classification of 1st 
degree relative with 
bladder cancer - 
Relative 3 
10 Parent 
    11 Father 
    12 Mother 
    20 Sibling 
    21 Sister 
    22 Brother 
    30 Offspring 
    31 Daughter 
    32 Son 
    .c Not applicable 
    .b Not known - data not asked 
    .a Missing data 
F06 Classification of 1st 
degree relative with 







    11 Father 
    12 Mother 
    20 Sibling 
    21 Sister 
    22 Brother 
    30 Offspring 
    31 Daughter 
    32 Son 
    .c Not applicable 
    .b Not known - data not asked 
    .a Missing data 
F07 Classification of 1st 
degree relative with 
bladder cancer - 
Relative 5 
10 Parent 
    11 Father 
    12 Mother 
    20 Sibling 
    21 Sister 
    22 Brother 
    30 Offspring 
    31 Daughter 
    32 Son 
    .c Not applicable 
    .b Not known - data not asked 
    .a Missing data 
F08 2nd degree relative 
with bladder cancer 
1 Yes 
    2 No 
    .b Not known - data not asked 
    .a Missing data 
F09 No. of 2nd degree 
relatives with bladder 
cancer 
  Number of 2nd degree relatives with bladder cancer 
F10 Classification of 2nd 
degree relative with 
bladder cancer - 
Relative 1 
1 Paternal relative 
    2 Maternal relative 
    .c Not applicable 
    .b Not known - data not asked 
    .a Missing data 
F11 Classification of 2nd 
degree relative with 
bladder cancer - 
Relative 2 
1 Paternal relative 
    2 Maternal relative 
    .c Not applicable 
    .b Not known - data not asked 
    .a Missing data 
F12 Classification of 2nd 
degree relative with 
bladder cancer - 






    2 Maternal relative 
    .c Not applicable 
    .b Not known - data not asked 
    .a Missing data 
F13 Classification of 2nd 
degree relative with 
bladder cancer - 
Relative 4 
1 Paternal relative 
    2 Maternal relative 
    .c Not applicable 
    .b Not known - data not asked 
    .a Missing data 
F14 Classification of 2nd 
degree relative with 
bladder cancer - 
Relative 5 
1 Paternal relative 
    2 Maternal relative 
    .c Not applicable 
    .b Not known - data not asked 
    .a Missing data 
EC010000P Milk and milk 
products in portions 
  Portions per week 
EC010000G Milk and milk 
products in grammes 
  Grammes per week 
EC010000ML Milk and milk 
products in millilitres 
  Millilitres per week 




  Portions per week 




  Grammes per week 




  Millilitres per week 
EC010100P Liquid milks in portions   Portions per week 
EC010100ML Liquid milks in 
millilitres 
  Millilitres per week 
EC010100P Liquid milks - 
MISCELLANEOUS- in 
portions  
  Portions per week 
EC010100ML Liquid milks - 
MISCELLANEOUS- in 
millilitres 
  Millilitres per week 
EC010110P Milk >4% fat in 
portions 
  Portions per week 
EC010110ML Milk >4% fat in 
millilitres 
  Millilitres per week 
EC010120P Milk 3-4% fat in 
portions 
  Portions per week 






EC010130P Milk 1-2.9% fat in 
portions 
  Portions per week 
EC010130ML Milk 1-2.9% fat in 
millilitres 
  Millilitres per week 
EC010140P Milk <1% fat in 
portions 
  Portions per week 
EC010140ML Milk <1% fat in 
millilitres 
  Millilitres per week 
EC010200P Processed milks in 
portions 
  Portions per week 
EC010200ML Processed milks in 
millilitres 
  Millilitres per week 
EC010210P Chocolate-flavoured 
milk in portions 
  Portions per week 
EC010210ML Chocolate-flavoured 
milk in millilitres 
  Millilitres per week 
EC010220P Fruit-flavoured milk in 
portions 
  Portions per week 
EC010220ML Fruit-flavoured milk in 
millilitres 
  Millilitres per week 
EC010230P Evaporated milk in 
portions 
  Portions per week 
EC010230G Evaporated milk in 
grammes 
  Grammes per week 
EC010230ML Evaporated milk in 
millilitres 
  Millilitres per week 
EC010240P Condensed milk in 
portions 
  Portions per week 
EC010240G Condensed milk in 
grammes 
  Grammes per week 
EC010240ML Condensed milk in 
millilitres 
  Millilitres per week 
EC010250P Dried milk in portions   Portions per week 
EC010250G Dried milk in grammes   Grammes per week 
EC010250ML Dried milk in millilitres   Millilitres per week 
EC010260P Filled milk in portions   Portions per week 
EC010260G Filled milk in grammes   Grammes per week 
EC010260ML Filled milk in millilitres   Millilitres per week 
EC010270P Buttermilk in portions   Portions per week 
EC010270G Buttermilk in grammes   Grammes per week 
EC010270ML Buttermilk in millilitres   Millilitres per week 
EC010280P Acidophilus milk in 
portions 
  Portions per week 
EC010280G Acidophilus milk in 
grammes 
  Grammes per week 
EC010280ML Acidophilus milk in 
millilitres 
  Millilitres per week 
EC010290P Whey in portions   Portions per week 
EC010290G Whey in grammes   Grammes per week 
EC010290ML Whey in millilitres   Millilitres per week 
EC010300P Cream in portions   Portions per week 
EC010300G Cream in grammes   Grammes per week 
EC010300ML Cream in millilitres   Millilitres per week 






EC010310G Cream >50% fat in 
grammes 
  Grammes per week 
EC010310ML Cream >50% fat in 
millilitres 
  Millilitres per week 
EC010320P Cream 31-50% fat in 
portions 
  Portions per week 
EC010320G Cream 31-50% fat in 
grammes 
  Grammes per week 
EC010320ML Cream 31-50% fat in 
millilitres 
  Millilitres per week 
EC010330P Cream 15-30% fat in 
portions 
  Portions per week 
EC010330G Cream 15-30% fat in 
grammes 
  Grammes per week 
EC010330ML Cream 15-30% fat in 
millilitres 
  Millilitres per week 
EC010340P Cream <15% fat in 
portions 
  Portions per week 
EC010340G Cream <15% fat in 
grammes 
  Grammes per week 
EC010340ML Cream <15% fat in 
millilitres 
  Millilitres per week 
EC010400P Yoghurt in portions   Portions per week 
EC010400G Yoghurt in grammes   Grammes per week 
EC010400ML Yoghurt in millilitres   Millilitres per week 
EC010410P Yoghurt >3% fat in 
portions 
  Portions per week 
EC010410G Yoghurt >3% fat in 
grammes 
  Grammes per week 
EC010410ML Yoghurt >3% fat in 
millilitres 
  Millilitres per week 
EC010420P Yoghurt 1-3% fat in 
portions 
  Portions per week 
EC010420G Yoghurt 1-3% fat in 
grammes 
  Grammes per week 
EC010240ML Yoghurt 1-3% fat in 
millilitres 
  Millilitres per week 
EC010430P Yoghurt <1% fat in 
portions 
  Portions per week 
EC010430G Yoghurt <1% fat in 
grammes 
  Grammes per week 
EC010430ML Yoghurt <1% fat in 
millilitres 
  Millilitres per week 
EC010500P Cheese in portions   Portions per week 
EC010500G Cheese in grammes   Grammes per week 
EC010510P Fresh cheese in 
portions 
  Portions per week 
EC010510G Fresh cheese in 
grammes 
  Grammes per week 
EC010511P Fresh cheese >60% 
fat in portions 
  Portions per week 
EC010511G Fresh cheese >60% 
fat in grammes 
  Grammes per week 
EC010512P Fresh cheese 46-60% 
fat in portions 





EC010512G Fresh cheese 46-60% 
fat in grammes 
  Grammes per week 
EC010513P Fresh cheese 31-45% 
fat in portions 
  Portions per week 
EC010513G Fresh cheese 31-45% 
fat in grammes 
  Grammes per week 
EC010514P Fresh cheese 15-30% 
fat in portions 
  Portions per week 
EC010514G Fresh cheese 15-30% 
fat in grammes 
  Grammes per week 
EC010515P Fresh cheese <15% 
fat in portions 
  Portions per week 
EC010515G Fresh cheese <15% 
fat in grammes 
  Grammes per week 
EC010520P Soft cheese in portions   Portions per week 
EC010520G Soft cheese in 
grammes 
  Grammes per week 
EC010521P Soft cheese >60% fat 
in portions 
  Portions per week 
EC010521G Soft cheese >60% fat 
in grammes 
  Grammes per week 
EC010522P Soft cheese 46-60% 
fat in portions 
  Portions per week 
EC010522G Soft cheese 46-60% 
fat in grammes 
  Grammes per week 
EC010523P Soft cheese 30-45% 
fat in portions 
  Portions per week 
EC010523G Soft cheese 30-45% 
fat in grammes 
  Grammes per week 
EC010524P Soft cheese <30% fat 
in portions 
  Portions per week 
EC010524G Soft cheese <30% fat 
in grammes 
  Grammes per week 
EC010530P Semi-hard cheese in 
portions 
  Portions per week 
EC010530G Semi-hard cheese in 
grammes 
  Grammes per week 
EC010531P Semi-hard cheese 
>60% fat in portions 
  Portions per week 
EC010531G Semi-hard cheese 
>60% fat in grammes 
  Grammes per week 
EC010532P Semi-hard cheese 46-
60% fat in portions 
  Portions per week 
EC010532G Semi-hard cheese 46-
60% fat in grammes 
  Grammes per week 
EC010533P Semi-hard cheese 30-
45% Fat in portions 
  Portions per week 
EC010533G Semi-hard cheese 30-
45% Fat in grammes 
  Grammes per week 
EC010534P Semi-hard cheese 
<30% fat in portions 
  Portions per week 
EC010534G Semi-hard cheese 
<30% fat in grammes 
  Grammes per week 
EC010540P Hard cheese in 
portions 
  Portions per week 
EC010540G Hard cheese in 
grammes 





EC010541P Hard cheese >50% fat 
in portions 
  Portions per week 
EC010541G Hard cheese >50% fat 
in grammes 
  Grammes per week 
EC010542P Hard cheese 30-50% 
fat in portions 
  Portions per week 
EC010542G Hard cheese 30-50% 
fat in grammes 
  Grammes per week 
EC010543P Hard cheese <30% fat 
in portions 
  Portions per week 
EC010543G Hard cheese <30% fat 
in grammes 
  Grammes per week 
EC010550P Blue cheese in 
portions 
  Portions per week 
EC010550G Blue cheese in 
grammes 
  Grammes per week 
EC010551P Blue cheese >50% fat 
in portions 
  Portions per week 
EC010551G Blue cheese >50% fat 
in grammes 
  Grammes per week 
EC010552P Blue cheese 30-50% 
fat in portions 
  Portions per week 
EC010552G Blue cheese 30-50% 
fat in grammes 
  Grammes per week 
EC010553P Blue cheese <30% fat 
in portions 
  Portions per week 
EC010553G Blue cheese <30% fat 
in grammes 
  Grammes per week 
EC010560P Smoked cheese in 
portions 
  Portions per week 
EC010560G Smoked cheese in 
grammes 
  Grammes per week 
EC010570P Processed cheese in 
portions 
  Portions per week 
EC010570G Processed cheese in 
grammes 
  Grammes per week 
EC010580P Whey cheese in 
portions 
  Portions per week 
EC010580G Whey cheese in 
grammes 
  Grammes per week 
EC010600P Imitation milk and 
cream in portions 
  Portions per week 
EC010600G Imitation milk and 
cream in grammes 
  Grammes per week 
EC010610P Soya milk in portions   Portions per week 
EC010610ML Soya milk in millilitres   Millilitres per week 
EC010620P Non-dairy coffee 
creamer in portions 
  Portions per week 
EC010620ML Non-dairy coffee 
creamer in millilitres 
  Millilitres per week 
EC010630P Imitation cream >20% 
fat in portions 
  Portions per week 
EC010630ML Imitation cream >20% 
fat in millilitres 
  Millilitres per week 
EC010640P Imitation cream < 20% 
fat in portions 





EC010640ML Imitation cream < 20% 
fat in millilitres 
  Millilitres per week 
EC010650P Soya yoghurt in 
grammes 
  Grammes per week 
EC010650G Soya yoghurt in 
portions 
  Portions per week 
EC010650ML Soya yoghurt in 
millilitres 
  Millilitres per week 
EC010660P Soya cheese in 
portions 
  Portions per week 
EC010660G Soya cheese in 
grammes 
  Millilitres per week 
EC010700P Milk beverage 
powders in portions 
  Portions per week 
EC010700G Milk beverage 
powders in millilitres 
  Millilitres per week 
EC010710P Milk shake powder in 
portions 
  Portions per week 
EC010710G Milk shake powder in 
grammes 
  Millilitres per week 
EC010720P Malt beverage powder 
in portions 
  Portions per week 
EC010720G Malt beverage powder 
in grammes 
  Millilitres per week 
EC010730P Drinking chocolate 
powder in portions 
  Portions per week 
EC010730G Drinking chocolate 
powder in grammes 
  Millilitres per week 
EC010800P Ices in portions   Portions per week 
EC010800G Ices in grammes   Grammes per week 
EC010800ML Ices in millilitres   Millilitres per week 
EC010810P Dairy ice cream in 
portions 
  Portions per week 
EC010810G Dairy ice cream in 
grammes 
  Grammes per week 
EC010810ML Dairy ice cream in 
millilitres 
  Millilitres per week 
EC010820P Non-dairy ice cream in 
portions 
  Portions per week 
EC010820G Non-dairy ice cream in 
grammes 
  Grammes per week 
EC010820ML Non-dairy ice cream in 
millilitres 
  Millilitres per week 
EC010830P Water ice in portions   Portions per week 
EC010830G Water ice in grammes   Grammes per week 
EC010830ML Water ice in millilitres   Millilitres per week 
EC010840P Garnita in portions   Portions per week 
EC010840G Garnita in grammes   Grammes per week 
EC010840ML Garnita in millilitres   Millilitres per week 
EC010850P Sorbet in portions   Portions per week 
EC010850G Sorbet in grammes   Grammes per week 
EC010850ML Sorbet in mililitres   Millilitres per week 
EC020000P Eggs in portions   Portions per week 
EC020000G Eggs in grammes   Grammes per week 







EC020000XG Eggs - 
MISCELLANEOUS - 
in grammes 
  Grammes per week 
EC020100P Chicken eggs in 
portions 
  Portions per week 
EC020100G Chicken eggs in 
grammes 
  Grammes per week 
EC020110P Whole chicken egg in 
portions 
  Portions per week 
EC020110G Whole chicken egg in 
grammes 
  Grammes per week 
EC020120P Chicken egg yolk in 
portions 
  Portions per week 
EC020120G Chicken egg yolk in 
grammes 
  Grammes per week 
EC020130P Chicken egg white in 
portions 
  Portions per week 
EC020130G Chicken egg white in 
grammes 
  Grammes per week 
EC020200P Turkey eggs in 
portions 
  Portions per week 
EC020200G Turkey eggs in 
grammes 
  Grammes per week 
EC020300P Duck eggs in portions   Portions per week 
EC020300G Duck eggs in 
grammes 
  Grammes per week 
EC020400P Goose eggs in 
portions 
  Portions per week 
EC020400G Goose eggs in 
grammes 
  Grammes per week 
EC020500P Quail eggs in portions   Portions per week 
EC020500G Quail eggs in 
grammes 
  Grammes per week 
EC020600P Ostrich eggs in 
portions 
  Portions per week 
EC020600G Ostrich eggs in 
grammes 
  Grammes per week 
EC020700P Seagull eggs in 
portions 
  Portions per week 
EC020700G Seagull eggs in 
grammes 
  Grammes per week 
EC020800P Egg products in 
portions 
  Portions per week 
EC020800G Egg products in 
grammes 
  Grammes per week 
EC020810P Scotch egg in portions   Portions per week 
EC020810G Scotch egg in 
grammes 
  Grammes per week 
EC020900P Egg dishes in portions   Portions per week 
EC020900G Egg dishes in 
grammes 
  Grammes per week 
EC020910P Omelette in portions   Portions per week 
EC020910G Omelette in grammes   Grammes per week 






EC020920G Soufflé Meringue in 
grammes 
  Grammes per week 
EC020930P Egg nog in portions   Portions per week 
EC020930G Egg nog in grammes   Grammes per week 
EC030000P Meat and meat 
products in portions 
  Portions per week 
EC030000G Meat and meat 
products in grammes 
  Grammes per week 




  Portions per week 




  Grammes per week 
EC030100P Beef in portions   Portions per week 
EC030100G Beef in grammes   Grammes per week 
EC030110P Beef Tenderloin in 
portions 
  Portions per week 
EC030110G Beef Tenderloin in 
grammes 
  Grammes per week 
EC030120P Beef Striploin in 
portions 
  Portions per week 
EC030120G Beef Striploin in 
grammes 
  Grammes per week 
EC030130P Beef Fore-rib in 
portions 
  Portions per week 
EC030130G Beef Fore-rib in 
grammes 
  Grammes per week 
EC030140P Beef Topside in 
portions 
  Portions per week 
EC030140G Beef Topside in 
grammes 
  Grammes per week 
EC030150P Beef Silverside in 
portions 
  Portions per week 
EC030150G Beef Silverside in 
grammes 
  Grammes per week 
EC030160P Beef Shoulder clod in 
portions 
  Portions per week 
EC030160G Beef Shoulder clod in 
grammes 
  Grammes per week 
EC030170P Beef Chuck tender in 
portions 
  Portions per week 
EC030170G Beef Chuck tender in 
grammes 
  Grammes per week 
EC030200P Veal in portions   Portions per week 
EC030200G Veal in grammes   Grammes per week 
EC030300P Pork in portions   Portions per week 
EC030300G Pork in grammes   Grammes per week 
EC030310P Pork Loin in portions   Portions per week 
EC030310G Pork Loin in grammes   Grammes per week 
EC030320P Pork Tenderloin in 
portions 





EC030320G Pork Tenderloin in 
grammes 
  Grammes per week 
EC030330P Pork Neck in portions   Portions per week 
EC030330G Pork Neck in grammes   Grammes per week 
EC030340P Pork Belly in portions   Portions per week 
EC030340G Pork Belly in grammes   Grammes per week 
EC030350P Pork Chump in 
portions 
  Portions per week 
EC030350G Pork Chump in 
grammes 
  Grammes per week 
EC030360P Pork Leg in portions   Portions per week 
EC030360G Pork Leg in grammes   Grammes per week 
EC030400P Mutton/Lamb in 
portions 
  Portions per week 
EC030400G Mutton/Lamb in 
grammes 
  Grammes per week 
EC030500P Mammals in portions   Portions per week 
EC030500G Mammals in grammes   Grammes per week 
EC030510P Horse in portions   Portions per week 
EC030510G Horse in grammes   Grammes per week 
EC030520P Goat in portions   Portions per week 
EC030520G Goat in grammes   Grammes per week 
EC030530P Rabbit in portions   Portions per week 
EC030530G Rabbit in grammes   Grammes per week 
EC030540P Wild pig/boar in 
portions 
  Portions per week 
EC030540G Wild pig/boar in 
grammes 
  Grammes per week 
EC030550P Venison in portions   Portions per week 
EC030550G Venison in grammes   Grammes per week 
EC030560P Elk in portions   Portions per week 
EC030560G Elk in grammes   Grammes per week 
EC030570P Reindeer in portions   Portions per week 
EC030570G Reindeer in grammes   Grammes per week 
EC030580P Chamois in portions   Portions per week 
EC030580G Chamois in grammes   Grammes per week 
EC030590P Kangaroo in portions   Portions per week 
EC030590G Kangaroo in grammes   Grammes per week 
EC030600P Poultry in portions   Portions per week 
EC030600G Poultry in grammes   Grammes per week 
EC030610P Chicken in portions   Portions per week 
EC030610G Chicken in grammes   Grammes per week 
EC030611P Chicken breast in 
portions 
  Portions per week 
EC030611G Chicken breast in 
grammes 
  Grammes per week 
EC030612P Chicken leg in portions   Portions per week 
EC030612G Chicken leg in 
grammes 
  Grammes per week 
EC030613P Chicken wing in 
portions 
  Portions per week 
EC030613G Chicken wing in 
grammes 





EC030620P Turkey in portions   Portions per week 
EC030620G Turkey in grammes   Grammes per week 
EC030621P Turkey breast in 
portions 
  Portions per week 
EC030621G Turkey breast in 
grammes 
  Grammes per week 
EC030622P Turkey leg in portions   Portions per week 
EC030622G Turkey leg in grammes   Grammes per week 
EC030623P Turkey wing in 
portions 
  Portions per week 
EC030623G Turkey wing in 
grammes 
  Grammes per week 
EC030700P Birds in portions   Portions per week 
EC030700G Birds in grammes   Grammes per week 
EC030710P Duck in portions   Portions per week 
EC030710G Duck in grammes   Grammes per week 
EC030720P Goose in portions   Portions per week 
EC030720G Goose in grammes   Grammes per week 
EC030730P Pigeon in portions   Portions per week 
EC030730G Pigeon in grammes   Grammes per week 
EC030740P Guinea fowl in portions   Portions per week 
EC030740G Guinea fowl in 
grammes 
  Grammes per week 
EC030750P Pheasant in portions   Portions per week 
EC030750G Pheasant in grammes   Grammes per week 
EC030760P Partridge in portions   Portions per week 
EC030760G Partridge in grammes   Grammes per week 
EC030770P Quail in portions   Portions per week 
EC030770G Quail in grammes   Grammes per week 
EC030780P Grouse in portions   Portions per week 
EC030780G Grouse in grammes   Grammes per week 
EC030790P Ostrich in portions   Portions per week 
EC030790G Ostrich in grammes   Grammes per week 
EC030800P Liver in portions   Portions per week 
EC030800G Liver in grammes   Grammes per week 
EC030810P Beef liver in portions   Portions per week 
EC030810G Beef liver in grammes   Grammes per week 
EC030820P Veal liver in portions   Portions per week 
EC030820G Veal liver in grammes   Grammes per week 
EC030830P Pork liver in portions   Portions per week 
EC030830G Pork liver in grammes   Grammes per week 
EC030840P Mutton/Lamb liver in 
portions 
  Portions per week 
EC030840G Mutton/Lamb liver in 
grammes 
  Grammes per week 
EC030850P Chicken liver in 
portions 
  Portions per week 
EC030850G Chicken liver in 
grammes 
  Grammes per week 
EC030860P Turkey liver in portions   Portions per week 
EC030860G Turkey liver in 
grammes 





EC030870P Duck liver in portions   Portions per week 
EC030870G Duck liver in grammes   Grammes per week 
EC030880P Goose liver in portions   Portions per week 
EC030880G Goose liver in 
grammes 
  Grammes per week 
EC030900P Kidney in portions   Portions per week 
EC030900G Kidney in grammes   Grammes per week 
EC030910P Beef kidney in portions   Portions per week 
EC030910G Beef kidney in 
grammes 
  Grammes per week 
EC030920P Veal kidney in portions   Portions per week 
EC030920G Veal kidney in 
grammes 
  Grammes per week 
EC030930P Pork kidney in portions   Portions per week 
EC030930G Pork kidney in 
grammes 
  Grammes per week 
EC030940P Mutton/lamb kidney in 
portions 
  Portions per week 
EC030940G Mutton/lamb kidney in 
grammes 
  Grammes per week 
EC031000P Other offal in portions   Portions per week 
EC031000G Other offal in grammes   Grammes per week 
EC031010P Tongue in portions   Portions per week 
EC031010G Tongue in grammes   Grammes per week 
EC031020P Heart in portions   Portions per week 
EC031020G Heart in grammes   Grammes per week 
EC031030P Lungs in portions   Portions per week 
EC031030G Lungs in grammes   Grammes per week 
EC031040P Stomach in portions   Portions per week 
EC031040G Stomach in grammes   Grammes per week 
EC031050P Intestines in portions   Portions per week 
EC031050G Intestines in grammes   Grammes per week 
EC031060P Marrowbone in 
portions 
  Portions per week 
EC031060G Marrowbone in 
grammes 
  Grammes per week 
EC031070P Tail in portions   Portions per week 
EC031070G Tail in grammes   Grammes per week 
EC031080P Trotters and feet in 
portions 
  Portions per week 
EC031080G Trotters and feet in 
grammes 
  Grammes per week 
EC031090P Giblets in portions   Portions per week 
EC031090G Giblets in grammes   Grammes per week 
EC031100P Preserved meats in 
portions 
  Portions per week 
EC031100G Preserved meats in 
grammes 
  Grammes per week 
EC031110P Ham in portions   Portions per week 
EC031110G Ham in grammes   Grammes per week 
EC031120P Bacon in portions   Portions per week 
EC031120G Bacon in grammes   Grammes per week 






EC031130G Preserved beef in 
grammes 
  Grammes per week 
EC031140P Preserved poultry in 
portions 
  Portions per week 
EC031140G Preserved poultry in 
grammes 
  Grammes per week 
EC040000P Fish and fish 
products in portions 
  Portions per week 
EC040000G Fish and fish 
products in grammes 
  Grammes per week 




  Portions per week 




  Grammes per week 
EC040100P Clupeiformes in 
portions 
  Portions per week 
EC040100G Clupeiformes in 
grammes 
  Grammes per week 
EC040110P Herring  in portions   Portions per week 
EC040110G Herring  in grammes   Grammes per week 
EC040120P Sprat in portions   Portions per week 
EC040120G Sprat in grammes   Grammes per week 
EC040130P Sardine and pilchard 
in portions 
  Portions per week 
EC040130G Sardine and pilchard 
in grammes 
  Grammes per week 
EC040140P Anchovy in portions   Portions per week 
EC040140G Anchovy in grammes   Grammes per week 
EC040150P Shad in portions   Portions per week 
EC040150G Shad in grammes   Grammes per week 
EC040160P Salmon and trout in 
portions 
  Portions per week 
EC040160G Salmon and trout in 
grammes 
  Grammes per week 
EC040170P Char in portions   Portions per week 
EC040170G Char in grammes   Grammes per week 
EC040180P Smelt in portions   Portions per week 
EC040180G Smelt in grammes   Grammes per week 
EC040190P Whitefish in portions   Portions per week 
EC040190G Whitefish in grammes   Grammes per week 
EC040200P Perciformes in 
portions 
  Portions per week 
EC040200G Perciformes in 
grammes 
  Grammes per week 
EC040210P Perch in portions   Portions per week 
EC040210G Perch in grammes   Grammes per week 
EC040220P Bass Surgeon-fish in 
portions 
  Portions per week 
EC040220G Bass Surgeon-fish in 
grammes 





EC040230P Mackerel in portions   Portions per week 
EC040230G Mackerel in grammes   Grammes per week 
EC040240P Tuna in portions   Portions per week 
EC040240G Tuna in grammes   Grammes per week 
EC040250P Sea catfish and wolf-
fish in portions 
  Portions per week 
EC040250G Sea catfish and wolf-
fish in grammes 
  Grammes per week 
EC040260P Grey mullet in portions   Portions per week 
EC040260G Grey mullet in 
grammes 
  Grammes per week 
EC040300P Gadiformes in portions   Portions per week 
EC040300G Gadiformes in 
grammes 
  Grammes per week 
EC040310P Cod and whiting in 
portions 
  Portions per week 
EC040310G Cod and whiting in 
grammes 
  Grammes per week 
EC040320P Hake in portions   Portions per week 
EC040320G Hake in grammes   Grammes per week 
EC040400P Pleuronectiformes in 
portions 
  Portions per week 
EC040400G Pleuronectiformes in 
grammes 
  Grammes per week 
EC040410P Flounder in portions   Portions per week 
EC040410G Flounder in grammes   Grammes per week 
EC040420P Halibut in portions   Portions per week 
EC040420G Halibut in grammes   Grammes per week 
EC040430P Plaice in portions   Portions per week 
EC040430G Plaice in grammes   Grammes per week 
EC040440P Sole in portions   Portions per week 
EC040440G Sole in grammes   Grammes per week 
EC040500P Cypriniformes in 
portions 
  Portions per week 
EC040500G Cypriniformes in 
grammes 
  Grammes per week 
EC040510P Roach in portions   Portions per week 
EC040510G Roach in grammes   Grammes per week 
EC040520P Carp in portions   Portions per week 
EC040520G Carp in grammes   Grammes per week 
EC040530P Babel in portions   Portions per week 
EC040530G Babel in grammes   Grammes per week 
EC040540P Bream in portions   Portions per week 
EC040540G Bream in grammes   Grammes per week 
EC040600P Other fish in portions   Portions per week 
EC040600G Other fish in grammes   Grammes per week 
EC040610P Eels in portions   Portions per week 
EC040610G Eels in grammes   Grammes per week 
EC040620P Zeomorphi in portions   Portions per week 
EC040620G Zeomorphi in 
grammes 
  Grammes per week 
EC040630P Lophiiformes in 
portions 





EC040630G Lophiiformes in 
grammes 
  Grammes per week 
EC040640P Selachoidei in portions   Portions per week 
EC040640G Selachoidei in 
grammes 
  Grammes per week 
EC040650P Rays in portions   Portions per week 
EC040650G Rays in grammes   Grammes per week 
EC040660P Acipenseriformes in 
portions 
  Portions per week 
EC040660G Acipenseriformes in 
grammes 
  Grammes per week 
EC040700P Crustaceans in 
portions 
  Portions per week 
EC040700G Crustaceans in 
grammes 
  Grammes per week 
EC040710P Crab in portions   Portions per week 
EC040710G Crab in grammes   Grammes per week 
EC040720P Lobster in portions   Portions per week 
EC040720G Lobster in grammes   Grammes per week 
EC040730P Prawns in portions   Portions per week 
EC040730G Prawns in grammes   Grammes per week 
EC040740P Shrimps in portions   Portions per week 
EC040740G Shrimps in grammes   Grammes per week 
EC040750P Crayfish in portions   Portions per week 
EC040750G Crayfish in grammes   Grammes per week 
EC040800P Molluscs in portions   Portions per week 
EC040800G Molluscs in grammes   Grammes per week 
EC040810P Quid in portions   Portions per week 
EC040810G Quid in grammes   Grammes per week 
EC040820P Octopus in portions   Portions per week 
EC040820G Octopus in grammes   Grammes per week 
EC040830P Cuttlefish in portions   Portions per week 
EC040830G Cuttlefish in grammes   Grammes per week 
EC040840P Abalone in portions   Portions per week 
EC040840G Abalone in grammes   Grammes per week 
EC040850P Clam in portions   Portions per week 
EC040850G Clam in grammes   Grammes per week 
EC040860P Cockle in portions   Portions per week 
EC040860G Cockle in grammes   Grammes per week 
EC040870P Mussel in portions   Portions per week 
EC040870G Mussel in grammes   Grammes per week 
EC040880P Oyster in portions   Portions per week 
EC040880G Oyster in grammes   Grammes per week 
EC040890P Scallop in portions   Portions per week 
EC040890G Scallop in grammes   Grammes per week 
EC040900P Fish offal in portions   Portions per week 
EC040900G Fish offal in grammes   Grammes per week 
EC040910P Herring roe in portions   Portions per week 
EC040910G Herring roe in 
grammes 
  Grammes per week 
EC040920P Salmon roe in portions   Portions per week 






EC040930P Cod roe in portions   Portions per week 
EC040930G Cod roe in grammes   Grammes per week 
EC040940P Mullet roe in portions   Portions per week 
EC040940G Mullet roe in grammes   Grammes per week 
EC040950P Caviar in portions   Portions per week 
EC040950G Caviar in grammes   Grammes per week 
EC041000P Dried and salted fish in 
portions 
  Portions per week 
EC041000G Dried and salted fish in 
grammes 
  Grammes per week 
EC041010P Dried cod in portions   Portions per week 
EC041010G Dried cod in grammes   Grammes per week 
EC041020P Bombay duck in 
portions 
  Portions per week 
EC041020G Bombay duck in 
grammes 
  Grammes per week 
EC041030P Shark's fin in portions   Portions per week 
EC041030G Shark's fin in grammes   Grammes per week 
EC041040P Jellyfish/seaweed in 
portions 
  Portions per week 
EC041040G Jellyfish/seaweed in 
grammes 
  Grammes per week 
EC041100P Smoked fish in 
portions 
  Portions per week 
EC041100G Smoked fish in 
grammes 
  Grammes per week 
EC041110P Smoked herring in 
portions 
  Portions per week 
EC041110G Smoked herring in 
grammes 
  Grammes per week 
EC041120P Smoked sprat in 
portions 
  Portions per week 
EC041120G Smoked sprat in 
grammes 
  Grammes per week 
EC041130P Smoked haddock in 
portions 
  Portions per week 
EC041130G Smoked haddock in 
grammes 
  Grammes per week 
EC041140P Smoked salmon and 
trout in portions 
  Portions per week 
EC041140G Smoked salmon and 
trout in grammes 
  Grammes per week 
EC041150P Smoked mackerel in 
portions 
  Portions per week 
EC041150G Smoked mackerel in 
grammes 
  Grammes per week 
EC041160P Smoked halibut in 
portions 
  Portions per week 
EC041160G Smoked halibut in 
grammes 
  Grammes per week 
EC041170P Smoked eel in portions   Portions per week 
EC041170G Smoked eel in 
grammes 
  Grammes per week 






EC041180G Smoked sturgeon in 
grammes 
  Grammes per week 
EC041200P Canned fish in 
portions 
  Portions per week 
EC041200G Canned fish in 
grammes 
  Grammes per week 
EC041210P Canned herring in 
portions 
  Portions per week 
EC041210G Canned herring in 
grammes 
  Grammes per week 
EC041220P Canned sardine in 
portions 
  Portions per week 
EC041220G Canned sardine in 
grammes 
  Grammes per week 
EC041230P Canned mussels in 
portions 
  Portions per week 
EC041230G Canned mussels in 
grammes 
  Grammes per week 
EC041240P Canned anchovy in 
portions 
  Portions per week 
EC041240G Canned anchovy in 
grammes 
  Grammes per week 
EC041250P Canned salmon in 
portions 
  Portions per week 
EC041250G Canned salmon in 
grammes 
  Grammes per week 
EC041260P Canned mackerel in 
portions 
  Portions per week 
EC041260G Canned mackerel in 
grammes 
  Grammes per week 
EC041270P Canned tuna in 
portions 
  Portions per week 
EC041270G Canned tuna in 
grammes 
  Grammes per week 
EC041280P Canned crab in 
portions 
  Portions per week 
EC041280G Canned crab in 
grammes 
  Grammes per week 
EC041290P Cabend abalone in 
portions 
  Portions per week 
EC041290G Cabend abalone in 
grammes 
  Grammes per week 
EC041300P Pickled fish in portions   Portions per week 
EC041300G Pickled fish in 
grammes 
  Grammes per week 
EC041400P Restructed fish - 
Crabsticks in portions 
  Portions per week 
EC041400G Restructed fish - 
Crabsticks in grammes 
  Grammes per week 
EC041500P Fish products in 
portions 
  Portions per week 
EC041500G Fish products in 
grammes 
  Grammes per week 
EC041510P Fishballs in portions   Portions per week 





EC041520P Fishcakes in portions   Portions per week 
EC041520G Fishcakes in grammes   Grammes per week 
EC041530P Fish fingers in portions   Portions per week 
EC041530G Fish fingers in 
grammes 
  Grammes per week 
EC041540P Fish past in portions   Portions per week 
EC041540G Fish past in grammes   Grammes per week 
EC041550P Taramasalata in 
portions 
  Portions per week 
EC041550G Taramasalata in 
grammes 
  Grammes per week 
EC041600P Marine mammals in 
portions 
  Portions per week 
EC041600G Marine mammals in 
grammes 
  Grammes per week 
EC041700P Amphibians in portions   Portions per week 
EC041700G Amphibians in 
grammes 
  Grammes per week 
EC041800P Reptiles in portions   Portions per week 
EC041800G Reptiles in grammes   Grammes per week 
EC041900P Insects in portions   Portions per week 
EC041900G Insects in grammes   Grammes per week 
EC050000P Fats and oils in 
portions 
  Portions per week 
EC050000G Fats and oils in 
grammes 
  Grammes per week 
EC050000XP Fats and oils - 
MISCELLANEOUS - 
in portions 
  Portions per week 
EC050000XG Fats and oils - 
MISCELLANEOUS - 
in grammes 
  Grammes per week 
EC050100P Butter in portions   Portions per week 
EC050100G Butter in grammes   Grammes per week 
EC050110P Salted butter in 
portions 
  Portions per week 
EC050110G Salted butter in 
grammes 
  Grammes per week 
EC050120P Unsalted butter in 
portions 
  Portions per week 
EC050120G Unsalted butter in 
grammes 
  Grammes per week 
EC050130P Butter spread >50%fat 
in portions 
  Portions per week 
EC050130G Butter spread >50%fat 
in grammes 
  Grammes per week 
EC050140P Butter spread < 50% 
fat in portions 
  Portions per week 
EC050140G Butter spread < 50% 
fat in grammes 
  Grammes per week 
EC050150P Butter ghee in portions   Portions per week 
EC050150G Butter ghee in 
grammes 
  Grammes per week 
EC050200P Margarine in portions   Portions per week 





EC050210P Margarine >25% 
saturates in portions 
  Portions per week 
EC050210G Margarine >25% 
saturates in grammes 
  Grammes per week 
EC050220P Margarine <25% 
saturates in portions 
  Portions per week 
EC050220G Margarine <25% 
saturates in grammes 
  Grammes per week 
EC050300P Fat spread in portions   Portions per week 
EC050300G Fat spread in 
grammes 
  Grammes per week 
EC050310P Fat spread >65% fat 
>25 % saturates in 
portions 
  Portions per week 
EC050310G Fat spread >65% fat 
>25 % saturates in 
grammes 
  Grammes per week 
EC050320P Fat spread >65% fat 
<25% saturates in 
portions 
  Portions per week 
EC050320G Fat spread >65% fat 
<25% saturates in 
grammes 
  Grammes per week 
EC050330P Fat spread 45-65% fat, 
>25% saturates in 
portions 
  Portions per week 
EC050330G Fat spread 45-65% fat, 
>25% saturates in 
grammes 
  Grammes per week 
EC050340P Fat spread 45-65% fat 
<25% saturates in 
portions 
  Portions per week 
EC050340G Fat spread 45-65% fat 
<25% saturates in 
grammes 
  Grammes per week 
EC050350P Fat spread 30-45 % fat 
in portions 
  Portions per week 
EC050350G Fat spread 30-45 % fat 
in grammes 
  Grammes per week 
EC050360P Fat spread <30% fat in 
portions 
  Portions per week 
EC050360G Fat spread <30% fat in 
grammes 
  Grammes per week 
EC050400P Animal fat in portions   Portions per week 
EC050400G Animal fat in grammes   Grammes per week 
EC050410P Beef fat in portions   Portions per week 
EC050410G Beef fat in grammes   Grammes per week 
EC050420P Pork fat in portions   Portions per week 
EC050420G Pork fat in grammes   Grammes per week 
EC050430P Sheep fat in portions   Portions per week 
EC050430G Sheep fat in grammes   Grammes per week 
EC050440P Goose fat in portions   Portions per week 
EC050440G Goose fat in grammes   Grammes per week 
EC050450P Duck fat in portions   Portions per week 





EC050460P Other animal fat in 
portions 
  Portions per week 
EC050460G Other animal fat in 
grammes 
  Grammes per week 
EC050500P Marine oil in portions   Portions per week 
EC050500G  Marine oil in grammes    Grammes per week  
EC050500ML Marine oil in millilitres   Millilitres per week 
EC050510P Herring oil in portions   Portions per week 
EC050510G  Herring oil in grammes    Grammes per week  
EC050510ML Herring oil in millilitres   Millilitres per week 
EC050520P Whale oil in portions   Portions per week 
EC050520G  Whale oil in grammes    Grammes per week  
EC050520ML Whale oil in millilitres   Millilitres per week 
EC050530P Shark oil in portions   Portions per week 
EC050530G  Shark oil in grammes    Grammes per week  
EC050530ML Shark oil in millilitres   Millilitres per week 
EC050540P Sardine oil in portions   Portions per week 
EC050540G  Sardine oil in 
grammes  
  Grammes per week  
EC050540ML Sardine oil in millilitres   Millilitres per week 
EC050550P Other marine oil in 
portions 
  Portions per week 
EC050550G  Other marine oil in 
grammes  
  Grammes per week  
EC050550ML Other marine oil in 
millilitres 
  Millilitres per week 
EC050600P Vegetable fats and oils 
in portions 
  Portions per week 
EC050600G  Vegetable fats and oils 
in grammes  
  Grammes per week  
EC050600ML Vegetable fats and oils 
in millilitres 
  Millilitres per week 
EC050610P Cocoa butter in 
portions 
  Portions per week 
EC050610G  Cocoa butter in 
grammes  
  Grammes per week  
EC050610ML Cocoa butter in 
millilitres 
  Millilitres per week 
EC050620P Coconut oil in portions   Portions per week 
EC050620G  Coconut oil in 
grammes  
  Grammes per week  
EC050620ML Coconut oil in millilitres   Millilitres per week 
EC050630P Olive oil/Sunflower oil 
in portions 
  Portions per week 
EC050630G  Olive oil/Sunflower oil 
in grammes  
  Grammes per week  
EC050630ML Olive oilSunflower oil 
in millilitres 
  Millilitres per week 
EC050640P Corn oil in portions   Portions per week 
EC050640G  Corn oil in grammes    Grammes per week  
EC050640ML Corn oil in millilitres   Millilitres per week 
EC050650P Soya bean oil in 
portions 
  Portions per week 






EC050650ML Soya bean oil in 
millilitres 
  Millilitres per week 
EC050660P Rapesee oil in portions   Portions per week 
EC050660G  Rapesee oil in 
grammes  
  Grammes per week  
EC050661ML Rapesee oil in 
millilitres 
  Millilitres per week 
EC050670P Sesame oil in portions   Portions per week 
EC050670G  Sesame oil in 
grammes  
  Grammes per week  
EC050670ML Sesame oil in millilitres   Millilitres per week 
EC050680P Peanut oil in portions   Portions per week 
EC050680G  Peanut oil in grammes    Grammes per week  
EC050680ML Peanut oil in millilitres   Millilitres per week 
EC050700P Compound fats and 
oils in portions 
  Portions per week 
EC050700G  Compound fats and 
oils in grammes  
  Grammes per week  
EC050700ML Compound fats and 
oils in millilitres 
  Millilitres per week 
EC060000P Grain and grain 
products in portions 
  Portions per week 
EC060000G Grain and grain 
products in grammes 
  Grammes per week 




  Portions per week 




  Grammes per week 
EC060100P Wheat basic products 
in portions 
  Portions per week 
EC060100G Wheat basic products 
in grammes 
  Grammes per week 
EC060110P Whole grain wheat in 
portions 
  Portions per week 
EC060110G Whole grain wheat in 
grammes 
  Grammes per week 
EC060120P Bulgar in portions   Portions per week 
EC060120G Bulgar in grammes   Grammes per week 
EC060130P Wheat flour - 
wholemeal in portions 
  Portions per week 
EC060130G Wheat flour - 
wholemeal in 
grammes 
  Grammes per week 
EC060140P Wheat flour - 80% 
extraction rate in 
portions 
  Portions per week 
EC060140G Wheat flour - 80% 
extraction rate in 
grammes 
  Grammes per week 
EC060150P Wheat flour - 72% 
extraction rate in 






EC060150G Wheat flour - 72% 
extraction rate in 
grammes 
  Grammes per week 
EC060160P Wheat flour - patent in 
portions 
  Portions per week 
EC060160G Wheat flour - patent in 
grammes 
  Grammes per week 
EC060170P Wheat flour - brown in 
portions 
  Portions per week 
EC060170G Wheat flour - brown in 
grammes 
  Grammes per week 
EC060180P Semolina in portions   Portions per week 
EC060180G Semolina in grammes   Grammes per week 
EC060200P Rye flour in portions   Portions per week 
EC060200G Rye flour in grammes   Grammes per week 
EC060300P Oats basic products in 
portions 
  Portions per week 
EC060300G Oats basic products in 
grammes 
  Grammes per week 
EC060310P Groats in portions   Portions per week 
EC060310G Groats in grammes   Grammes per week 
EC060320P Rolled oats in portions   Portions per week 
EC060320G Rolled oats in 
grammes 
  Grammes per week 
EC060330P Oatmeal in portions   Portions per week 
EC060330G Oatmeal in grammes   Grammes per week 
EC060340P Oatflour in portions   Portions per week 
EC060340G Oatflour in grammes   Grammes per week 
EC060400P Barley basic products 
in portions 
  Portions per week 
EC060400G Barley basic products 
in grammes 
  Grammes per week 
EC060410P Whole grain barley in 
portions 
  Portions per week 
EC060410G Whole grain barley in 
grammes 
  Grammes per week 
EC060420P Pearl barley in 
portions 
  Portions per week 
EC060420G Pearl barley in 
grammes 
  Grammes per week 
EC060430P Barley flakes in 
portions 
  Portions per week 
EC060430G Barley flakes in 
grammes 
  Grammes per week 
EC060440P Barley meal in portions   Portions per week 
EC060440G Barley meal in 
grammes 
  Grammes per week 
EC060450P Barley flour in portions   Portions per week 
EC060450G Barley flour in 
grammes 
  Grammes per week 
EC060500P Maize basic products 
in portions 
  Portions per week 
EC060500G Maize basic products 
in grammes 





EC060510P Maize rice in portions   Portions per week 
EC060510G Maize rice in grammes   Grammes per week 
EC060520P Cornmeal in portions   Portions per week 
EC060520G Cornmeal in grammes   Grammes per week 
EC060530P Maize flour in portions   Portions per week 
EC060530G Maize flour in 
grammes 
  Grammes per week 
EC060540P Cornflour in portions   Portions per week 
EC060540G Cornflour in grammes   Grammes per week 
EC060550P Custard powder in 
portions 
  Portions per week 
EC060550G Custard powder in 
grammes 
  Grammes per week 
EC060600P Rice basic products in 
portions 
  Portions per week 
EC060600G Rice basic products in 
grammes 
  Grammes per week 
EC060610P Rice flour in portions   Portions per week 
EC060610G Rice flour in grammes   Grammes per week 
EC060620P Rice flakes in portions   Portions per week 
EC060620G Rice flakes in 
grammes 
  Grammes per week 
EC060630P Brown rice in portions   Portions per week 
EC060630G Brown rice in 
grammes 
  Grammes per week 
EC060640P Basmati rice in 
portions 
  Portions per week 
EC060640G Basmati rice in 
grammes 
  Grammes per week 
EC060650P Glutinous rice in 
portions 
  Portions per week 
EC060650G Glutinous rice in 
grammes 
  Grammes per week 
EC060660P Polished rice in 
portions 
  Portions per week 
EC060660G Polished rice in 
grammes 
  Grammes per week 
EC060700P Basic products of 
other cereals in 
portions 
  Portions per week 
EC060700G Basic products of 
other cereals in 
grammes 
  Grammes per week 
EC060710P Buckwheat in portions   Portions per week 
EC060710G Buckwheat in 
grammes 
  Grammes per week 
EC060720P Buckwheat flour in 
portions 
  Portions per week 
EC060720G Buckwheat flour in 
grammes 
  Grammes per week 
EC060730P Millet in portions   Portions per week 
EC060730G Millet in grammes   Grammes per week 
EC060740P Millet flour in portions   Portions per week 
EC060740G Millet flour in grammes   Grammes per week 





starches in portions 
EC060800G Substitute flours and 
starches in grammes 
  Grammes per week 
EC060810P Soya flour in portions   Portions per week 
EC060810G Soya flour in grammes   Grammes per week 
EC060820P Potato flour in portions   Portions per week 
EC060820G Potato flour in 
grammes 
  Grammes per week 
EC060830P Lotus root flour in 
portions 
  Portions per week 
EC060830G Lotus root flour in 
grammes 
  Grammes per week 
EC060840P Arrowroot in portions   Portions per week 
EC060840G Arrowroot in grammes   Grammes per week 
EC060850P Sago in portions   Portions per week 
EC060850G Sago in grammes   Grammes per week 
EC060860P Tapioca in portions   Portions per week 
EC060860G Tapioca in grammes   Grammes per week 
EC060900P Pasta and noodles in 
portions 
  Portions per week 
EC060900G Pasta and noodles in 
grammes 
  Grammes per week 
EC060910P Dried main-dish pasta 
in portions 
  Portions per week 
EC060910G Dried main-dish pasta 
in grammes 
  Grammes per week 
EC060920P Dried miniature pasta 
in portions 
  Portions per week 
EC060920G Dried miniature pasta 
in grammes 
  Grammes per week 
EC060930P Fresh main-dish pasta 
in portions 
  Portions per week 
EC060930G Fresh main-dish pasta 
in grammes 
  Grammes per week 
EC060940P Fresh miniature pasta 
in portions 
  Portions per week 
EC060940G Fresh miniature pasta 
in grammes 
  Grammes per week 
EC060950P Egg noodles in 
portions 
  Portions per week 
EC060950G Egg noodles in 
grammes 
  Grammes per week 
EC060960P Plain noodles in 
portions 
  Portions per week 
EC060960G Plain noodles in 
grammes 
  Grammes per week 
EC060970P Rice noodles in 
portions 
  Portions per week 
EC060970G Rice noodles in 
grammes 
  Grammes per week 
EC060980P Transparent noodles 
in portions 
  Portions per week 
EC060980G Transparent noodles 
in grammes 
  Grammes per week 






EC061000G Leavened breads in 
grammes 
  Grammes per week 
EC061010P Wheat bread - 
wholemeal in portions 
  Portions per week 
EC061010G Wheat bread - 
wholemeal in 
grammes 
  Grammes per week 
EC061020P Wheat bread - white in 
portions 
  Portions per week 
EC061020G Wheat bread - white in 
grammes 
  Grammes per week 
EC061030P Wheat bread - brown 
in portions 
  Portions per week 
EC061030G Wheat bread - brown 
in grammes 
  Grammes per week 
EC061040P Naan bread in portions   Portions per week 
EC061040G Naan bread in 
grammes 
  Grammes per week 
EC061050P Soda bread in portions   Portions per week 
EC061050G Soda bread in 
grammes 
  Grammes per week 
EC061060P Rye bread in portions   Portions per week 
EC061060G Rye bread in grammes   Grammes per week 
EC061070P Potato bread in 
portions 
  Portions per week 
EC061070G Potato bread in 
grammes 
  Grammes per week 
EC061080P Bread - other flour in 
portions 
  Portions per week 
EC061080G Bread - other flour in 
grammes 
  Grammes per week 
EC061090P Bread - mixed flour in 
portions 
  Portions per week 
EC061090G Bread - mixed flour in 
grammes 
  Grammes per week 
EC061100P Unleavened breads 
and crispbreads in 
portions 
  Portions per week 
EC061100G Unleavened breads 
and crispbreads in 
grammes 
  Grammes per week 
EC061110P Bannock in portions   Portions per week 
EC061110G Bannock in grammes   Grammes per week 
EC061120P Pitta bread in portions   Portions per week 
EC061120G Pitta bread in 
grammes 
  Grammes per week 
EC061130P Matzo in portions   Portions per week 
EC061130G Matzo in grammes   Grammes per week 
EC061140P Tortilla in portions   Portions per week 
EC061140G Tortilla in grammes   Grammes per week 
EC061150P Crispbread in portions   Portions per week 
EC061150G Crispbread in 
grammes 
  Grammes per week 






EC061200G Bread products in 
grammes 
  Grammes per week 
EC061210P Breadcrumbs in 
portions 
  Portions per week 
EC061210G Breadcrumbs in 
grammes 
  Grammes per week 
EC061220P Bread stuffing in 
portions 
  Portions per week 
EC061220G Bread stuffing in 
grammes 
  Grammes per week 
EC061230P Bread pudding in 
portions 
  Portions per week 
EC061230G Bread pudding in 
grammes 
  Grammes per week 
EC061300P Fine bakery wares in 
portions 
  Portions per week 
EC061300G Fine bakery wares in 
grammes 
  Grammes per week 
EC061310P Savoury biscuits in 
portions 
  Portions per week 
EC061310G Savoury biscuits in 
grammes 
  Grammes per week 
EC061320P Sweet biscuits and 
cookies in portions 
  Portions per week 
EC061320G Sweet biscuits and 
cookies in grammes 
  Grammes per week 
EC061330P Croissants in portions   Portions per week 
EC061330G Croissants in 
grammes 
  Grammes per week 
EC061340P Currant bun in portions   Portions per week 
EC061340G Currant bun in 
grammes 
  Grammes per week 
EC061350P Dough cakes in 
portions 
  Portions per week 
EC061350G Dough cakes in 
grammes 
  Grammes per week 
EC061360P Scone in portions   Portions per week 
EC061360G Scone in grammes   Grammes per week 
EC061370P Doughnut in portions   Portions per week 
EC061370G Doughnut in grammes   Grammes per week 
EC061380P Danish pastry in 
portions 
  Portions per week 
EC061380G Danish pastry in 
grammes 
  Grammes per week 
EC061390P Cake in portions   Portions per week 
EC061390G Cake in grammes   Grammes per week 
EC061400P Savoury cereal dishes 
in portions 
  Portions per week 
EC061400G Savoury cereal dishes 
in grammes 
  Grammes per week 
EC061410P Dumpling in portions   Portions per week 
EC061410G Dumpling in grammes   Grammes per week 
EC061420P Savoury pancake in 
portions 





EC061420G Savoury pancake in 
grammes 
  Grammes per week 
EC061430P Couscous in portions   Portions per week 
EC061430G Couscous in grammes   Grammes per week 
EC061440P Risotto in portions   Portions per week 
EC061440G Risotto in grammes   Grammes per week 
EC061450P Pizza in portions   Portions per week 
EC061450G Pizza in grammes   Grammes per week 
EC061460P Savoury pie in portions   Portions per week 
EC061460G Savoury pie in 
grammes 
  Grammes per week 
EC061500P Sweet puddings in 
portions 
  Portions per week 
EC061500G Sweet puddings in 
grammes 
  Grammes per week 
EC061510P Custard in portions   Portions per week 
EC061510G Custard in grammes   Grammes per week 
EC061520P Trifle in portions   Portions per week 
EC061520G Trifle in grammes   Grammes per week 
EC061530P Fruit crumble in 
portions 
  Portions per week 
EC061530G Fruit crumble in 
grammes 
  Grammes per week 
EC061540P Fruit pie in portions   Portions per week 
EC061540G Fruit pie in grammes   Grammes per week 
EC061550P Milk pudding in 
portions 
  Portions per week 
EC061550G Milk pudding in 
grammes 
  Grammes per week 
EC061560P Rice pudding  in 
portions 
  Portions per week 
EC061560G Rice pudding  in 
grammes 
  Grammes per week 
EC061570P Sponge pudding in 
portions 
  Portions per week 
EC061570G Sponge pudding in 
grammes 
  Grammes per week 
EC061580P Suet pudding in 
portions 
  Portions per week 
EC061580G Suet pudding in 
grammes 
  Grammes per week 
EC061600P Breakfast cereals in 
portions 
  Portions per week 
EC061600G Breakfast cereals in 
grammes 
  Grammes per week 
EC061610P Cereals - wheat based 
in portions 
  Portions per week 
EC061610G Cereals - wheat based 
in grammes 
  Grammes per week 
EC061620P Cereals - rye based in 
portions 
  Portions per week 
EC061620G Cereals - rye based in 
grammes 
  Grammes per week 
EC061630P Cereals oats based in 
portions 





EC061630G Cereals oats based in 
grammes 
  Grammes per week 
EC061640P Cereals rice based in 
portions 
  Portions per week 
EC061640G Cereals rice based in 
grammes 
  Grammes per week 
EC061650P Cereals mixed grain in 
portions 
  Portions per week 
EC061650G Cereals mixed grain in 
grammes 
  Grammes per week 
EC061660P Muesli in portions   Portions per week 
EC061660G Muesli in grammes   Grammes per week 
EC070000P Pulses, seeds, 
kernels and nut 
products in portions 
  Portions per week 
EC070000G Pulses, seeds, 
kernels and nut 
products in grammes 
  Grammes per week 
EC070000XP Pulses, seeds, 




  Portions per week 
EC070000XG Pulses, seeds, 




  Grammes per week 
EC070100P Pulses in portions   Portions per week 
EC070100G Pulses in grammes   Grammes per week 
EC070110P Dried pea in portions   Portions per week 
EC070110G Dried pea in grammes   Grammes per week 
EC070120P Chick pea in portions   Portions per week 
EC070120G Chick pea in grammes   Grammes per week 
EC070130P Dried broad bean in 
portions 
  Portions per week 
EC070130G Dried broad bean in 
grammes 
  Grammes per week 
EC070140P Lentil in portions   Portions per week 
EC070140G Lentil in grammes   Grammes per week 
EC070150P Common  bean in 
portions 
  Portions per week 
EC070150G Common  bean in 
grammes 
  Grammes per week 
EC070160P Dried lima bean  in 
portions 
  Portions per week 
EC070160G Dried lima bean  in 
grammes 
  Grammes per week 
EC070170P Mung bean in portions   Portions per week 
EC070170G Mung bean in 
grammes 
  Grammes per week 
EC070180P Black eye bean in 
portions 
  Portions per week 
EC070180G Black eye bean in 
grammes 





EC070190P Soya beans in portions   Portions per week 
EC070190G Soya beans in 
grammes 
  Grammes per week 
EC070200P Underground pulses - 
peanut in portions 
  Portions per week 
EC070200G Underground pulses - 
peanut in grammes 
  Grammes per week 
EC070300P Seeds and kernels in 
portions 
  Portions per week 
EC070300G Seeds and kernels in 
grammes 
  Grammes per week 
EC070310P Linseed in portions   Portions per week 
EC070310G Linseed in grammes   Grammes per week 
EC070320P Sunflower seed in 
portions 
  Portions per week 
EC070320G Sunflower seed in 
grammes 
  Grammes per week 
EC070330P Poppy seed in portions   Portions per week 
EC070330G Poppy seed in 
grammes 
  Grammes per week 
EC070340P Cotton seed in 
portions 
  Portions per week 
EC070340G Cotton seed in 
grammes 
  Grammes per week 
EC070350P Rape seed in portions   Portions per week 
EC070350G Rape seed in 
grammes 
  Grammes per week 
EC070360P Beechnut seed in 
portions 
  Portions per week 
EC070360G Beechnut seed in 
grammes 
  Grammes per week 
EC070370P Sesame seed in 
portions 
  Portions per week 
EC070370G Sesame seed in 
grammes 
  Grammes per week 
EC070380P Olive seed in portions   Portions per week 
EC070380G Olive seed in 
grammes 
  Grammes per week 
EC070390P Pumpkin seed in 
portions 
  Portions per week 
EC070390G Pumpkin seed in 
grammes 
  Grammes per week 
EC070400P Nuts in portions   Portions per week 
EC070400G Nuts in grammes   Grammes per week 
EC070410P Walnut in portions   Portions per week 
EC070410G Walnut in grammes   Grammes per week 
EC070420P Hazelnut in portions   Portions per week 
EC070420G Hazelnut in grammes   Grammes per week 
EC070430P Coconut in portions   Portions per week 
EC070430G Coconut in grammes   Grammes per week 
EC070440P Brazil nut in portions   Portions per week 
EC070440G Brazil nut in grammes   Grammes per week 
EC070450P Cashew nut in portions   Portions per week 
EC070450G Cashew nut in 
grammes 





EC070460P Almond in portions   Portions per week 
EC070460G Almond in grammes   Grammes per week 
EC070470P Pistachio in portions   Portions per week 
EC070470G Pistachio in grammes   Grammes per week 
EC070480P Chestnut in portions   Portions per week 
EC070480G Chestnut in grammes   Grammes per week 
EC070500P Pulse products in 
portions 
  Portions per week 
EC070500G Pulse products in 
grammes 
  Grammes per week 
EC070510P Soya paste in portions   Portions per week 
EC070510G Soya paste in 
grammes 
  Grammes per week 
EC070520P Peanut butter in 
portions 
  Portions per week 
EC070520G Peanut butter in 
grammes 
  Grammes per week 
EC070600P Nut and seed products 
in portions 
  Portions per week 
EC070600G Nut and seed products 
in grammes 
  Grammes per week 
EC070610P Coconut milk in 
portions 
  Portions per week 
EC070610G Coconut milk in 
grammes 
  Grammes per week 
EC070620P Chestnut puree in 
portions 
  Portions per week 
EC070620G Chestnut puree in 
grammes 
  Grammes per week 
EC070630P Tahini paste in 
portions 
  Portions per week 
EC070630G Tahini paste in 
grammes 
  Grammes per week 
EC080000P Vegetables in 
portions 
  Portions per week 
EC080000G Vegetables in 
grammes 
  Grammes per week 
EC080000XP Vegetables - 
MISCELLANEOUS - 
in portions 
  Portions per week 
EC080000XG Vegetables - 
MISCELLANEOUS - 
in grammes 
  Grammes per week 
EC080100P Leaf vegetables in 
portions 
  Portions per week 
EC080100G Leaf vegetables in 
grammes 
  Grammes per week 
EC080110P Lettuce in portions   Portions per week 
EC080110G Lettuce in grammes   Grammes per week 
EC080120P Spinach in portions   Portions per week 
EC080120G Spinach in grammes   Grammes per week 
EC080130P Watercress in portions   Portions per week 
EC080130G Watercress in 
grammes 
  Grammes per week 






EC080140G Mustard seedling in 
grammes 
  Grammes per week 
EC080150P Cress seedling in 
portions 
  Portions per week 
EC080150G Cress seedling in 
grammes 
  Grammes per week 
EC080160P Vine leaf in portions   Portions per week 
EC080160G Vine leaf in grammes   Grammes per week 
EC080170P Nettle in portions   Portions per week 
EC080170G Nettle in grammes   Grammes per week 
EC080180P Sorrel in portions   Portions per week 
EC080180G Sorrel in grammes   Grammes per week 
EC080190P Parsley in portions   Portions per week 
EC080190G Parsley in grammes   Grammes per week 
EC080200P Brassicas in portions   Portions per week 
EC080200G Brassicas in grammes   Grammes per week 
EC080210P Broccoli in portions   Portions per week 
EC080210G Broccoli in grammes   Grammes per week 
EC080220P Cauliflower in portions   Portions per week 
EC080220G Cauliflower in 
grammes 
  Grammes per week 
EC080230P Cabbage in portions   Portions per week 
EC080230G Cabbage in grammes   Grammes per week 
EC080240P Red cabbage in 
portions 
  Portions per week 
EC080240G Red cabbage in 
grammes 
  Grammes per week 
EC080250P Chinese cabbage in 
portions 
  Portions per week 
EC080250G Chinese cabbage in 
grammes 
  Grammes per week 
EC080260P Brussel sprouts in 
portions 
  Portions per week 
EC080260G Brussel sprouts in 
grammes 
  Grammes per week 
EC080270P Turnip in portions   Portions per week 
EC080270G Turnip in grammes   Grammes per week 
EC080280P Curly kale in portions   Portions per week 
EC080280G Curly kale in grammes   Grammes per week 
EC080300P Stalk vegetables in 
portions 
  Portions per week 
EC080300G Stalk vegetables in 
grammes 
  Grammes per week 
EC080310P Celery in portions   Portions per week 
EC080310G Celery in grammes   Grammes per week 
EC080320P Fennel in portions   Portions per week 
EC080320G Fennel in grammes   Grammes per week 
EC080330P Sea kale in portions   Portions per week 
EC080330G Sea kale in grammes   Grammes per week 
EC080340P Rhubarb in portions   Portions per week 
EC080340G Rhubarb in grammes   Grammes per week 






EC080400G Shoot vegetables in 
grammes 
  Grammes per week 
EC080410P Asparagus in portions   Portions per week 
EC080410G Asparagus in 
grammes 
  Grammes per week 
EC080420P Chicory in portions   Portions per week 
EC080420G Chicory in grammes   Grammes per week 
EC080430P Artichoke in portions   Portions per week 
EC080430G Artichoke in grammes   Grammes per week 
EC080440P Bamboo shoot in 
portions 
  Portions per week 
EC080440G Bamboo shoot in 
grammes 
  Grammes per week 
EC080450P Palm heart in portions   Portions per week 
EC080450G Palm heart in 
grammes 
  Grammes per week 
EC080500P Onion-family 
vegetables in portions 




  Grammes per week 
EC080510P Onion in portions   Portions per week 
EC080510G Onion in grammes   Grammes per week 
EC080520P Spring onion in 
portions 
  Portions per week 
EC080520G Spring onion in 
grammes 
  Grammes per week 
EC080530P Shallot in portions   Portions per week 
EC080530G Shallot in grammes   Grammes per week 
EC080540P Leek in portions   Portions per week 
EC080540G Leek in grammes   Grammes per week 
EC080550P Garlic in portions   Portions per week 
EC080550G Garlic in grammes   Grammes per week 
EC080560P Chives in portions   Portions per week 
EC080560G Chives in grammes   Grammes per week 
EC080600P Tubers in portions   Portions per week 
EC080600G Tubers in grammes   Grammes per week 
EC080610P New potato in portions   Portions per week 
EC080610G New potato in 
grammes 
  Grammes per week 
EC080620P Main crop potato in 
portions 
  Portions per week 
EC080620G Main crop potato in 
grammes 
  Grammes per week 
EC080630P Jerusalem artichoke in 
portions 
  Portions per week 
EC080630G Jerusalem artichoke in 
grammes 
  Grammes per week 
EC080640P Sweet potato in 
portions 
  Portions per week 
EC080640G Sweet potato in 
grammes 
  Grammes per week 





EC080650G Yam in grammes   Grammes per week 
EC080660P Taro in portions   Portions per week 
EC080660G Taro in grammes   Grammes per week 
EC080700P Root vegetables in 
portions 
  Portions per week 
EC080700G Root vegetables in 
grammes 
  Grammes per week 
EC080710P Carrot in portions   Portions per week 
EC080710G Carrot in grammes   Grammes per week 
EC080720P Celeriac in portions   Portions per week 
EC080720G Celeriac in grammes   Grammes per week 
EC080730P Parsnip in portions   Portions per week 
EC080730G Parsnip in grammes   Grammes per week 
EC080740P Turnip in portions   Portions per week 
EC080740G Turnip in grammes   Grammes per week 
EC080750P Swede in portions   Portions per week 
EC080750G Swede in grammes   Grammes per week 
EC080760P Radish in portions   Portions per week 
EC080760G Radish in grammes   Grammes per week 
EC080770P Beetroot in portions   Portions per week 
EC080770G Beetroot in grammes   Grammes per week 
EC080800P Fruit vegetables in 
portions 
  Portions per week 
EC080800G Fruit vegetables in 
grammes 
  Grammes per week 
EC080810P Tomato in portions   Portions per week 
EC080810G Tomato in grammes   Grammes per week 
EC080811P Raw tomatoes in 
portions 
  Portions per week 
EC080811G Raw tomatoes in 
grammes 
  Grammes per week 
EC080812P Cooked tomatoes in 
portions 
  Portions per week 
EC080812G Cooked tomoatoes in 
grammes 
  Grammes per week 
EC080820P Aubergine in portions   Portions per week 
EC080820G Aubergine in grammes   Grammes per week 
EC080830P Sweet pepper in 
portions 
  Portions per week 
EC080830G Sweet pepper in 
grammes 
  Grammes per week 
EC080840P Chilli pepper in 
portions 
  Portions per week 
EC080840G Chilli pepper in 
grammes 
  Grammes per week 
EC080850P Cucumber in portions   Portions per week 
EC080850G Cucumber in grammes   Grammes per week 
EC080860P Courgette in portions   Portions per week 
EC080860G Courgette in grammes   Grammes per week 
EC080870P Plantain in portions   Portions per week 
EC080870G Plantain in grammes   Grammes per week 
EC080880P Avocado in portions   Portions per week 





EC080890P Olive in portions   Portions per week 
EC080890G Olive in grammes   Grammes per week 
EC080900P Pod and seed 
vegetables in portions 
  Portions per week 
EC080900G Pod and seed 
vegetables in 
grammes 
  Grammes per week 
EC080910P Pea in portions   Portions per week 
EC080910G Pea in grammes   Grammes per week 
EC080920P Broad bean in portions   Portions per week 
EC080920G Broad bean in 
grammes 
  Grammes per week 
EC080930P Wax beans in portions   Portions per week 
EC080930G Wax beans in 
grammes 
  Grammes per week 
EC080940P French bean in 
portions 
  Portions per week 
EC080940G French bean in 
grammes 
  Grammes per week 
EC080950P Runner beans in 
portions 
  Portions per week 
EC080950G Runner beans in 
grammes 
  Grammes per week 
EC080960P Sweet corn in portions   Portions per week 
EC080960G Sweet corn in 
grammes 
  Grammes per week 
EC080970P Okra in portions   Portions per week 
EC080970G Okra in grammes   Grammes per week 
EC081000P Edible fungi in portions   Portions per week 
EC081000G Edible fungi in 
grammes 
  Grammes per week 
EC081010P Cultivated mushroom 
in portions 
  Portions per week 
EC081010G Cultivated mushroom 
in grammes 
  Grammes per week 
EC081020P Field mushroom in 
portions 
  Portions per week 
EC081020G Field mushroom in 
grammes 
  Grammes per week 
EC081030P Honey mushroom in 
portions 
  Portions per week 
EC081030G Honey mushroom in 
grammes 
  Grammes per week 
EC081040P Truffle in portions   Portions per week 
EC081040G Truffle in grammes   Grammes per week 
EC081050P Morel in portions   Portions per week 
EC081050G Morel in grammes   Grammes per week 
EC081060P Cantharelle in portions   Portions per week 
EC081060G Cantharelle in 
grammes 
  Grammes per week 
EC081070P Oyster mushroom in 
portions 
  Portions per week 
EC081070G Oyster mushroom in 
grammes 
  Grammes per week 






EC081080G Shitake mushroom in 
grammes 
  Grammes per week 
EC081090P Straw mushroom in 
portions 
  Portions per week 
EC081090G Straw mushroom in 
grammes 
  Grammes per week 
EC081100P Seaweeds in portions   Portions per week 
EC081100G Seaweeds in grammes   Grammes per week 
EC081200P Vegetable mixes in 
portions 
  Portions per week 
EC081200G Vegetable mixes in 
grammes 
  Grammes per week 
EC081300P Vegetable products in 
portions 
  Portions per week 
EC081300G Vegetable products in 
grammes 
  Grammes per week 
EC081310P Mushy peas in 
portions 
  Portions per week 
EC081310G Mushy peas in 
grammes 
  Grammes per week 
EC081320P Garlic puree in 
portions 
  Portions per week 
EC081320G Garlic puree in 
grammes 
  Grammes per week 
EC081330P Tomato puree in 
portions 
  Portions per week 
EC081330G Tomato puree in 
grammes 
  Grammes per week 
EC081340P Vegetable puree in 
portions 
  Portions per week 
EC081340G Vegetable puree in 
grammes 
  Grammes per week 
EC081350P Pickled gherkins in 
portions 
  Portions per week 
EC081350G Pickled gherkins in 
grammes 
  Grammes per week 
EC081360P Pickled onion in 
portions 
  Portions per week 
EC081360G Pickled onion in 
grammes 
  Grammes per week 
EC081370P Pickled red cabbage in 
portions 
  Portions per week 
EC081370G Pickled red cabbage in 
grammes 
  Grammes per week 
EC081380P Sauerkraut in portions   Portions per week 
EC081380G Sauerkraut in 
grammes 
  Grammes per week 
EC090000P Fruits and fruit 
products in portions 
  Portions per week 
EC090000G Fruits and fruit 
products in grammes 
  Grammes per week 













  Grammes per week 
EC090100P Malaceious fruit in 
portions 
  Portions per week 
EC090100G Malaceious fruit in 
grammes 
  Grammes per week 
EC090110P Dessert apple in 
portions 
  Portions per week 
EC090110G Dessert apple in 
grammes 
  Grammes per week 
EC090120P Cooking apple in 
portions 
  Portions per week 
EC090120G Cooking apple in 
grammes 
  Grammes per week 
EC090130P Pear in portions   Portions per week 
EC090130G Pear in grammes   Grammes per week 
EC090200P Prunus species fruit in 
portions 
  Portions per week 
EC090200G Prunus species fruit in 
grammes 
  Grammes per week 
EC090210P Apricot in portions   Portions per week 
EC090210G Apricot in grammes   Grammes per week 
EC090220P Peach in portions   Portions per week 
EC090220G Peach in grammes   Grammes per week 
EC090230P Nectarine in portions   Portions per week 
EC090230G Nectarine in grammes   Grammes per week 
EC090240P Plum in portions   Portions per week 
EC090240G Plum in grammes   Grammes per week 
EC090250P Cherry in portions   Portions per week 
EC090250G Cherry in grammes   Grammes per week 
EC090260P Plum in portions   Portions per week 
EC090260G Plum in grammes   Grammes per week 
EC090300P Other stone fruit in 
portions 
  Portions per week 
EC090300G Other stone fruit in 
grammes 
  Grammes per week 
EC090310P Date in portions   Portions per week 
EC090310G Date in grammes   Grammes per week 
EC090320P Lychee in portions   Portions per week 
EC090320G Lychee in grammes   Grammes per week 
EC090400P Berries in portions   Portions per week 
EC090400G Berries in grammes   Grammes per week 
EC090410P Grapes in portions   Portions per week 
EC090410G Grapes in grammes   Grammes per week 
EC090420P Strawberries in 
portions 
  Portions per week 
EC090420G Strawberries in 
grammes 
  Grammes per week 
EC090430P Raspberries in 
portions 
  Portions per week 
EC090430G Raspberries in 
grammes 





EC090440P Blackberries in 
portions 
  Portions per week 
EC090440G Blackberries in 
grammes 
  Grammes per week 
EC090450P Gooseberries in 
portions 
  Portions per week 
EC090450G Gooseberries in 
grammes 
  Grammes per week 
EC090460P Elderberries in 
portions 
  Portions per week 
EC090460G Elderberries in 
grammes 
  Grammes per week 
EC090470P Currants in portions   Portions per week 
EC090470G Currants in grammes   Grammes per week 
EC090480P Cranberries in portions   Portions per week 
EC090480G Cranberries in 
grammes 
  Grammes per week 
EC090490P Blueberries in portions   Portions per week 
EC090490G Blueberries in 
grammes 
  Grammes per week 
EC090500P Citrus fruit in portions   Portions per week 
EC090500G Citrus fruit in grammes   Grammes per week 
EC090510P Lemon in portions   Portions per week 
EC090510G Lemon in grammes   Grammes per week 
EC090520P Orange in portions   Portions per week 
EC090520G Orange in grammes   Grammes per week 
EC090530P Tangerine in portions   Portions per week 
EC090530G Tangerine in grammes   Grammes per week 
EC090540P Grapefruit in portions   Portions per week 
EC090540G Grapefruit in grammes   Grammes per week 
EC090550P Pomelo in portions   Portions per week 
EC090550G Pomelo in grammes   Grammes per week 
EC090560P Lime in portions   Portions per week 
EC090560G Lime in grammes   Grammes per week 
EC090570P Kumquat in portions   Portions per week 
EC090570G Kumquat in grammes   Grammes per week 
EC090600P Miscellaneous fruit in 
portions 
  Portions per week 
EC090600G Miscellaneous fruit in 
grammes 
  Grammes per week 
EC090610P Banana in portions   Portions per week 
EC090610G Banana in grammes   Grammes per week 
EC090620P Pineapple in portions   Portions per week 
EC090620G Pineapple in grammes   Grammes per week 
EC090630P Kiwi fruit in portions   Portions per week 
EC090630G Kiwi fruit in grammes   Grammes per week 
EC090640P Melon in portions   Portions per week 
EC090640G Melon in grammes   Grammes per week 
EC090650P Water melon in 
portions 
  Portions per week 
EC090650G Water melon in 
grammes 
  Grammes per week 





EC090660G Fig in grammes   Grammes per week 
EC090670P Mango in portions   Portions per week 
EC090670G Mango in grammes   Grammes per week 
EC090680P Pomegranate in 
portions 
  Portions per week 
EC090680G Pomegranate in 
grammes 
  Grammes per week 
EC090690P Passion fruit in 
portions 
  Portions per week 
EC090690G Passion fruit in 
grammes 
  Grammes per week 
EC090700P Fruit mixtures in 
portions 
  Portions per week 
EC090700G Fruit mixtures in 
grammes 
  Grammes per week 
EC090710P Fruit cocktail in 
portions 
  Portions per week 
EC090710G Fruit cocktail in 
grammes 
  Grammes per week 
EC090720P Fruit salad in portions   Portions per week 
EC090720G Fruit salad in grammes   Grammes per week 
EC090800P Fruit products in 
portions 
  Portions per week 
EC090800G Fruit products in 
grammes 
  Grammes per week 
EC090810P Dried mixed fruit in 
portions 
  Portions per week 
EC090810G Dried mixed fruit in 
grammes 
  Grammes per week 
EC090820P Mixed peel in portions   Portions per week 
EC090820G Mixed peel in 
grammes 
  Grammes per week 
EC090830P Glace cherry in 
portions 
  Portions per week 
EC090830G Glace cherry in 
grammes 
  Grammes per week 
EC090840P Apple sauce in 
portions 
  Portions per week 
EC090840G Apple sauce in 
grammes 
  Grammes per week 
EC090850P Cranberry sauce in 
portions 
  Portions per week 
EC090850G Cranberry sauce in 
grammes 
  Grammes per week 
EC100000P Sugar and sugar 
products in portions 
  Portions per week 
EC100000G Sugar and sugar 
products in grammes 
  Grammes per week 




  Portions per week 









EC100100P Sugar in portions   Portions per week 
EC100100G Sugar in grammes   Grammes per week 
EC100101P White sugar in 
portions 
  Portions per week 
EC100101G White sugar in 
grammes 
  Grammes per week 
EC100102P Brown sugar in 
portions 
  Portions per week 
EC100102G Brown sugar in 
grammes 
  Grammes per week 
EC100200P Other sugars in 
portions 
  Portions per week 
EC100200G Other sugars in 
grammes 
  Grammes per week 
EC100210P Glucose in portions   Portions per week 
EC100210G Glucose in grammes   Grammes per week 
EC100210ML Glucose in millilitres   Millilitres per week 
EC100220P Fructose in portions   Portions per week 
EC100220G Fructose in grammes   Grammes per week 
EC100220ML Fructose in millilitres   Millilitres per week 
EC100230P Malt sugar in portions   Portions per week 
EC100230G Malt sugar in grammes   Grammes per week 
EC100240P Milk sugar in portions   Portions per week 
EC100240G Milk sugar in grammes   Grammes per week 
EC100240ML Milk sugar in millilitres   Millilitres per week 
EC100300P Sugar substitutes in 
portions 
  Portions per week 
EC100300G Sugar substitutes in 
grammes 
  Grammes per week 
EC100310P Non-nutritive 
sweeteners in portions 




  Grammes per week 
EC100320P Nutritive sweeteners in 
portions 
  Portions per week 
EC100320G Nutritive sweeteners in 
grammes 
  Grammes per week 
EC100400P Honey in portions   Portions per week 
EC100400G Honey in grammes   Grammes per week 
EC100400ML Honey in millilitres   Millilitres per week 
EC100500P Syrups in portions   Portions per week 
EC100500G Syrups in grammes   Grammes per week 
EC100500ML Syrups in millilitres   Millilitres per week 
EC100510P Molasses in portions   Portions per week 
EC100510G Molasses in grammes   Grammes per week 
EC100510ML Molasses in millilitres   Millilitres per week 
EC100520P Black treacle in 
portions 
  Portions per week 
EC100520G Black treacle in 
grammes 
  Grammes per week 
EC100520ML Black treacle in 
millilitres 
  Millilitres per week 






EC100530G Golden syrup in 
grammes 
  Grammes per week 
EC100530ML Golden syrup in 
millilitres 
  Millilitres per week 
EC100540P Maple syrup in 
portions 
  Portions per week 
EC100540G Maple syrup in 
grammes 
  Grammes per week 
EC100540ML Maple syrup in 
millilitres 
  Millilitres per week 
EC100550P Fruit syrup in portions   Portions per week 
EC100550G Fruit syrup in 
grammes 
  Grammes per week 
EC100550ML Fruit syrup in millilitres   Millilitres per week 
EC100560P Glucose syrup in 
portions 
  Portions per week 
EC100560G Glucose syrup in 
grammes 
  Grammes per week 
EC100560ML Glucose syrup in 
millilitres 
  Millilitres per week 
EC100570P Sugar syrup in 
portions 
  Portions per week 
EC100570G Sugar syrup in 
grammes 
  Grammes per week 
EC100570ML Sugar syrup in 
millilitres 
  Millilitres per week 
EC100600P Jams, marmalades 
and spreads in 
portions 
  Portions per week 
EC100600G Jams, marmalades 
and spreads in 
grammes 
  Grammes per week 
EC100610P Fruit jam in portions   Portions per week 
EC100610G Fruit jam in grammes   Grammes per week 
EC100620P Fruit jelly preserve in 
portions 
  Portions per week 
EC100620G Fruit jelly preserve in 
grammes 
  Grammes per week 
EC100630P Marmalade in portions   Portions per week 
EC100630G Marmalade in 
grammes 
  Grammes per week 
EC100700P Jelly in portions   Portions per week 
EC100700G Jelly in grammes   Grammes per week 
EC100800P Non-chocolate dessert 
topping in portions 
  Portions per week 
EC100800G Non-chocolate dessert 
topping in grammes 
  Grammes per week 
EC100900P Chocolate and 
chocolate products in 
portions 
  Portions per week 
EC100900G Chocolate and 
chocolate products in 
grammes 
  Grammes per week 
EC100910P Cocoa powder in 
portions 





EC100910G Cocoa powder in 
grammes 
  Grammes per week 
EC100920P Milk  chocolate bar in 
portions 
  Portions per week 
EC100920G Milk  chocolate bar in 
grammes 
  Grammes per week 
EC100930P Plain chocolate bar in 
portions 
  Portions per week 
EC100930G Plain chocolate bar in 
grammes 
  Grammes per week 
EC100940P Other chocolate goods 
in portions 
  Portions per week 
EC100940G Other chocolate goods 
in grammes 
  Grammes per week 
EC101000P Chocolate-coated 
confectionery bars in 
portions 
  Portions per week 
EC101000G Chocolate-coated 
confectionery bars in 
grammes 








  Grammes per week 
EC101110P Sweet in portions   Portions per week 
EC101110G Sweet in grammes   Grammes per week 
EC101120P Liquorice in portions   Portions per week 
EC101120G Liquorice in grammes   Grammes per week 
EC101130P Fudge in portions   Portions per week 
EC101130G Fudge in grammes   Grammes per week 
EC101140P Toffee in portions   Portions per week 
EC101140G Toffee in grammes   Grammes per week 
EC101150P Marshmallow in 
portions 
  Portions per week 
EC101150G Marshmallow in 
grammes 
  Grammes per week 
EC101160P Nougat in portions   Portions per week 
EC101160G Nougat in grammes   Grammes per week 
EC101170P Turkish delight in 
portions 
  Portions per week 
EC101170G Turkish delight in 
grammes 
  Grammes per week 
EC101180P Cereal bar in portions   Portions per week 
EC101180G Cereal bar in grammes   Grammes per week 
EC101190P Chewing gum in 
portions 
  Portions per week 
EC101190G Chewing gum in 
grammes 
  Grammes per week 
EC101200P Sugar products in 
portions 
  Portions per week 
EC101200G Sugar products in 
grammes 
  Grammes per week 





EC101210G Marzipan in grammes   Grammes per week 
EC101220P Candied fruit in 
portions 
  Portions per week 
EC101220G Candied fruit in 
grammes 
  Grammes per week 
EC101230P Preserved ginger in 
portions 
  Portions per week 
EC101230G Preserved ginger in 
grammes 
  Grammes per week 
EC110000P Beverages in 
portions 
  Portions per week 
EC110000ML Beverages in 
millilitres 
  Millilitres per week 
EC110000XP Beverages - 
MISCELLANEOUS - 
in portions 
  Portions per week 
EC110000XML Beverages - 
MISCELLANEOUS - 
in millilitres 
  Millilitres per week 
EC110100P Beers and malt 
beverages in portions 
  Portions per week 
EC110100ML Beers and malt 
beverages in millilitres 
  Millilitres per week 
EC110110P Beer - alcohol >5% in 
portions 
  Portions per week 
EC110110ML Beer - alcohol >5% in 
millilitres 
  Millilitres per week 
EC110120P Beer - alcohol 3.1-5% 
in portions 
  Portions per week 
EC110120ML Beer - alcohol 3.1-5% 
in millilitres 
  Millilitres per week 
EC110130P Beer - alcohol 1-3% in 
portions 
  Portions per week 
EC110130ML Beer - alcohol 1-3% in 
millilitres 
  Millilitres per week 
EC110140P Beer - alcohol <1% in 
portions 
  Portions per week 
EC110140ML Beer - alcohol <1% in 
millilitres 
  Millilitres per week 
EC110150P Barley beer in portions   Portions per week 
EC110150ML Barley beer in 
millilitres 
  Millilitres per week 
EC110200P Ciders in portions   Portions per week 
EC110200ML Ciders in millilitres   Millilitres per week 
EC110210P Cider in portions   Portions per week 
EC110210ML Cider in millilitres   Millilitres per week 
EC110220P Perry in portions   Portions per week 
EC110220ML Perry in millilitres   Millilitres per week 
EC110230P Ginger beer in portions   Portions per week 
EC110230ML Ginger beer in 
millilitres 
  Millilitres per week 
EC110240P Elderflower in portions   Portions per week 
EC110240ML Elderflower in millilitres   Millilitres per week 
EC110300P Wines in portions   Portions per week 





EC110310P Wine - alcohol >9% in 
portions 
  Portions per week 
EC110310ML Wine - alcohol >9% in 
millilitres 
  Millilitres per week 
EC110320P Wine - alcohol 5.1.a% 
in portions 
  Portions per week 
EC110320ML Wine - alcohol 5.1.a% 
in millilitres 
  Millilitres per week 
EC110330P Wine - alcohol 1-5% in 
portions 
  Portions per week 
EC110330ML Wine - alcohol 1-5% in 
millilitres 
  Millilitres per week 
EC110340P Wine - alcohol <1% in 
portions 
  Portions per week 
EC110340ML Wine - alcohol <1% in 
millilitres 
  Millilitres per week 
EC110350P Dessert wine in 
portions 
  Portions per week 
EC110350ML Dessert wine in 
millilitres 
  Millilitres per week 
EC110360P Homemade wine in 
portions 
  Portions per week 
EC110360ML Homemade wine in 
millilitres 
  Millilitres per week 
EC110400P Fortified and liqueur 
wines in portions 
  Portions per week 
EC110400ML Fortified and liqueur 
wines in millilitres 
  Millilitres per week 
EC110410P Port in portions   Portions per week 
EC110410ML Port in millilitres   Millilitres per week 
EC110420P Sherry in portions   Portions per week 
EC110420ML Sherry in millilitres   Millilitres per week 
EC110430P Madeira in portions   Portions per week 
EC110430ML Madeira in millilitres   Millilitres per week 
EC110440P Marsala in portions   Portions per week 
EC110440ML Marsala in millilitres   Millilitres per week 
EC110450P Vermouth in portions   Portions per week 
EC110450ML Vermouth in millilitres   Millilitres per week 
EC110460P Ginger wine in 
portions 
  Portions per week 
EC110460ML Ginger wine in 
millilitres 
  Millilitres per week 
EC110500P Liqueurs in portions   Portions per week 
EC110500ML Liqueurs in millilitres   Millilitres per week 
EC110510P Fruit liqueurs in 
portions 
  Portions per week 
EC110510ML Fruit liqueurs in 
millilitres 
  Millilitres per week 
EC110520P Herb liqueurs in 
portions 
  Portions per week 
EC110520ML Herb liqueurs in 
millilitres 
  Millilitres per week 
EC110530P Seed liqueurs in 
portions 
  Portions per week 






EC110540P Chocolate liqueurs in 
portions 
  Portions per week 
EC110540ML Chocolate liqueurs in 
millilitres 
  Millilitres per week 
EC110550P Coffee liqueurs in 
portions 
  Portions per week 
EC110550ML Coffee liqueurs in 
millilitres 
  Millilitres per week 
EC110560P Egg liqueurs in 
portions 
  Portions per week 
EC110560ML Egg liqueurs in 
millilitres 
  Millilitres per week 
EC110600P Spirits in portions   Portions per week 
EC110600ML Spirits in millilitres   Millilitres per week 
EC110610P Brandy in portions   Portions per week 
EC110610ML Brandy in millilitres   Millilitres per week 
EC110620P Whisky in portions   Portions per week 
EC110620ML Whisky in millilitres   Millilitres per week 
EC110630P Gin in portions   Portions per week 
EC110630ML Gin in millilitres   Millilitres per week 
EC110640P Vodka in portions   Portions per week 
EC110640ML Vodka in millilitres   Millilitres per week 
EC110650P Rum in portions   Portions per week 
EC110650ML Rum in millilitres   Millilitres per week 
EC110700P Alcoholic mixed drinks 
in portions 
  Portions per week 
EC110700ML Alcoholic mixed drinks 
in millilitres 
  Millilitres per week 
EC110710P Cocktails in portions   Portions per week 
EC110710ML Cocktails in millilitres   Millilitres per week 
EC110720P Punch - alcohol >1% 
in portions 
  Portions per week 
EC110720ML Punch - alcohol >1% 
in millilitres 
  Millilitres per week 
EC110730P Punch - alcohol <1% 
in portions 
  Portions per week 
EC110730ML Punch - alcohol <1% 
in millilitres 
  Millilitres per week 
EC110740P Shandy in portions   Portions per week 
EC110740ML Shandy in millilitres   Millilitres per week 
EC110750P Laced coffee in 
portions 
  Portions per week 
EC110750ML Laced coffee in 
millilitres 
  Millilitres per week 
EC110800P Carbonated soft drinks 
in portions 
  Portions per week 
EC110800ML Carbonated soft drinks 
in millilitres 
  Millilitres per week 
EC110810P Tonic water in portions   Portions per week 
EC110810ML Tonic water in 
millilitres 
  Millilitres per week 
EC110820P Soda water in portions   Portions per week 






EC110830P Carbonated lemonade 
in portions 
  Portions per week 
EC110830ML Carbonated lemonade 
in millilitres 
  Millilitres per week 
EC110840P Carbonated fruit drink 
in portions 
  Portions per week 
EC110840ML Carbonated fruit drink 
in millilitres 
  Millilitres per week 
EC110850P Cola in portions   Portions per week 
EC110850ML Cola in millilitres   Millilitres per week 
EC110860P Root beer in portions   Portions per week 
EC110860ML Root beer in millilitres   Millilitres per week 
EC110870P Cream soda in 
portions 
  Portions per week 
EC110870ML Cream soda in 
millilitres 
  Millilitres per week 
EC110880P Dr Pepper in portions   Portions per week 
EC110880ML Dr Pepper in millilitres   Millilitres per week 
EC110890P Lucozade in portions   Portions per week 
EC110890ML Lucozade in millilitres   Millilitres per week 
EC110900P Non-dilution still drinks 
in portions 
  Portions per week 
EC110900ML Non-dilution still drinks 
in millilitres 
  Millilitres per week 
EC110910P Still lemonade in 
portions 
  Portions per week 
EC110910ML Still lemonade in 
millilitres 
  Millilitres per week 
EC111000P Dilution drinks in 
portions 
  Portions per week 
EC111000ML Dilution drinks in 
millilitres 
  Millilitres per week 
EC111010P Blackcurrant drink in 
portions 
  Portions per week 
EC111010ML Blackcurrant drink in 
millilitres 
  Millilitres per week 
EC111020P Fruit squash in 
portions 
  Portions per week 
EC111020ML Fruit squash in 
millilitres 
  Millilitres per week 
EC111030P Fruit cordial in portions   Portions per week 
EC111030ML Fruit cordial in 
millilitres 
  Millilitres per week 
EC112000P Infusion drinks in 
portions 
  Portions per week 
EC112000ML Infusion drinks in 
millilitres 
  Millilitres per week 
EC112010P Black tea in portions   Portions per week 
EC112010ML Black tea in millilitres   Millilitres per week 
EC112020P Oolon tea in portions   Portions per week 
EC112020ML Oolon tea in millilitres   Millilitres per week 
EC112030P Green tea in portions   Portions per week 
EC112030ML Green tea in millilitres   Millilitres per week 





EC112040ML Herbal tea in millilitres   Millilitres per week 
EC112050P White tea in portions   Portions per week 
EC112050ML White tea in millilitres   Millilitres per week 
EC112060P Instant tea powder in 
portions 
  Portions per week 
EC112060ML Instant tea powder in 
millilitres 
  Millilitres per week 
EC112070P Coffee in portions   Portions per week 
EC112070ML Coffee in millilitres   Millilitres per week 
EC112071P Decaffeinated coffee 
in portions 
  Portions per week 
EC112071ML Decaffeinated coffee 
in millilitres 
  Millilitres per week 
EC112072P Caffeinated coffee in 
portions 
  Portions per week 
EC112072ML Caffeinated coffee in 
millilitres 
  Millilitres per week 
EC112080P Instant coffee in 
portions 
  Portions per week 
EC112080ML Instant coffee in 
millilitres 
  Millilitres per week 
EC112081P Instant decaffeinated 
coffee in portions 
  Portions per week 
EC112081ML Instant decaffeinated 
coffee in millilitres 
  Millilitres per week 
EC112082P Instant caffeinated 
coffee in portions 
  Portions per week 
EC112082ML Instant caffeinated 
coffee in millilitres 
  Millilitres per week 
EC113000P Water in portions   Portions per week 
EC113000ML Water in millilitres   Millilitres per week 
EC113010P Tap water in portions   Portions per week 
EC113010ML Tap water in millilitres   Millilitres per week 
EC113020P Demineralised tap 
water in portions 
  Portions per week 
EC113020ML Demineralised tap 
water in millilitres 
  Millilitres per week 
EC113030P Carbonated mineral 
water in portions 
  Portions per week 
EC113030ML Carbonated mineral 
water in millilitres 
  Millilitres per week 
EC113040P Still mineral water in 
portions 
  Portions per week 
EC113040ML Still mineral water in 
millilitres 
  Millilitres per week 
EC114000P Fruit juices in portions   Portions per week 
EC114000ML Fruit juices in millilitres   Millilitres per week 
EC114010P Orange juice in 
portions 
  Portions per week 
EC114010ML Orange juice in 
millilitres 
  Millilitres per week 
EC114020P Grapefruit juice in 
portions 
  Portions per week 
EC114020ML Grapefruit juice in 
millilitres 





EC114030P Lemon juice in 
portions 
  Portions per week 
EC114030ML Lemon juice in 
millilitres 
  Millilitres per week 
EC114040P Apple juice in portions   Portions per week 
EC114040ML Apple juice in millilitres   Millilitres per week 
EC114050P Prune juice in portions   Portions per week 
EC114050ML Prune juice in millilitres   Millilitres per week 
EC114060P Grape juice in portions   Portions per week 
EC114060ML Grape juice in 
millilitres 
  Millilitres per week 
EC114070P Mango juice in 
portions 
  Portions per week 
EC114070ML Mango juice in 
millilitres 
  Millilitres per week 
EC114080P Mixed fruit juice in 
portions 
  Portions per week 
EC114080ML Mixed fruit juice in 
millilitres 
  Millilitres per week 
EC115000P Vegetable juices in 
portions 
  Portions per week 
EC115000ML Vegetable juices in 
millilitres 
  Millilitres per week 
EC115010P Tomato juices in 
portions 
  Portions per week 
EC115010ML Tomato juices in 
millilitres 
  Millilitres per week 
EC115020P Carrot juices in 
portions 
  Portions per week 
EC115020ML Carrot juices in 
millilitres 
  Millilitres per week 
EC116000P Fruit and vegetable 
nectars in portions 
  Portions per week 
EC116000ML Fruit and vegetable 
nectars in millilitres 
  Millilitres per week 
EC117000P Other juices in 
portions 
  Portions per week 
EC117000ML Other juices in 
millilitres 
  Millilitres per week 
EC117010P Coconut milk in 
portions 
  Portions per week 
EC117010ML Coconut milk in 
millilitres 
  Millilitres per week 
EC120000P Miscellaneous in 
portions 
  Portions per week 
EC120000G Miscellaneous in 
grammes 
  Grammes per week 
EC120000XP Miscellaneous in 
portions 
  Portions per week 
EC120000XG Miscellaneous in 
grammes 
  Grammes per week 
EC120100P Baking goods in 
portions 
  Portions per week 
EC120100G Baking goods in 
grammes 
  Grammes per week 






EC120110G Sodium bicarbonate in 
grammes 
  Grammes per week 
EC120120P Cream of tartar in 
portions 
  Portions per week 
EC120120G Cream of tartar in 
grammes 
  Grammes per week 
EC120130P Baking powder in 
portions 
  Portions per week 
EC120130G Baking powder in 
grammes 
  Grammes per week 
EC120140P Gelatine in portions   Portions per week 
EC120140G Gelatine in grammes   Grammes per week 
EC120150P Gum in portions   Portions per week 
EC120150G Gum in grammes   Grammes per week 
EC120160P Yeast in portions   Portions per week 
EC120160G Yeast in grammes   Grammes per week 
EC120200P Flavourings and 
essences in portions 
  Portions per week 
EC120200G Flavourings and 
essences in grammes 
  Grammes per week 
EC120210P Almond essence in 
portions 
  Portions per week 
EC120210G Almond essence in 
grammes 
  Grammes per week 
EC120220P Vanilla pods in 
portions 
  Portions per week 
EC120220G Vanilla pods in 
grammes 
  Grammes per week 
EC120300P Seasoning in portions   Portions per week 
EC120300G Seasoning in 
grammes 
  Grammes per week 
EC120310P Salt in portions   Portions per week 
EC120310G Salt in grammes   Grammes per week 
EC120320P Monosodium 
glutamate in portions 
  Portions per week 
EC120320G Monosodium 
glutamate in grammes 
  Grammes per week 
EC120330P Stock cubes/powder in 
portions 
  Portions per week 
EC120330G Stock cubes/powder in 
grammes 
  Grammes per week 
EC120340P Gravy in portions   Portions per week 
EC120340ML Gravy in millilitres   Millilitres per week 
EC120350P Vinegar in portions   Portions per week 
EC120350ML Vinegar in millilitres   Millilitres per week 
EC120400P Herbs in portions   Portions per week 
EC120400G Herbs in grammes   Grammes per week 
EC120500P Spices in portions   Portions per week 
EC120500G Spices in grammes   Grammes per week 
EC120600P Condiments in 
portions 
  Portions per week 
EC120600G Condiments in 
grammes 





EC120610P Mustard in portions   Portions per week 
EC120610G Mustard in grammes   Grammes per week 
EC120620P Tomato ketchup in 
portions 
  Portions per week 
EC120620G Tomato ketchup in 
grammes 
  Grammes per week 
EC120620ML Tomato ketchup in 
millilitres 
  Millilitres per week 
EC120630P Brown sauce in 
portions 
  Portions per week 
EC120630G Brown sauce in 
grammes 
  Grammes per week 
EC120630ML Brown sauce in 
millilitres 
  Millilitres per week 
EC120640P Worcestershire sauce 
in portions 
  Portions per week 
EC120640G Worcestershire sauce 
in grammes 
  Grammes per week 
EC120640ML Worcestershire sauce 
in millilitres 
  Millilitres per week 
EC120650P Tabasco sauce in 
portions 
  Portions per week 
EC120650G Tabasco sauce in 
grammes 
  Grammes per week 
EC120650ML Tabasco sauce in 
millilitres 
  Millilitres per week 
EC120660P Horseradish sauce in 
portions 
  Portions per week 
EC120660G Horseradish sauce in 
grammes 
  Grammes per week 
EC120660ML Horseradish sauce in 
millilitres 
  Millilitres per week 
EC120670P Mint sauce in portions   Portions per week 
EC120670G Mint sauce in 
grammes 
  Grammes per week 
EC120670ML Mint sauce in millilitres   Millilitres per week 
EC120680P Tartare sauce in 
portions 
  Portions per week 
EC120680G Tartare sauce in 
grammes 
  Grammes per week 
EC120680ML Tartare sauce in 
millilitres 
  Millilitres per week 
EC120700P Dressings in portions   Portions per week 
EC120700G Dressings in grammes   Grammes per week 
EC120710P Salad dressing in 
portions 
  Portions per week 
EC120710G Salad dressing in 
grammes 
  Grammes per week 
EC120720P Mayonnaise in 
portions 
  Portions per week 
EC120720G Mayonnaise in 
grammes 
  Grammes per week 
EC120800P Chutney and pickles in 
portions 
  Portions per week 
EC120800G Chutney and pickles in 
grammes 





EC120810P Mixed chutney in 
portions 
  Portions per week 
EC120810G Mixed chutney in 
grammes 
  Grammes per week 
EC120820P Apple chutney in 
portions 
  Portions per week 
EC120820G Apple chutney in 
grammes 
  Grammes per week 
EC120830P Cucumber chutney in 
portions 
  Portions per week 
EC120830G Cucumber chutney in 
grammes 
  Grammes per week 
EC120840P Tomato chutney in 
portions 
  Portions per week 
EC120840G Tomato chutney in 
grammes 
  Grammes per week 
EC120850P Relish in portions   Portions per week 
EC120850G Relish in grammes   Grammes per week 
EC120860P Pickle in portions   Portions per week 
EC120860G Pickle in grammes   Grammes per week 
EC120900P Savoury sauces in 
portions 
  Portions per week 
EC120900G  Savoury sauces in 
grammes  
  Grammes per week  
EC120900ML Savoury sauces in 
millilitres 
  Millilitres per week 
EC120910P White sauce in 
portions 
  Portions per week 
EC120910G  White sauce in 
grammes  
  Grammes per week  
EC120910ML White sauce in 
millilitres 
  Millilitres per week 
EC120920P Butter sauce in 
portions 
  Portions per week 
EC120920G  Butter sauce in 
grammes  
  Grammes per week  
EC120920ML Butter sauce in 
millilitres 
  Millilitres per week 
EC120930P Fish sauce in portions   Portions per week 
EC120930G  Fish sauce in 
grammes  
  Grammes per week  
EC120930ML Fish sauce in millilitres   Millilitres per week 
EC120940P Tomato sauce in 
portions 
  Portions per week 
EC120940G  Tomato sauce in 
grammes  
  Grammes per week  
EC120940ML Tomato sauce in 
millilitres 
  Millilitres per week 
EC121000P Dessert sauces in 
portions 
  Portions per week 
EC121000G  Dessert sauces in 
grammes  
  Grammes per week  
EC121000ML Dessert sauces in 
millilitres 
  Millilitres per week 
EC121010P Fruit sauce in portions   Portions per week 











EC121010ML Fruit sauce in millilitres   Millilitres per week 
EC121020P Chocolate sauce in 
portions 
  Portions per week 
EC121020G  Chocolate sauce in 
grammes  
  Grammes per week  
EC121020ML Chocolate sauce in 
millilitres 
  Millilitres per week 
EC122000P Soups in portions   Portions per week 
EC122000ML Soups in millilitres   Millilitres per week 
EC122010P Milk/egg soup in 
portions 
  Portions per week 
EC122010ML Milk/egg soup in 
millilitres 
  Millilitres per week 
EC122020P Meat/poultry soup in 
portions 
  Portions per week 
EC122020ML Meat/poultry soup in 
millilitres 
  Millilitres per week 
EC122030P Fish soup in portions   Portions per week 
EC122030ML Fish soup in millilitres   Millilitres per week 
EC122040P Vegetable soup in 
portions 
  Portions per week 
EC122040ML Vegetable soup in 
millilitres 
  Millilitres per week 
EC123000P Savoury snacks in 
portions 
  Portions per week 
EC123000G Savoury snacks in 
grammes 
  Grammes per week 
EC123010P Potato-based snacks 
in portions 
  Portions per week 
EC123010G Potato-based snacks 
in grammes 
  Grammes per week 
EC123020P Maize-based snacks in 
portions 
  Portions per week 
EC123020G Maize-based snacks in 
grammes 
  Grammes per week 
EC123030P Wheat-based snacks 
in portions 
  Portions per week 
EC123030G Wheat-based snacks 
in grammes 
  Grammes per week 
EC123040P Rice-based snacks in 
portions 
  Portions per week 
EC123040G Rice-based snacks in 
grammes 





Appendix 4.3 Sample of do file 
PORDENONE STUDY 
**-read in data as DTA FILE--* 
use "$path/data/pordenone", clear 
 
*---check whether anything has changed since last time data was read  
save "$path/temp/pordenone", replace 
cf _all using "$path/temp/pordenone" 
 
*-check whether data has changed-* 
datasignature 
assert r(datasignature)== "1794:52(60900):877230665:365421863" 
 
*RENAME/CODE VARIABLES* 
gen A01 = 123 
 
recode v2 (.=.a) 
tostring v2, replace 
gen str15 A02=v2 
 
gen A04 = 10 
gen A05 = 12 
gen A06 = .b 
gen A07 = 12 
gen A08 = v3 
gen A09 = centro 
gen B01 = .b 
gen B02 = v11 
gen B03 = v6 
gen B04 = .b 
gen C01 = cond(A08==2, .c , .b) 
gen C02 = cond(A08==2, .c , .b) 
gen C03 = .b 
recode C03 (.b=.c) if A08==2 
gen C04 = .b 
recode C04 (.b=.c) if A08==2 
gen D01 = v24 
recode D01 (1=3) (2=1) (3=2) 
gen D02 = v24  
recode D02 (1=3) (2=1) (3=2) 
gen D03 = .b 
gen D04 = (v26*v29)/20   
replace D04 = 0 if D01 == 3 
recode D04 (.=.a) 
gen D05 = v26 
recode D05 (.=0) if D01==3 
recode D05 (.=0) if D02==3 





gen D06 = v29 
recode D06 (.=0) if D01==3 
recode D06 (.=0) if D02==3 
recode D06 (.=.a) 
 
gen E01 = v118 
gen E02 = v124 
gen E03 = .a 
gen E04 = .b 
gen E05 = .b 
gen E06 = .b 
gen F01 = . 
replace F01 =1 if  v120==2 
replace F01 = 1 if  v122==2 
replace F01 =2 if v120 ==1 
replace F01 =2 if v120 ==1 
recode F01 (.=.a) 
egen F02= anyvalue(F01),values(1) 
recode F02 (.=.a) 
gen F03 = .a 
gen G01 = .a 
gen G02 = .a 
gen G03 = .a 
gen H01 = .a 
gen H02 = .a 




*GENERATE NEW STUDY ID* 
*===================================================
============================ 
set seed 22782938 
generate random = runiform() 
 
*CHECK WHETHER UNIQUE* 




sort A02 A08 random, stable 
egen A03 = seq() 
tostring A03, replace 















gen EC010500P = v6 
 
*LIQUID MILK* 






*2. EGG AND EGG PRODUCTS (EC020000)* 
*===================================================
============================ 





*3. MEAT AND MEAT PRODUCTS (EC030000)* 
*===================================================
============================ 
egen EC030000XP =rowtotal(v52  v58) , missing 





*4. FISH AND FISH PRODUCTS (EC040000)* 
*===================================================
============================ 




*8. VEGETABLES (EC080000)* 
*===================================================
============================ 
gen EC080710P = v54 









*9. FRUITS AND FRUIT PRODUCTS (EC090000)* 
*===================================================
============================ 
gen EC090000XP = v56 
 
*10. Bread 
gen EC061030P = v61 








gen EC112002XP = v31 * 7 
gen EC112002XML = EC112002XP * 250 
 
*DECAF COFFEE* 
gen EC112071P = v33 * 7 
gen EC112071ML = EC112071P * 250 
 
egen EC112070P = rowtotal (EC112071P EC112002XP), missing 
egen EC112070ML = rowtotal (EC112071ML EC112002XML), missing 
 
*TEA* 
gen EC112001XP = v35 * 7 
gen EC112001XML = EC112001XP * 250 
 
*COLA* 
gen EC110850P = v37 * 7 
gen EC110850ML = EC110850P * 250 
 
*BEER 
destring beermed , generate (beer) dpcomma force 
gen EC110100P = beer*7 
gen EC110100ML = EC110100P * 360 
 
*WINE 
destring winemed , generate (wine) dpcomma force 
gen EC110300P = wine*7 




destring liqmed , generate (liq) dpcomma force 
gen EC110500P = liq*7 







egen EC110000ML = rowtotal(EC112070ML  EC112001XML  
EC110850ML EC110100ML EC110300ML EC110500ML), missing 
egen EC110000P  = rowtotal(EC112070P  EC112001XP  EC110850P 
EC110100P EC110300P EC110500P), missing 
 
/*label variable A08 "Subject status" 
label define casecontrol 1 "Case (1)" 2 " Control (2)" 3 "Cohort (3)"  
label values A08 casecontrol 
tabstat EC112070ML  EC112001XML  EC110850ML EC110100ML 












order A01 A02 A03 A04 A05 A06 A07 A08 A09 B01 B02 B03 B04 D01 
D02 D03 D04  /// 
D05 D06 E01 E02 E04 E05 E06 F01 F02 F03 G01 G02 G03 H01 H02 
H03 EC* 
 
*RECODING MISSING VALUES FOR CONTINUOUS 
VARIABLES* 
foreach var of varlist EC010500P-EC110500P { 
label values `var' miss 





keep A01 A02 A03 A04 A05 A06 A07 A08 A09 B01 B02 B03 B04 C01 
C02 C03 C04 /// 

















assert inlist(D01, 1,2,3,.a,.b) 
assert inrange(B02, 20, 79) 








foreach var of varlist EC010500P-EC110500P { 
cap: assert inrange(`var', 0, 100) 
local x = `var' 
if _rc di as err "Values for `var' not between 0 and 100.; value is: `x'!"      
} 
 
list D01 if D04==0 & D01==2 
list D01 if D04==0 & D01==1 
list B03 if B03 > 2 
list B03 if B03 < 0 
list D01 if D04 < 0 & D01==3 
list D01 if D04 > 0 & D01==3 
list D01 if D04 == .a 
list D02 if D04 < 0 & D02==3 
list D02 if D04 > 0 & D02==3 
 
recode D02 (2=.a) if A03 == "123_952" 
recode D02 (1=.a) if A03 == "123_390" 
recode D02 (2=.a) if A03 == "123_1254" 
recode D02 (2=.a) if A03 == "123_1643" 
recode D02 (2=.a) if A03 == "123_1693" 
recode D02 (1=.a) if A03 == "123_196" 
recode D02 (1=.a) if A03 == "123_243" 
recode D02 (1=.a) if A03 == "123_245" 
recode D02 (1=.a) if A03 == "123_522" 
list D02 if D04==0 & D02==2 
list D02 if D04==0 & D02==1 
 
recode D04 (0=.a) if A03 == "123_1402" 
recode D04 (0=.a) if A03 == "123_1754" 
recode D04 (0=.a) if A03 == "123_347" 
recode D04 (0=.a) if A03 == "123_645" 









*--Check all missings are either .a or .b and not . 
ds , has(type numeric) 
foreach var of varlist `r(varlist)' { 
//assert `var' !=. 
list `var' if `var' ==. 
  
}  
save "$path/output/pordenone", replace 
exit 
 
 
 
 
 
 
 
 
 
 
 
 
 
